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One challenge in clinical medicine is that of the correct diagnosis of disease. Medical researchers
invest considerable time and effort to improving accurate disease diagnosis and following from
this diagnostic tests are important components in modern medical practice. The receiver oper-
ating characteristic (ROC) is a statistical tool commonly used for describing the discriminatory
accuracy and performance of a diagnostic test. A popular summary index of discriminatory
accuracy is the area under ROC curve (AUC). In the medical research data, scientists are
simultaneously evaluating hundreds of biomarkers. A critical challenge is the combination
of biomarkers into models that give insight into disease. In infectious disease, biomarkers
are often evaluated as well as in the micro organism or virus causing infection, adding more
complexity to the analysis. In addition to providing an improved understanding of factors
associated with infection and disease development, combinations of relevant markers are im-
portant to the diagnosis and treatment of disease. Taken together, this extends the role of, the
statistical analyst and presents many novel and major challenges. This thesis discusses some
of the various strategies and issues in using statistical data analysis to address the diagnosis
problem, of selecting and combining multiple markers to estimate the predictive accuracy of
test results. We also consider different methodologies to address missing data and to improve
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the predictive accuracy in the presence of incomplete data.
The thesis is divided into five parts. The first part is an introduction to the theory behind
the methods that we used in this work. The second part places emphasis on the so called
classic ROC analysis, which is applied to cross sectional data. The main aim of this chap-
ter is to address the problem of how to select and combine multiple markers and evaluate
the appropriateness of certain techniques used in estimating the area under the ROC curve
(AUC). Logistic regression models offer a simple method for combining markers. We applied
resampling methods to adjust for over-fitting associated with model selection. We simulated
several multivariate models to evaluate the performance of the resampling approaches in this
setting. We applied these methods to data collected from a study of tuberculosis immune
reconstitution inflammatory syndrome (TB-IRIS) in Cape Town, South Africa. Baseline levels
of five biomarkers were evaluated and we used this dataset to evaluate whether a combination
of these biomarkers could accurately discriminate between TB-IRIS and non TB-IRIS patients,
by applying AUC analysis and resampling methods.
The third part is concerned with a time dependent ROC analysis with event-time outcome
and comparative analysis of the techniques applied to incomplete covariates. Three different
methods are assessed and investigated, namely mean imputation, nearest neighbor hot deck
imputation and multivariate imputation by chain equations (MICE). These methods were used
together with bootstrap and cross-validation to estimate the time dependent AUC using a
non-parametric approach and a Cox model. We simulated several models to evaluate the
performance of the resampling approaches and imputation methods. We applied the above
methods to a real data set.
The fourth part is concerned with applying more advanced variable selection methods to predict
the survival of patients using time dependent ROC analysis. The least absolute shrinkage and
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selection operator (LASSO) Cox model is applied to estimate the bootstrap cross-validated, 632
and 632+ bootstrap AUCs for TBM/HIV data set from KwaZulu-Natal in South Africa. We
also suggest the use of ridge-Cox regression to estimate the AUC and two level bootstrapping
to estimate the variances for AUC, in addition to evaluating these suggested methods.
The last part of the research is an application study using genetic HIV data from rural
KwaZulu-Natal to evaluate the sequence of ambiguities as a biomarker to predict recent infec-
tion in HIV patients.
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1.1. Motivation, purposes and objectives
One challenge in clinical medicine is that of the correct diagnosis of disease. It is patently
undesirable to declare someone as being infected with a serious disease when in fact the in-
dividual is disease free and likewise undesirable to declare someone as disease-free when in
fact the individual is diseased. Both errors have serious implications to the individual and
the community at large. Medical researchers invest considerable time and efforts to improve
accurate disease diagnosis. The receiver operating characteristic (ROC) is a commonly used
statistical tool for describing the discriminatory accuracy and performance of diagnostic tests
(Pepe [104]). The ROC curve was first used in signal detection theory (Egan [40]; and Green
and Swets [59]). In the late 1980’s, researchers started applying ROC curves methodology
to medical diagnostic test evaluation (Hanley [61], Shapiro [119]). However the use of ROC
curves in Radiology was earlier reported in the 1980s in a paper by Swets and Pickett [132].
In general the ROC analysis has been extended for use in visualizing and analysing the behav-
ior of diagnostic systems (Swets [134]). A receiver operating characteristic (ROC) graph is a
technique for visualizing and ranking classifiers based on their performance. It is a commonly
1
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used statistical tool for describing the discriminatory accuracy of a diagnostic test. In order to
appropriately define the ROC curve in relation to disease diagnosis, one needs to understand
the difference between sensitivity and specificity of a test. Sensitivity is the probability that
the test result is positive given the individual is truly diseased. Specificity is the probability
that the test result is negative given the individual is truly disease free. Suppose the classifica-
tion of a sample from an individual into diseased or disease free depends on a set threshold or
cut-off value of a continuous biomarker. At each of these cut-offs an estimate of the sensitivity
and specificity of the test can be found. The ROC is a plot of sensitivity versus 1−specificity
for different values of the cut-off points of the continuous biomarker.
Combining multiple biomarkers to estimate the area under the ROC curve or the AUC is of
interest in this era of multiple assessments. When we have several biomarkers we can combine
them to obtain better diagnostic accuracy and improve the AUC by maximizing its value over
all possible combinations of the biomarkers (Fang et al. [44]). We are interested in combining,
selecting and evaluating biomarkers to estimate the AUC and predict specified diseases. For
this purpose we use Logistic regression as it is commonly used when the outcome or response of
the presence is binary. A Cox model is also used in case of a time to event outcome or response.
In order to obtain a better AUC we applied feature selection, also known as variable selection,
which is desirable in order to obtain an interpretable prediction rule. This is a technique of
selecting a subset of relevant features for building models and it improves model performance.
Two methods are used, namely stepwise selection and LASSO, the latter being very attractive
as it simultaneously performs variable selection and shrinkage.
In our work, we use resampling procedures which are non-parametric inference methods based
on generating repeated samples drawn from the original sample. They can be implemented
computationally by simulating these new samples.
2
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The Cross-Validation method is a standard tool for estimating prediction error and it is a
specialized resampling procedure for application in model validation problems. It is mainly
used in settings where the goal is prediction and one is interested in estimating how accurately
a predictive model will perform in practice.
In 1979 Efron [37] introduced the bootstrap as a general method for estimating the sampling
distribution of a statistic based on the observed data. This method is also used for assigning
measures of accuracy to statistical estimates. Bootstrapping is accomplished by drawing with
replacement n observations from among the original set of n observations (unlike in the cross-
validation). In addition to that we also use the 632+ bootstrap method which was proposed by
Efron [37] and Efron and Tibshirani [39] in order to reduce the upward bias of the parameter
of the leave-one-out bootstrap method.
Some methodologists have described the problem of missing data as one of the most important
statistical and design problems in research. This is of greater concern when decisions are
to be made about the appropriateness of the care a patient should receive and also when
one is interested in using the predictive model to discriminate subjects as likely to have a
certain characteristic from those who do not. Missing values can severely affect the results
if there is dependence between the outcome and the missing data process, therefore dealing
with missingness in the data becomes necessary. Current available methods in analysing ROC
curves are limited to complete data sets and classical ROC analysis. In the development of
prognostic models the presence of missing data is a frequently encountered problem. Thus we
use the time dependent area under ROC curves to compare different imputation methods.
The main purpose of this thesis is to examine the performance of different resampling methods
with a particular interest to cross-validation and Bootstrap methods to estimate the AUC for
procedures that select and combine biomarkers and also to make inferences. We simulated
3
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several multivariate models to evaluate the performance of the resampling approaches in this
setting. We applied the resampling methods to data collected to study TB-IRIS by the Institute
of Infectious Disease and Molecular Medicine (IIDMM), University of Cape Town, South Africa.
The author was given permission to use the data through Professor Robert Wilkinson the lead
PI in the project. TB-IRIS occurs in 8%−43% of HIV-infected patients receiving TB treatment
after starting antiretroviral therapy (ART) [90, 95]. Baseline levels of five biomarkers were
evaluated and this dataset was used to investigate whether a combination of these markers could
accurately discriminate between IRIS and non-IRIS patients by applying the AUC analysis and
resampling methods.
In addition, we applied time dependent ROC analysis to data collected at GF Jooste Hospital
in Cape Town - a secondary-level hospital. This was done to predict the survival of patients
having meningitis in a high TB/HIV prevalence setting in this era of increasing availability
of ART. The hospital serves high density low income patients: it is a 200-bed public sector
referral hospital that serves adult patients from a community of approximately 1.3 million
people. We use this data set to explain how well the predictor index of combined variables in
TBM/HIV patients can accurately discriminate between the patients that may die during the
first six months and those who may be still alive beyond that time. Moreover we have extended
our discussion to genetic data on HIV drug resistance collected by the Genomics centre of the
University of KwaZulu-Natal.
The thesis objectives can be expressed as follow:
• To provide a solid understanding of the diagnosis of diseases and the use of ROC curves
for this purpose.
• To evaluate whether a combination of biomarkers can accurately discriminate between
4
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two groups of patients - namely diseased and non-diseased subjects and examining the
performances of different methods, with a particular interest in cross-validation and
bootstrap cross-validation, as methods for the estimation of the AUC and its variance.
• To handle missing values in the data and to, compare the different imputation methods in
evaluating different resampling methods and to estimate the time dependent area under
ROC curves.
• To compare resampling methods with respect to predictive power. These methods were
used together with the penalized Cox model using the LASSO method. We proposed
ridge Cox model to estimate time dependent AUC using bootstrap methods. We also
proposed two level bootstrapping techniques to estimate variances and evaluated these
techniques through simulation studies.
• To apply ROC analysis to a genetic data set and to evaluate the effect of genetic ambi-
guities in biomarker detection of recent HIV infection. We then examine which variables
are correlated with recently infected patients.
1.2. Background and related studies on ROC analysis
The history of ROC curves goes back to the Second World War where the methodology was
firstly used in analysing radar signals and later used in signal-detection theory (see Fawcett [47]
or Green and Swets [59]). Since then the usage and applications of ROC curves has spread to
many other fields such as psychophysics, medicine (Hanley [61], Shapiro [119]), epidemiology
(Aoki et al. [8]), radiology (Metz [97]), social sciences and evaluation of machine learning
techniques (Spackman [126]). ROC analysis is a very rich area for research and a large number
of articles have been published in the last two decades.
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The medical decision-making community has extensive literature on the use of ROC graphs
for diagnostic testing (Zou [157]). Swets et al. [135] brought ROC curves to the attention of
the wider public with their Scientific American article.
One of the earliest adopters of ROC graphs in machine learning was Spackman [126], who
demonstrated the value of ROC curves in evaluating and comparing algorithms. Recent years
have seen an increase in the use of ROC graphs in the machine learning community and for
examining the effectiveness of diagnostic markers in distinguishing between diseased (D) and
non-diseased (D) individuals (Greiner et al., [60], Pepe [104], Shapiro [119] and Zhou et al.
[156]). A diagnostic test result can be binary, ordinal or continuous. A binary test result
simply provides the diagnosis as positive or negative. Ordinal and continuous tests provide
measurements (on an ordinal or continuous scale). For instance, blood pressure, as an indicator
of hypertension, serves as an example of a continuous marker. Ordinal markers are widely
used in radiology for examining X−rays, where radiologists provide rankings corresponding to
likelihood of disease.
The area under the ROC curve (AUC) is a popular measure to summarize the ROC curve in
diagnostic testing. It is also used in non-diagnostic testing systems, for example the use of
AUC in clinical trials (Hauck [64]) and in toxicology (Bosch et. al. [48]).
Some experimental studies comparing different accuracy estimation methods have been previ-
ously proposed but most of them were on artificial or small datasets. We now briefly describe
some of these studies:
Dodd and Pepe [32] proposed a new method for making inferences about covariate effects
on the performance of a classifier. The advantage of this approach is that “it can be simply
applied by adapting standard binary regression methods as it requires fewer assumptions than
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existing ROC regression methods”.
Zhang et al., [155] considered clinical trials with two treatments and a non-normally distributed
response variable. The authors mentioned that the semi-parametric area under the ROC curve
(AUC) regression model proposed by Dodd and Pepe [32] can be used. However, because
a logistic regression procedure is used to obtain parameter estimates and a bootstrapping
method is needed for computing parameter standard errors, their method may be cumbersome
to implement. In [155] it is proposed that a set of AUC estimates be used to obtain parameter
estimates and combine DeLong’s method [29] and the delta method for computing parameter
standard errors. Their new method avoids the heavy computation associated with the method
of Dodd and Pepe and hence is easy to implement.
An estimation of the AUC is of interest. The resampling methods, such as Cross-Validation
and Bootstrap can be used for this purpose.
Efron [38] conducted five sampling experiments and compared leave-one-out cross-validation,
several variants of bootstrap and several other methods. The purpose of the experiments was
to investigate some related estimators, which seem to offer considerably improved estimation in
small samples. The results indicated that a leave-one-out cross-validation gives nearly unbiased
estimates of the accuracy, but often with unacceptably high variability, particularly for small
samples and that the 632 bootstrap performed best.
Fang et. al. [44] considered the optimal linear combination that maximises the AUC and
compared the estimation of the AUC associated with the estimated coefficients using cross-
validation, bootstrap and re-substitution methods. The authors recommended the cross-
validation procedure, which works very well as an estimate for the AUC associated with the
estimated coefficients.
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The authors of [152] proposed two easily-implemented algorithms, to find the best linear com-
bination of multiple biomarkers that optimise the partial AUC (pAUC), for given a range of
specificity values. Analysis of synthesized and real datasets shows that the proposed algorithms
achieve larger predictive pAUC values on future observations than existing methods, such as
Su and Lius method [130], logistic regression and others.
1.3. Thesis outlines
In this thesis we are mainly concerned with the ROC curves in the context of biomedical
research diagnostic testing and the computations of the area under the ROC curves (AUC).
The thesis is structured into nine chapters.
Chapter 1, which is the current chapter is an introduction to the thesis, which is itself divided
into three sections. In Sections 1.1 and 1.2 we introduce the purposes of the thesis, the ideas
and background behind the ROC curves analysis. Section 1.3 - the current section - describes
the structure of this thesis.
In Chapter 2 we discuss the concept of Receiver Operating Characteristic (ROC) Curves. This
chapter is divided into eight sections. We first give some important definitions and basic
concepts in Section 2.1. Section 2.2 is mainly concerned with using ROC curves for continuous
tests. In Section 2.3, we introduce four important indices of ROC curves; each is discussed in
a separate subsection. Section 2.4 discusses binormal ROC curves. In Section 2.5, we discuss
ROC curves for ordinal data. The ROC estimation is discussed in Section 2.6 and this is
divided into three subsections. This chapter also briefly discusses the modeling of covariates
effects on test results (Section 2.7) and on ROC curves (Section 2.8).
In Chapter 3, we discuss time dependent ROC curves. Section 3.1 is an extension of classical
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sensitivity and specificity analysis in the context of time dependent ROCs. Section 3.2 explains
time dependent true and false positive fractions. Section 3.3 illustrates the combination of time
dependent true and false positive fractions.
In Chapter 4 we discuss missing values in data sets. Section 4.1 explains the reasons for
missing values and this section is divided into four subsections. In Section 4.2 the imputation
strategies are discussed; these are the mean imputation, nearest neighbor hot deck imputation
and multivariate imputation via chain equation.
In Chapter 5 we start applying the proposed methods using a cross sectional data set. We give
an introduction in the beginning of this chapter (Section 5.1). Section 5.2 discusses variable
selection methods for biomarkers. This section is divided into three subsections. In Section 5.3,
we discuss some of the resampling methods in the context of multiple biomarkers. We divided
this section into ten subsections discussing over-fitting and various resampling methods, while
the last two subsections contain two algorithms to obtain and estimate the AUC through cross-
validation and bootstrapping respectively. The next two sections (5.4 and 5.5) discuss logistic
regression and linear discriminant models respectively. Section 5.6 presents our proposed
algorithm to obtain the AUC. In Section 5.7 we are concerned with simulation studies, while
in Section 5.8 we apply resampling methods to a real dataset that has been collected from a
study of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in Cape Town.
Chapter 6 discusses the problem of combining multiple variables to estimate predictive accu-
racy; however the response variable in this chapter is time dependent. We also introduce the
problem of estimation accuracy in presence of missing values in some variables. This chapter
includes an introduction (Section 6.1), methods to address the missing data problem (Section
6.2), methods for estimating time dependent AUC (Section 6.3) and Section 6.4 discusses the
models that have been used in the analysis. Section 6.5 is an algorithm. Section 6.6 presents
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the simulation studies, followed by an application using real data (Section 6.7) and specific
conclusions to the chapter (Section 6.8).
In Chapter 7 we are mainly interested in predicting the outcome for TBM/HIV dataset from
Cape Town. Section 7.1 is an introduction. Section 7.2 discusses estimation methods for
predictive accuracy using the penalized Cox model, followed by important resampling methods
in Section 7.3. Section 7.4 is an algorithm. Section 7.5 presents the simulation studies, followed
by an application to TBM in Section 7.6 and a conclusion (Section 7.7).
Chapter 8 evaluates proportion of ambiguities as a biomarker to predict recent HIV infection
in rural KwaZulu- Natal, South Africa. This chapter includes three sections, where Section 8.1
is an introduction, Section 8.2 introduces the HIV data with genetic information and discusses
the methods used and in Section 8.3 we give key results and a discussion.
Finally, Chapter 9 is a conclusion to the thesis where also suggest some future work that can
be done as an extension to the current work.
We would like to mention that key publications out of this thesis are under review and prepa-
ration. These are:
1. M. B. Elshareef, L. Dodd and H. G. Mwambi, Combining multiple biomarkers in di-
agnostic testing with an application to TB disease data from Cape Town, submitted to
African Health Sciences.
2. M. B. Elshareef and H. G. Mwambi, Predictive accuracy of multiple time dependent
biomarkers with missing values in diagnostic testing, submitted to Pakistan Journal of
Statistics.
3. M. B. Elshareef and H. G. Mwambi, The role of ambiguous nucleotides as biomarkers of
10
Chapter 1 – Introduction
recent HIV infection in rural KwaZulu-Natal, South Africa, to be submitted.
4. M. B. Elshareef and H. G. Mwambi, Use of resampling methods to predict the outcome in
tuberculous meningitis in a high HIV prevalence patients in South Africa, to be submitted.
5. M. B. Elshareef and H. G. Mwambi, Classic and time dependent AUC estimations: A





We would like to mention that in most of the work on this chapter we follow mainly the book
of Pepe [104] supplemented with our own understanding of the problem.
2.1. Definitions and basic concepts
In this section we present some of the basic and important definitions and concepts that will
be required throughout this thesis.
If a subject is classified as diseased or non-diseased and a test result as positive or negative, -
indicating the presence or absence of the disease, - then there are four possible test result-true
status outcome combinations. These are
• when the test reports a positive result for a person who actually has the disease. We
refer to this result as a true positive (TP),
• when the test reports a negative result for a person who actually is disease-free. We refer
to this result as a true negative (TN),
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• when the test reports a positive result for a person who is disease-free. We refer to this
result as a false positive (FP),
• when the test reports a negative result for a person who actually has the disease. We
refer to this result as a false negative (FN).
When a single test is performed, the person may in fact have the disease (D = 1) or the person
may be disease-free (D = 0). The test result may be positive (Y = 1), indicating the presence
of disease, or the test result may be negative (Y = 0), indicating the absence of the disease.
Using these actual disease status and test results variables, the previous four test result-true
status combinations can be summarized in the following table.
D = 1 D = 0
Y = 1 True Positives (TP) False Positives (FP)
Y = 0 False Negatives (FN) True Negatives (TN)








Definition 2.1.1. The sensitivity (true positive fraction TPF ) is defined to be the proba-
bility that a test result will be positive when the disease is present in the individual, while the
specificity (true negative fraction TNF ) is defined to be the probability that a test result will
be negative when the disease is not present.
In probability notation the sensitivity and specificity are written respectively as
TPF = P (Y = 1|D = 1) = TP/(TP + FN) and (2.1)
TNF = P (Y = 0|D = 0) = TN/(TN + FP ). (2.2)
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Sensitivity and specificity describe how well the test discriminates between patients with and
without disease. In fact we are also interested in the probability of disease, given a positive
test result and likewise the probability of no disease given a negative test result. This leads to
two predictive values of the test formally defined below.
Definition 2.1.2. The positive predictive value, PPV, is defined as the probability that
disease is present when the test is positive, while the negative predictive value NPV is
defined as the probability that disease is not present when the test is negative.
In probability notation, the PPV and NPV are written respectively as
PPV = P (D = 1|Y = 1) = TP/(TP + FP ) and
NPV = P (D = 0|Y = 0) = TN/(TN + FN).
Definition 2.1.3. The likelihood ratio, LR, is the probability of a given test result among
people with the disease divided by the probability of that the test result among people without
the disease.
In probability notation the LR is written as P (Y = a|D = 1)/P (Y = a|D = 0), where a = 0
or 1 in the case of a binary test result.
Definition 2.1.4. The positive likelihood ratio, LR+, is defined to be the ratio between
the probability of a positive test result given the presence of the disease and the probability of
a positive test result given the absence of the disease, while the negative likelihood ratio,
LR−, is defined to be the ratio between the probability of a negative test result given the presence
of the disease and the probability of a negative test result given the absence of the disease.
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In probability notation the LR+ and LR− are written respectively as
LR+ = P (Y = 1|D = 1)/P (Y = 1|D = 0) and
LR− = P (Y = 0|D = 1)/P (Y = 0|D = 0).








2.2. Introduction to receiver operator characteristic curve (ROC) for continuous
tests
Definition of ROC Curves
A continuous test means a test based on a continuous test variable or biomarker as a measure
of presence of disease. For a threshold c, a binary test from the continuous test result Y is
said to be positive if Y ≥ c and negative if Y < c. The corresponding true and false positive
fractions, at threshold c, are defined to be
TPF (c) = P [Y ≥ c|D = 1], (2.3)
FPF (c) = P [Y ≥ c|D = 0], (2.4)
respectively.
Definition 2.2.1. The ROC curve based on a continuous is the set of all possible true and
false positive fractions for Y for all c. That is to say
ROC(.) = {(FPF (c), TPF (c))| c ∈ R}. (2.5)
The ROC curve shows the trade-off between specificity and sensitivity as the threshold for
determining positivity varies.
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Remark 2.2.1. Note that as c increases, both FPF (c) and TPF (c) decrease, while if c
decrease, then both FPF (c) and TPF (c) increase. In the special cases of c −→ ∞, then
limc−→∞FPF (c) = limc−→∞ TPF (c) = 0 and if c −→ −∞, then limc−→−∞ FPF (c) =
limc−→−∞ TPF (c) = 1. Thus the ROC curve is a monotone increasing function in (0, 1)×(0, 1)
(see Figure 4.1 of Pepe [104] and Figure 2.1 below).
The ROC curve can also be written in the form (see Pepe [104]):
ROC(.) = {(t, ROC(t))| t ∈ (0, 1)}, (2.6)
where t 7→ TPF (c), thus this defines the ROC function and c is the corresponding threshold
given by the solution to FPF (c) = t.
Figure 2.1: A sketch of a ROC curve
2.2.1 Properties and attributes of ROC curves
A test result is said to be perfect if TPF (c) = 1 and FPF (c) = 0 for some threshold c.
Graphically, the diagnostic accuracy increases as its ROC curve approaches the left upper
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corner as shown in Figure 2.2.
On the other hand an uninformative test result is defined to be the test that does not separate
between diseased and non-diseased subjects. That is TPF (c) = FPF (c), ∀c. Graphically the
ROC curve of a uninformative test result is a straight line with slope 1 (i.e., the straight line
joining the points (0, 0) and (1, 1) and the area under such curve is 0.5.
Figure 2.2: ROC curves for perfect, uninformative and two tests A and B. Test A is better
than B
In the following proposition we quote some important results from Pepe [104].
Proposition 2.2.1. (i) The ROC curve is invariant to strictly increasing transformations of
Y,
(ii) if SD and SD denote the survivor function for Y in diseased and non-diseased populations,
where SD(y) = P [Y ≥ y| D = 1] and SD(y) = P [Y ≥ y| D = 0], then the ROC curve
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(t)), t ∈ (0, 1), (2.7)
(iii) with LR being the likelihood ratio, the optimal criterion based on Y for classifying sub-
jects as positive for disease is LR(Y ) > c, in the sense that it achieves the highest
true positive fraction among all possible criteria based on Y with false positive fractions
t = P (LR(Y ) > c|D = 0).
Proof . We only show (ii). For other statements see Results 4.1, and 4.4 of Pepe [104]. Now
to show Equation (2.7), let c = S−1
D
(t), that is the corresponding FPF = t. Thus we have
P [Y ≥ c| D = 0] = t. The corresponding TPF is P [Y ≥ c| D = 1] = SD(c). Therefore the





We conclude this section by listing some of the important attributes of the ROC curves. These
attributes have been listed in Table 4.1 of Pepe [104] and in Fawcett [47]. In summary the
ROC curve:
• Provides a tool for describing the test across a range of values and it is useful in early
evaluation of tests when specific thresholds are unknown.
• Can be a useful guide for choosing thresholds in real applications.
• Is a useful mechanism for comparison between different non-binary tests, as it is scale
invariant.
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2.3. Some of ROC curves indices
In this section we briefly go over some of the ROC indices, which provide important information
about the ROC curves. Many indices have been developed in the literature and are used in
various applications, for example see Shapiro [119], Greiner et al., [60], Zhou et al., [156] and
Pepe [104].
2.3.1 Area under ROC curves (AUC)
While the ROC curve contains most of the information about the accuracy of a continuous
marker, we may want to reduce ROC performance to a single statistic representing expected
performance. The most commonly used global index is the area under the ROC curve (AUC).





We note from Equation (2.8) that the AUC is a portion of the area of the unit square. Hence
its value is always bounded between 0 and 1. Values of AUC close to 1 indicate that the
marker has high diagnostic accuracy and a test is called perfect if its AUC = 1, while a test
is called an uninformative if its AUC = 0.5. AUCs less than 0.5 may suggest the scale needs
transformation so that increasing values indicate increasing likelihood of disease.
Definition 2.3.1. Let A and B be two tests. We say that A is better than B if
ROCA(t) ≥ ROCB(t), ∀ t ∈ (0, 1).
Proposition 2.3.1. Let A and B be two tests such that A is better than B. Then
AUCA ≥ AUCB.
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Remark 2.3.1. The converse of Proposition 2.3.1 is not necessarily true. For example it may
be the case that for some number k ∈ (0, 1), we have
ROCA(t) ≥ ROCB(t), ∀ t ∈ (0, k] and ROCB(t) ≥ ROCA(t), ∀ t ∈ [k, 1).
Thus ∀ t ∈ (0, k] test A is better than B and ∀ t ∈ [k, 1) test B is better than A
The AUC has an interesting statistical interpretation (Bamber [13], Hanley and McNeil [61],
Pepe [104]). It is equal to the probability that a test result chosen randomly from diseased
subjects is greater than a test result chosen randomly from non-diseased subjects. In general
AUC = P (YD > YD) +
1
2
P (YD = YD).
For a continuous test we have P (YD = YD) = 0. Thus the AUC for a continuous test will have
the form
AUC = P (YD > YD).






















P (YD > y, YD = y)dy
= P (YD > YD)
by change of variable from t to y = S−1
D
(t), where fD denotes the probability density function
of YD and independence of YD and YD, we can write the AUC in the form above.
The interpretation of AUC as probability of correctly ordering the diseased and non-diseased
subjects is an interesting result but it does not provide the best interpretation of this important
20
Chapter 2 – Receiver operating characteristic (ROC) curves
measure. We thus can regard the AUC as an average of TPF, averaged uniformly over the
whole range of FPF in (0, 1). Dodd [30] suggested the use of a weighted average approach,
weighting certain parts of FPF domain more than others.
2.3.2 The ROC(t0)
If we are interested in a specific FPF value say t0, then the corresponding TPF value ROC(t0)
provides a relevant summary index.
We can interpret ROC(t0) as a proportion of diseased subjects that have test results greater
than 1−t0 quantile for non-diseased observations. If t0 is small then the ROC(t0) is interpreted
as the proportion of diseased subjects with test result values above the normal range.
One of the restrictions of ROC(t0) is that it does not give all the information as the ROC(t).
For two tests A and B such that ROCA(t0) = ROCB(t0), if ROCA(t) ≥ ROCB(t) for any
t ∈ (0, t0), then it is obviously that test A is better than test B with regard to the overall
performance.
2.3.3 Partial AUC





It is a measure concerned with the values of FPF ∈ (0, t0) and it uses all points on (ROC(0),
ROC(t0)). A lower bound for pAUC is
t20
2
and this happens when the test is uninformative
(TPF (c) = FPF (c) for all thresholds c). An upper bound for pAUC is t0 and this happens
when the test is perfect.
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The normalised value of pAUC is defined to be pAUC(t0)/t0 and it clearly ranges from t0/2 to








That is to say it is the probability of correctly ordering a diseased and non-diseased observation
selected randomly given that the non-diseased observation is above 1− t0 quantile of the non
diseased distribution.
A more general formula for Equation (2.9) has been given in Dodd and Pepe [31].
2.3.4 Kolmogorov-Smirnov (KS) index
The maximum vertical distance between the ROC curve and TPF = FPF is an index we
refer to as the KS index. We have
KS = maxt|ROC(t)− t| = maxt|SD(S−1D (t))− t| = supc∈(−∞,∞)|SD(c)− SD(c)|.
We can see that this is exactly the Kolmogorov-Smirnov measure, which measures the dis-
tance between two distributions with survival functions SD and SD for two tests YD and YD
respectively (Gail and Green [52]). In fact we identify the index KS with Kolmogorov-Smirnov
measure.
Another well-known measure is the Youden index, which is a special case of Kolmogorov-
Smirnov measure. For more information on this index, refer to Fluss [49].
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2.4. Binormal ROC curves
The binormal ROC curve plays a major role in ROC analysis and it provides the classic model
for ROC curves. Its form is derived from normal distributions for test results. To derive the
functional form of binormal ROC curves, suppose that the test results are normally distributed
in diseased and non-diseased populations.
Proposition 2.4.1. Suppose that YD ∼ N(µD, σ2D) and YD ∼ N(µD, σ2D). Then







and Φ denotes the standard normal cumulative distribution
function.
Proof . Let c be any threshold. Then because of the symmetric nature of the normal distri-
bution we have












For FPF we can see that c = µD − σDΦ−1(t). Thus














and this completes the proof. 
Thus the binormal ROC curve is defined to be ROC(t) = Φ(a + bΦ−1(t)). The coefficients a
and b are referred to as the intercept and the slope of the binormal ROC curve respectively.
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Remark 2.4.1. Note that the slope of the ROC curve at t is the likelihood ratio at the
corresponding threshold c.
Now
• if b = 1, then the binormal ROC curve is concave everywhere,
• if b > 1, then the likelihood ratio decreases and then increases,
• if b < 1, then the likelihood ratio increases and then decreases, for t ∈ (0, 1).
Thus b 6= 1 leads to ill behaved ROC curve. Therefore the fact that the binormal ROC
curve may not have the monotone likelihood ratio raises some concern about using it for
approximation of real data. However Swets [133] and Hanley [62] and [63] showed that a
binormal ROC curve is a good approximation in practice.
We have seen in Proposition 2.2.1 that the ROC curve is invariant to monotone increasing data
transformations. Therefore if YD and YD have normal probability distributions and if we let
WD = h(YD) and WD = h(YD), where h(.) is a monotone strictly increasing function, then the
ROC curve for WD and WD is a binormal curve given by ROC(t) = Φ(a+bΦ
−1(t)). Conversely,
to say that the ROC curve for YD and YD is binormal simple means that for some strictly
increasing transformation h(.), the functions h(YD) and h(YD) have normal distributions (see
Pepe [104]).
Although the binormal form is the classic parametric form for ROC curves, other parametric
forms can be adopted. Any parametric form adopted can be fitted using ordinal data likelihood
methods. Usually the AUC summary indices are used as the basis for comparing binormal ROC
curves. The standard error of the difference is calculated using the delta method and alternative
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summary indices can likewise be used. Metz [97] suggested that instead of comparing summary
indices, the fitted ROC parameters can instead be compared.
We conclude by mentioning that the binormal assumption states that some monotone trans-
formation of the data exists to make YD and YD normally distributed and this can be taken
as a weak assumption.






Proof . Recall that AUC = P (YD > YD) = P (YD − YD > 0). Let W = YD − YD then
W ∼ N(µD − µD, σ2D + σ2D) and



























which completes the proof. 
Robustness of the binormal estimator
The choice of the binormal estimator to fit a ROC curve is usually justified by theoretical
considerations, mathematical tractability, familiarity with the normal model or just by conve-
nience.
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The word robust can have many different meanings. Here it is used in the sense of robust
statistics, i.e. meaning that in the presence of a certain amount of observations coming from
a non-normal distribution the binormal estimator will yield reliable results. Robustness, in
Swets [135] and Hanley [63], is understood as the ability of the binormal estimator to fit a
ROC curve that looks right in comparison either with the theoretical ROC curve or with the
observed rating method.
2.5. The ROC for ordinal tests
2.5.1 Ordered discrete tests results
Although many of test results are continuous, some tests yield discrete results. For example the
minimal inhibitory concentration of an antibiotic as standard measure of bacterial residence
is measured on a continuous scale, but some questionnaire reporting systems may also yield
discrete numeric results. However it should be noted that many tests are not numeric at all, for
example in the assessment of an image by a radiologist. In this case the radiologist assessment
that the disease is present is classified on an ordinal scale.
The key difference between qualitative assessments that are measured on ordinal scales and
quantitative assessments made on numeric scales is the recognition that different assessors can
use the ordinal scale differently. For example an image considered as highly suspicious for
cancer by one radiologist may be considered as possibly malignant by another even though
both have the same perception of the image. ROC analysis has been very popular for use
with rating data as it helps to disentangle the inherent discriminatory capacity of the test or
imaging device from the particular use of the scale by the assessor [104].
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2.5.2 The latent decision variable model
Suppose that there is an unobserved latent continuous variable L corresponding to the assessor’s
perception of the image. The reader or assessor has some thresholds values that correspond
to his/her classification or rating of the image. If Y denotes the reported classification, then:
cy−1 < L < cy, y = 1, · · · , P, where c0 = −∞ and cP = ∞ which yields a P -level ordinal
variable. The reader classifies the image in the yth category if L falls within the interval
corresponding to his/her implicit definition for the yth category in terms of the latent variable
L. Different raters might perceive an image in the same way but classify it differently because
their implicit decision thresholds may be different. The ROC curve for L can be defined as
follows: If Y ≥ y and L > cy−1 then we can denote the true and false positive fractions as
TPF (cy−1) and FPF (cy−1) respectively. Then the ROC curve in terms of L can be identified
for the P + 1 points and represented as follows: (FPF (cy−1), TPF (cy−1)), y = 1, · · · , P + 1.
The latent variable framework with decision thresholds that give rise to observed test results,
is an appealing conceptual model. However strictly speaking the latent variable does not have
an explicit clinical meaning and thus the interpretations of the ROC curve for L are somewhat
dubious. Also, the available set of points for the ROC curve are only the set of discrete
observable points and thus the curve is not fully identifiable.
2.5.3 The discrete ROC curve
One popular approach to ROC analysis for ordinal data is to simply define the ROC curve as
a discrete function. This alternative curve is defined as
ROC = (ty, ROC(ty)), y = 1, 2, · · · , P + 1. (2.11)
27
Chapter 2 – Receiver operating characteristic (ROC) curves
In Equation (2.11), ty = P [Y ≥ y|D = 0] and ROC(ty) = P [Y ≥ y|D = 1]. The first cutoff
point or threshold at y = 1 is the corner point (0, 0) while the threshold at y = P + 1 is the
(1,1) corner point. This difference between this definition and the one for continuous results
is that the set of possible false positive fractions (domain) is finite. One of the binormal form
with discrete domain T = {ty| y = 1, 2, · · · , P + 1} that can be used for discrete ROC function
is given by
ROC(ty) = Φ(a+ bΦ
−1(ty)), y = 1, 2, · · · , P + 1. (2.12)
The ROC curve for a discrete decision variable is not like the one for continuous decision
variable. It serves more as a visual aid to depict an ROC function associated with the discrete
observed decision variable Y . Moreover the discrete domain is required together with the
parameters a, b to completely characterise the discrete ROC function. A very important point
about discrete ROC functions is that two ROC functions differ if their domains differ, even if
their points lie on the same smooth curve. The discrete ROC analysis requires, in addition
to the trade-off between true and false positive fractions, consideration of the FPFs that are
attainable with the test. This is different from continuous tests as all FPFs in the range (0, 1)
are attainable.
For the discrete ROC functions the summary measure cannot be applied directly. A summary
of the discrete ROC curve can be calculated by joining the points and then calculating the area
relative to the resulting curve, but they are difficult to interpret. When the linearity is used for
joining points, the area under that curve has an interesting interpretation of the probability
of correctly ordering diseased and non-diseased observation. Thus formally the area under the
ROC function based on linear interpolation between points (AUC) is:
AUC = P [YD > YD] +
1
2
P [YD = YD]. (2.13)
When case and control values are tied, the ROC curve has simultaneous horizontal and vertical
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jumps and thus the AUC can be calculated as an averages of tie-corrected percentile values.
The second part of the RHS of the above equation represents a situation of indistinguishable
of diseased and non-diseased cases as a result of discretisation.
Finally we would like to conclude this section by mentioning that the ROC curve is the most
popular tool for describing the accuracy of a continuous or ordinal valued tests. The ROC curve
has been popular for a long time in radiology research, in addition to the fact that it provides a
description of separation between distributions and is still very useful in clinical trials research.
The binormal ROC curve described before in Section 2.4 is the classic parametric model, but
one of the weakness of the model is that in some applications it may not be concave.
2.6. The ROC curve estimation
This section introduces the statistical methodology for making inference about the ROC curve
from data. We describe three approaches for estimating the ROC curve and its summary
indices [104]. The first method is based on applying non-parametric empirical methods to
the data to obtain the empirical ROC curve from which the empirical summary measures can
be calculated especially for continuous test results. The second approach is by modeling the
distributions of YD and YD, after which the parameters in these distribution are estimated and
then the induced ROC curve is calculated. However this approach requires strong assumptions
about the form of the distributions of test results which make it less popular. The ROC curve
is concerned only with the relationship between the distributions of YD and YD. The third
approach is to use a smooth parametric function of the ROC curve rather than modeling the
distributions (second approach). The parameters of the third approach are estimated from the
rankings of the test results for diseased and non-diseased subjects.
We assume that the data can be presented as test results for nD cases and nD controls as
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follows: YDi , i = 1, · · · , nD and YDj , j = 1, · · · , nD. We assume that YDi and YDj are se-
lected randomly from the populations of test results associated with diseased and non-diseased
outcomes, respectively.
2.6.1 Non-parametric empirical estimator
The aim is to apply non-parametric empirical methods to the data to obtain an empirical ROC
curve, which is a popular choice for continuous tests results settings. The empirical estimator
of the ROC curve simply applies the definition of the ROC curve to the observed data. For








I[YDj ≥ c]/nD, (2.15)
where I(A) is a function which takes value 1 when A is true and 0 otherwise. Then it follows





where ŜD and ŜD are the empirical survivor functions for YD and YD, respectively. The
empirical ROC curve is a function based only on the rank of the data. That is it depends
on the relative ordering of the test results and their status as being from diseased and non-
diseased individuals. Therefore the empirical ROC curve is invariant to strictly increasing
transformations of the data. That is if YD > YD, then h(YD) > h(YD), where h(Y ) is the
increasing transformation of Y .
The empirical AUC given by
∫ 1
0 R̂OCe(t)dt, can be considered as a Mann-Whitney U-statistic
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[I[YDi > YDj ] +
1
2
I[YDi = YDj ]/nDnD]. (2.17)
Following Pepe and Cai [105], the ROC curve can be interpreted as a cumulative distribution
function for the discriminatory measure Y in the affected population (D = 1) after Y has
been standardised to the distribution in the reference population (D = 0). The standardised
values are called placement values. Using the distribution of YD as the reference distribution
the placement for y in the diseased population is defined as P [YD ≥ y] = SD(y) and then the
empirical placement value is given by ŜD(y). We can also write ÂUCe as the sample average







The variance of a summary measure such as R̂OCe is often complicated and in practice boot-
strapping is used to calculate confidence intervals.
Delong et al. [29] proposed an expression for var(ÂUCe) in terms of the variability of placement
values. This method provides a nice computational algorithm for estimating the variance of

















The variance is directly a function of the variability in the placement values of diseased obser-
vations within the non-diseased reference and of non-diseased observations within the reference
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An asymmetric confidence interval that guarantees an interval in (0, 1) is preferred. Thus we
can use a logistic transformation to compute the confidence interval for logit AUC (log(AUC/(1













An alternative representation of the asymptotic variance was derived by Hanley and McNeil
[61]. Assume that there are no ties between diseased and non-diseased observations, so that




i=1 I[YDi ≥ YDj ]/nDnD. Then the variance of the








Q1 = P [YDi ≥ YDj , YDi′ ≥ YDj ],
Q2 = P [YDi ≥ YDj , YDi ≥ YDj′ ],
(YDi , YDi′ ) and (YDj , YDj′
) denote random pairs of observations from the diseased and non-
diseased populations, respectively. Observe that empirical estimates of each component are
easily calculated to yield a variance estimator.
The empirical methods can be used for continuous or ordinal test results data. The methods
that rely on the ROC curve being defined as curves with domain on the interval (0, 1) and
therefore apply only to ROC curves for continuous tests.
The most commonly used statistic for comparing two ROC curves when test results are con-
tinuous is based on the difference in empirical AUC estimates. We denote the two curves by
ROCA and ROCB, then the estimated difference is given by,
∆ÂUCe = ÂUCAe − ÂUCBe.
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The null hypothesis H0 : ROCA = ROCB is tested by comparing the value of
∆ÂUCe√
var(∆ÂUCe)
with standard normal distribution tails values. If data for the two ROC curve estimates are
derived from independent samples, then
var(∆ÂUCe) = var(ÂUCAe) + var(ÂUCBe).
Other summary indices, estimated empirically can likewise be used as the basis for a non-
parametric comparison of ROC curves, with resampling methods employed for formal statistical
inference.
We can also use empirical methods to estimate discrete ROC functions for tests with ordinal
results. The R̂OCe is defined as in previous section except that linear interpolation between
estimated ROC points ( ˆFPF (y), ˆTPF (y)), y = 1, · · · , P is not performed. In finite samples
one will not know what false positive fractions are attainable with a discrete test. Hence fixing
t and making inferences about ROC(t) is not feasible in the same way that it is for continuous
test.
For discrete data, the empirical AUC index is usually calculated using a linear interpolation
between ROC points and the trapezoidal rule. Although, it is not interpreted as an area under
the curve because the ROC for an ordinal test is a discrete function not a curve. The AUC as
a summary index for the discrete ROC function is identical to the Mann-Whitney U-statistic
and its interpretation as the probability P [YD ≥ YD].
Similarly, comparisons between AUCs can be made as before, however it is not always sensible
to compare AUCs with two discrete ROC functions. Differences between two AUCs may exist
that are simply caused by the fact that their domains are different. Empirical methods can be
used for continuous or ordinal test result data.
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2.6.2 Modeling test results
Fully parametric modeling
The ROC(t) can be estimated through constituent distribution functions parametrically and
to calculate the induced ROC curve estimate. The fully parametric method makes strong
assumptions about the forms of the distributions, SD and SD. Suppose that we model each










The standard error for R̂OC(t) can be calculated using the variance of (α̂, γ̂) and delta method.
The ROC estimate will be fully efficient assuming that the models are correctly specified and
the parameters are estimated with maximum likelihood methods.
Comparing ROC curves in this framework is not easy because one cannot simply compare
parameters. The same ROC curve can result from different pairs of constituent test result
distributions. Comparing parameters of the distributions αA and αB and γA and γB for two
curves indexed by A and B does not achieve a comparison of ROC curves. Wieand [150]
evaluated the comparison of two ROC curves, with the difference in AUC indices estimated
with fully parametric normal models and this approach was compared with that based on the
non-parametric ∆ÂUCe. The parametric model is more efficient as expected.
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Semiparametric models
For the test results YDi and YDj , the semiparametric location scale model for independent
errors can be given by:
YDi = µD + σDεi ,
YDj = µD + σDεj ,
where ε are independent errors, mean = 0 and variance = 1 random variables with survivor
function S0. Pepe [104] suggested to leave S0 unspecified.

































The form of the function S0(.) is not specified, thus this model is semiparametric.
In [104], Pepe mentioned that the idea of modeling test results in order to estimate the ROC
curve is somewhat unnatural. The ROC curve is invariant to monotone increasing trans-
formations of the test results measurement. However the parametric and semi parametric
methods that model the test results in order to estimate the ROC are not invariant to such
data transformations. They are not distribution free in the sense that the ROC curve relies
on the distributional forms for both SD and SD, not just on their relationship or separation.
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Modeling the test results can be restated as modeling the quantiles of SD and SD. The main
advantages of this approach of modeling test results over the empirical methods are firstly, the
ROC curves are smoother and secondly, there is potential for increased statistical efficiency.
2.6.3 Parametric methods
We discussed non-parametric methods for making statistical inferences (see Subsection 2.6.1)
and then discussed an approach that modeled the distributions of test results in order to
estimate ROC curve in Subsection 2.6.2. We now discuss strategies that are intermediate
between these two methods [104].
The first approach is suggested by Metz et al. [97] in which the authors described a parametric
distribution free which is an extension of the one for ordinal data. One way to deal with
continuous data is to categorize them into a finite number of predefined categories and to
apply methods for fitting parametric ROC curves to ordinal data. Note that the ordinal
data methods only make assumptions about the parametric form for the ROC curve. No
assumptions are made about the survivor function SD for the discrete test result YD.
Another rank based estimator is suggested by Pepe [104]. She parameterised the form of the
ROC curve without making additional assumptions about the distributions of test results. This
approach produces smooth parametric ROC curves but does not require that the test result
distributions be modeled, rather they are based only on the ranks of the data. We previously
defined the ROC as:
ROC(t) = P [Y D > S−1
D
(t)]
= P [SD(YD) ≤ t].
Writing Uit = I[SD(YDi) ≤ t], the binary variable denoting whether or not the placement value
36
Chapter 2 – Receiver operating characteristic (ROC) curves
exceeds t we see that:
E(Uit) = P [SD(YD) ≤ t]
= ROC(t)





where g is a link function and h = h1, · · · , hS are specified functions. As a special case
the binormal model is specified when g = Φ−1, h1(t) = 1 and h2(t) = Φ
−1(t). The ROC
model in Equation (2.27) defines a generalised linear model for Uit with link function g and
covariates hs(t), s = 1, · · · , S. The ROC-GLM approach is designed to use procedures for
fitting generalised linear models to binary data in order to estimate the parameters αs, s =
1, 2, · · · , S. For a set T = t ∈ T over which the model is to be fitted the empirical placement
values ŜD(YDi )
, i = 1, · · · , nD are calculated. For each t ∈ T the binary indicators based on the
empirical placement values:
Ûit = I[ŜD(YDi) ≤ t],
for i = 1, · · · , nD. Binary regression methods with link function g and covariates h(t) =
h1(t), · · · , hS(t) provide estimates of α1, · · · , αS from the data arranged as nD × nT where nT
is the number of points in T
Ûit, h1(t), · · · , hS(t), t ∈ T, i = 1, · · · , nD.
The ROC-GLM procedure is based only on the ranks of the data and requires a model only
for the ROC curve, not for the distributions of the test results. Hence it is a parametric rank
based distribution free method. Pepe investigated the efficiency of ROC-GLM for estimating
a binormal ROC curve with ordinal data. She found that its performance was close to the
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method proposed by Dorfman [33]. The main advantage of ROC-GLM over the Dorfman [33]
method is that it is easier and faster computationally when data are continuous.
The ROC-GLM method provides estimates of parameters and an estimate of variance co-
variance matrix via resampling. Pointwise confidence intervals for ROC(t) can therefore be
constructed. Models can be fitted simultaneously for multiple curves and hypothesis tests for
parameter estimates can also be done.
Now we conclude this section by mentioning that [104]:
• Three approaches are described: empirical methods, distribution free parametric methods
and distributional modeling methods.
• The empirical and distribution free methods are based only on the ranks of data while
the latter is not.
• The distinction between the empirical and distribution free methods is that the the former
places no structure on the ROC curve while the later assume a parametric form for it.
• To compare two ROC curve when parametric form is assumed then the comparison can
be based on the estimated parameters and their standard errors.
• To traditionally compare two ROC curves, differences in AUCs are typically calculated
using the empirical or parametric distribution free methods.
2.7. Modeling covariate effects on test results
The first approach for evaluating covariate effects on the ROC curve was proposed by Tosteson
and Begg [141]. Their development was geared specifically towards ordinal data but it actually
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applies more generally. The basic idea is to model SD,Z in addition to SD,Z and then calcu-
late the induced covariate specific ROC curve, ROCZ(t) = SD,Z(S
−1
D,Z
(t)) for any particular
covariate values Z of interest. A comprehensive model that includes both YD and YD in one
model by incorporating disease status as a covariate can be fitted.
The strategy of modeling the test results distributions and calculating induced ROC curves is
the longest established approach for evaluating covariate effects on the ROC. It is popular in
part because distributional modelling is a familiar task for statisticians. However it does not
yield simple ways of summarizing covariate effects on the ROC curve.
2.8. Modeling covariate effects on ROC curve
We can model the covariate effects on ROC curves directly by modeling the ROC curve itself.
There are several advantages to direct modeling of the ROC approach.
• The interpretation of model parameters pertains directly to the ROC curves.
• Multiple tests can be accommodated simultaneously.
• It provides a mechanism for comparing two tests even when their results are quantified
in different units.
A ROC regression model to quantify covariate effects on the ROC curves has two components.
These are the covariables X and secondly a formulation for the ROC curve as a function of t.
Let h0(.) and g(.) denote monotone increasing functions on (0, 1) then the equation
g(ROCZ(t)) = h0(t) + βX,
with t ∈ TZ ⊂ (0, 1) is an ROC-GLM regression model. The link function g is specified as
part of the model and the baseline function h0(t) is unknown. A parametric form for it can be
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specified or it can remain completely unspecified.
The restriction on h0 and on g are meant to ensure that ROCZ(t) is an ROC curve in the
sense that the domain and range are in (0, 1) and that it is increasing in t. However the model
need not be defined for the entire interval t ∈ (0, 1) but possibly only on a proper or “concave”
subset [40] and that the subset can vary with Z. Thus these models are applicable to ordinal




Time dependent receiver operating
characteristic curves
In this chapter we will discuss time dependent ROC curves. In event-time analysis both time
to event and the binary outcome are observed. Assuming the event occurs, (Y = 1) then
the time to event is uncensored whereas if an individual is followed up and the event did not
occur (Y = 0) then the time to the event is censored. Event-time analysis is used to describe
data that correspond to the time from a time origin until the occurrence of the specified event
or end point. For example the time origin in medical research will often correspond to the
recruitment of an individual into an experimental study, the end point may be the death of
the patient, relief of pain and so on.
Event-time often refer to the development of a particular symptom or to relapse after remission
of a disease, as well as to the time to death. A significant and important feature of event-
time analysis studies is that the event of interest is very rarely observed in all subjects. Such
event-times are termed censored, to indicate that the period of observation was cut off before
the event of interest occurred. As an example suppose that in clinical trial, a patient moves
to another part of the country and can no longer be traced. In this case the time when the
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individual experiences the event will not be known hence the time to event will be censored
for such an individual.
The purpose of the ROC analysis is to characterise the prognostic potential of a marker (or
model) by focusing on the correct classification rates. The ROC can be extended to time
dependent ROC curves when we have time to event data.
The classical ROC curve deals with dichotomous diagnostic tasks (presence or absence of
disease at a given time), we call this a cross sectional data type. In the real world we often
deal with disease outcomes that depend on time and in this case the ROC curve will be a
function of time. In time to event studies, the end point is subject to censoring and ignoring
censoring will introduce bias. There are many existing proposed methods that accommodate
censored data, which we will discuss later in this chapter (Section 3.3).
Time dependent ROC curves entail extending the concepts of sensitivity and specificity to
time dependent binary variables such as vital status, allowing characterisation of diagnostic
accuracy for censored event-time outcomes.
For test results defined on continuous scales, the ROC curves are standard summaries of
accuracy. As described in Section 2.2, suppose Y denotes the diagnostic test or marker, with
higher values more indicative of disease and D is a binary indicator of disease status, then the
ROC curve for Y is a plot of the sensitivity associated with the dichotomized test Y > c versus
(1 - specificity) for all possible threshold values c.
Diagnostic tests are often developed to detect or predict the occurrence of an event, such as
the onset of cancer, infection and so forth. In this context D is a time dependent variable.
The time at which the diagnostic test is performed relative to the incidence of the event - or
outcome in general - has a big influence on its operating characteristics.
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Example: Mother to infant transmission of HIV-1 trial [127]
A biomarker evaluation for predicting the after birth HIV-1 infection events for babies delivered
by HIV-1 infected mothers, is a common example for the applications of time dependent ROC
curves. The study was carried out between November 1997 and January 2001 by the HIV
prevention trial network (HPTN) as mentioned in Hu [100]. The primary endpoints of this
trial were:
• HIV-1 infected rate of the infants and
• The proportion of those infants who were alive and free of HIV at 18 months of age.
The main purpose of the study was to compare the efficacy of two treatment regimens:
• Nevirapine (200 mg at labor onset and 2 mg/Kg for babies within 72 hours of birth) and
• Zidovudine (600 mg orally at labor onset then 300 mg every 3 hours until delivery and
4 mg/Kg orally twice daily for babies for 7 days).
One interesting question to be answered in this randomized trial is the evaluation of the
capacities of two baseline biomarkers, the maternity HIV-1 RNA level and CD4 for identifying
who would be infected by their mothers after birth at various points in time or at various time
intervals. There are various factors that may affect the biomarker distribution and performance
in predicting a disease event. These factors are those covariates that need to be adjusted in
time dependent ROC models. It is necessary to adjust for treatment regimens (Nevirapine and
Zidovudine) when constructing the time dependent ROC curve of the biomarkers as it has an
important impact on the prognostic capacity of HIV-1 RNA level and CD4.
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3.1. Extensions of sensitivity and specificity
It has been previously mentioned that ROC curves are commonly used in the analysis of
diagnostic test results Y for a binary disease outcome D. However in practice many disease
outcomes depend on time t, which we denote by D(t), and hence ROC curves that vary as a
function of time may be more appropriate and various definitions and estimators have been
proposed. Subjects are initially non-diseased but can succumb to disease during the course of
the study [67]. A common example of a time-dependent variable is vital status, where D(t) = 1
if a patient has died prior to time t and zero otherwise. It is clear that this type of data is
most appropriately handled using time to event or survival analysis.
Let Ti be the survival time for subject i and assume that we only observe the minimum of Ti
and Ci, where Ci represents an independent censoring time. Here survival times is interpreted
to mean the time until an individual experiences an event of interest and Ci ≤ Ti if the time
is censored. Define the follow-up time as Xi = min(Ti, Ci), and let ∆i = I(Ti, Ci) denote the
censoring indicator. The advantage of survival analysis approaches as opposed to a snapshot
cross-sectional analysis of the binary outcome at a given time is that the time accrual until
the event is taken into account. We then show that a certain choice of time dependent true
positive rate (TPR(t)) and false positive rate (FPR(t)) definitions leads to time dependent
ROC curves and time dependent AUC summaries. As we mentioned before with survival data
we need to take the time into account since the accuracy may be higher when the markers are
measured closer to the onset of disease.
To extend the notion of diagnostic accuracy to incorporate the time domain, the outcome is
the time elapsed until an event takes place. This can be viewed as a binary outcome of function
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of time. Equations (2.1) and (2.2) are now replaced by:
sensitivity(c, t) = P (Y > c|D(t) = 1) and (3.1)
specificity(c, t) = P (Y ≤ c|D(t) = 0), (3.2)
which signify that the sensitivity and specificity are functions of time in the context of time to
event data. Using Equations (3.1) and (3.2), we can estimate the sensitivity and specificity for
each c and plot these estimates to get the ROC curve at a specific time point t. These estimates
can be obtained using the following relations, which follow from definitions of conditional
probability as well as the application of Bayes’ Theorem:
P (Y > c|D(t) = 1) = 1− S(t|Y > c)P (Y > c)
1− S(t)
and
P (Y ≤ c|D(t) = 0) = S(t|Y ≤ c)P (Y ≤ c)
S(t)
,
where S(t) denotes the survival function, i.e. S(t) = P (T > t) and S(t|Y > c) is the conditional
survival function for the subset defined by Y > c.
The definition of the time dependent ROC curves follows from definitions of the usual ROC
curves and relies on first defining time dependent sensitivity and specificity. Then simple plots
of TPR vs FPR for different values of the threshold c will yield the ROC at time t. The time







There are several definitions of cases and controls in the survival outcome setting. It is nec-
essary to mention that the definitions of sensitivity and specificity are given in terms of the
actual survival time Ti. In addition censoring needs to be addressed for valid estimation. A
certain choice of time dependent true positive and false positive definitions leads to time de-
pendent ROC curves and time dependent AUC summaries. We remark that time dependent
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AUC summary is directly related to concordance summary for survival data. Concordance
probability measures how often predictions and outcomes are concordant. The probability of
concordance is defined as the number of concordant pairs plus the number of tied pairs divided
by the number of all informative pairs [55]. For a binary outcome, the area under the empirical
ROC curve is equivalent to the concordance probability, which is defined on a pair of subjects
where one of the pair has the outcome and the other does not. The probability that the subject




1 if Yi > Yj ,
0.5 if Yi = Yj ,
0 if Yi < Yj .
Hence ψ indicates which member of the pair has the higher value, with ties indicated by 0.5.









where n and m are the numbers of patients with and without outcome respectively. This
summation represents the number of pairs that have Yi > Yj , so the entire expression is the
fraction of patient pairs where the one with the higher marker value had the outcome.
The idea of concordance can be extended to time to event setting. Let T1 and T2 be the event
times in a given pair of patients with marker values Y1 and Y2. The concordance between a
marker Y and the time to event outcome T is defined as CP (Y, T ) = P (T1 > T2|Y1 > Y2).
3.2. Time dependent true positive rate (TPR(t)) and false positive rate (FPR(t))
This section discusses different definitions for time dependent true positive and false positive
rates [67].
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3.2.1 Time dependent true positive rate
True positive rate (TPR) or sensitivity in classic settings with binary outcomes is defined to be
the probability that a test result will be positive when the disease is present in the individual.
However in practical settings the outcome may be failure time, where in this case, there are
various definitions of TPR. In the following sections, we list two definitions of time dependent
TPR.
Incident true positive rate TPRI
The incident TPR for a biomarker value Y at event time t for any threshold c, denoted by
TPRI(c, t) is given by:
TPRI(c, t) = P (Y > c|T = t). (3.4)
Using this definition the cases are stratified according to the time at which events occur and
in this case we are more interested in the disease incidence at a fixed time. There are many
advantages of this definition of TPRI , given it is based on diseased cases occurring at a given
time. This feature is helpful when the total sample size is small. In addition this definition
does not contain redundant information on disease cases.
Cumulative true positive rate TPRC
The cumulative TPR for a biomarker Y at event time t for any threshold c, denoted by
TPRC(c, t) is given by:
TPRC(c, t) = P (Y > c|T ≤ t). (3.5)
TPRC evaluates the sensitivity of the biomarkers for detecting events occurring throughout
the follow up time up to t. Using this definition we are more interested in predicting the
disease prevalence of the study at a given time. Thus the definition of TPRC is useful when
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disease prevalence is of interest. The disease cases are calculated based on cumulative time
interval, which results in a large number of disease cases that are used for estimating the
sensitivity. However (TPRC) contains redundant information, unlike TPRI . In addition, it
cannot distinguish the sensitivity for early events from that for late events.
3.2.2 Time dependent false positive rate
False positive rate (FPR) with binary outcomes is defined to be the probability that a test
result will be positive when the disease is absent in the individual. Time dependent FPR are
of various types according to the definition of the controls. In the following sections we list
two definitions of time dependent FPR.
Static false positive rate FPRS
The static time dependent false positive rate denoted by FPRS for a biomarker value Y and
any threshold c, is defined to be:
FPRS(c, t∗) = P (Y > c|T > t∗). (3.6)
Using this definition controls are subjects who are event free through a fixed follow up time
(0, t∗), where t∗ is a fixed point in time. In the definition of FPRS controls are static over
time. Thus the time defining the controls differs from that defining those in the corresponding
TPR, no matter what type of TPR is used.
Dynamic false positive rate FPRD
Dynamic false positive rate for a biomarker value Y and any threshold c, denoted by FPRD
is given by:
FPRD(c, t) = P (Y > c|T > t). (3.7)
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Using in this definition, the time defining the event is dynamic, thus the controls at time t are
defined to be patients who were still event free at time t. The advantage of FPRD is that it
is based on the time defining the corresponding TPR in the ROC curve.
In summary we stress that a case i is said to be incident if Ti = t and cumulative if Ti ≤ t
for the two definitions of cases. It is also important to distinguish whether controls are static
defined as subjects with Ti > t
∗ for fixed value of t∗, or whether controls are dynamic defined
for time t as those subjects with Ti > t.
3.3. Combinations of time dependent TPR and FPR
Since the time dependent ROC curve is a compound function of TPR and FPR, a combination
of various types of the two rates need to be selected according to the purpose of study. Table
3.1 (see [100]) lists some combinations of TPR and FPR for constructing certain types of time
dependent ROC curve.
Table 3.1: Combinations of time dependent TPR and FPR
TPR (Cases) FPR (Controls) Examples from literature
Cumulative Dynamic Etzioni et al. (1999)
Heagerty et al. (2000)
Zheng and Heagerty (2004)
Song and Zhou (2008)
Incidence Dynamic Zheng and Heagerty (2004)
Heagerty ans Zheng (2005)
Incidence Static Cai et al. (2006)
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After presenting definitions for time dependent sensitivity and specificity, ROC curves and AUC
summaries can be computed and interpreted. We will present formulae for most commonly
used ones.
3.3.1 Incident-Static combination
Using the following definitions
SensitivityI(c, t) = P (Yi > c|Ti = t) and
SpecificityS(c, t∗) = P (Yi ≤ c|Ti > t∗).
each subject does not change disease status and is treated as either a case or a control. Cases are
stratified according to the time at which the event occurs (incident) and controls are defined
as those subjects who are event free though a fixed follow-up period (0, t∗) static. These
definitions facilitate the use of standard regression approach for characterising sensitivity and
specificity as the event time Ti can be used as a covariate.
The group of static controls mimics the group of individuals who never develop the disease,
meaning patients with preclinical diseases are eliminated from the control group as far as
possible if t is large enough. This can be viewed as the ideal control group in some situations.
The cumulative TPR can be computed from the incident TPR when the distribution of the
event time is known. Consider the incident TPR and static FPR as defined in Equations (3.4)








c P (T > t
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where g(y) is the probability density function of Y and f(t|y) = ∂P (T ≤ t|Y = y)/∂t is
conditional density function of T given Y = y.
Heagerty and Zheng [67] estimated the TPRI(c, t) using the Cox model of the form λ(t, Y ) =
λ0(t) exp(β(t)Y ), where λ(t, Y ) stands for the conditional hazard rate of T given Y while λ0
is the unspecified base line hazard rate. Let the notation R(t) denote the risk set at time t.
The authors mentioned that the distribution for the random variable Y ×exp(βY ) for subjects
in the risk set at time t is equal to the conditional distribution of Y given T = t. Setting
R(t) = i : Xi ≥ t, this leads to
TPRI(c, t) =
∑
i∈R(t) I(Yi > c) expβ(t)Yi∑
i∈R(t) expβ(t)Yi
.







where St = i : Xi > t
∗ is the control set and nt∗ is the cardinality of St∗ .
3.3.2 Incident-Dynamic combination
We recall that
SensitivityI(c, t) = P (Yi > c|Ti = t) and (3.8)
SpecificityD(c, t) = P (Yi ≤ c|Ti > t). (3.9)
Using the approach of incident-dynamic combination, a subject can play the role of a control
for an early time Ti > t, but then play the role of a case when Ti = t. Sensitivity is a measure
of the expected fraction of subjects with a marker greater than the threshold c among the
subpopulation of individuals who truly have the event at time t, while specificity measures the
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fraction of subjects with a marker less than or equal to c among those who survive or do not
experience the event beyond time t.
Incident-Dynamic ROC curves are defined following Equation (3.8) as the function ROC
I/D
t (ρ),
where ρ denotes the corresponding incident true positive rate. Let cρ be defined as the threshold
that yields a false positive rate of ρ : P (Yi > c
ρ|Ti > t) = 1 − specificityD(cρ, t) = ρ. The
true incident-dynamic positive rate, ROC
I/D
t (ρ) is the sensitivity that is obtained using this
threshold or ROC
I/D
t (ρ) = sensitivity
I(cρ, t) = P (Yi > c
ρ|Ti = t). Using the true and false
positive rate functions allows the ROC curve to be written as:
ROC
I/D






for ρ ∈ [0, 1],







So the ROC curve is simply the plot of TPR(c, t) = [P (Y > c|D(t) = 1)] and FPR(c, t) =








3.3.3 Cumulative-Dynamic AUC AUCC/D(t)
For a baseline marker value, Heagerty and et al. [66] proposed versions of time dependent
sensitivity and specificity under the cumulative case definition as
SensitivityC(c, t) = P (Yi > c|Ti ≤ t) and
SpecificityD(c, t) = P (Yi ≤ c|Ti > t).
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Using this approach, at any fixed time t the entire population is classified as either a case or a
control on the basis of vital status at time t. Also, each individual plays the role of control for
times Ti > t, but then contributes as a case for taken times Ti ≤ t. Cumulative and Dynamic
accuracy summaries are most appropriate when one is interested in discriminating between
subjects who experience an event of interest such as death prior to time t and those survive
beyond t.
The setting of cumulative cases and dynamic controls may be regarded as most natural when
specific evaluation times are of particular interest. It simply corresponds to defining cases at
time t as subjects who experienced the event prior to time t, and controls at time t as subjects
who were still event free at time t.
AUC
C/D
t (t) is then obtained by using these definitions of TPR
C and FPRD. However I(T ≤ t)
is not observed for all subjects due to presence of censoring before time t. To handle censoring,
Baye’s Theorem can be used to rewrite AUCC/D(t) as a function of the conditional survival
function P (T > t|Y = y). There are other approaches called Inverse Probability of Censoring
Weighted (IPCW) estimates. We first mention the method based on primary estimates of
P (T > t|Y = y), using Bayes’ Theorem where
TPRC(c, t) =
∫∞
c P (T ≤ t|Y = y)g(y)d(y)




c P (T > t|Y = y)g(y)d(y)
P (T > t)
.






P (T ≤ t|Y = y)P (T > t|Y = c)
P (T ≤ t)P (T > t)
g(y)g(c)dydc.
Since P (T > t) =
∫∞
−∞ P (T > t|Y = y)g(y)dy, we let Ŝn(t|y) to be the estimator of the
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Heagerty [66] suggested a conditional Kaplan-Meier estimator to derive estimates for Ŝn(t|y).
Also Hung et al. [69] suggested to use IPCW estimates, so we have:
TPRC(c, t) =
∑n
i=1 I(Yi > c, Ti ≤ t)
∆i
nŜC(Ti)∑n






i=1 I(Yi > c, Ti > t)∑n
i=1 I(Ti > t)
,
where ŜC(.) is Kaplan-Meier estimator of survival function of the censoring time C. Then the











where Ŝ(t) is Kaplan-Meier estimator of P (T > t). To conclude this section we would like to
mention that all time dependent ROC curves definitions can be used to evaluate and compare
biomarkers in classifying subjects based on their survival times. The Incidence-Static ROC
curve is useful in distinguishing subjects that fail at a given time from those failing after
another time. The Incidence-Dynamic ROC curve is useful in distinguishing subjects that fail
at a given time from those failing after that time. The Cumulative-Dynamic ROC curve is
useful in distinguishing subjects that fail by a given time from those failing after another time.
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Missing data and imputation
methods
Missing data are quite common in both designed clinical trials and observational research
studies. Some methodologists have described missing data as one of the most important
statistical and design problems in research. The problem of missing data is of a greater concern
when decisions are to be made about the appropriateness of the care a patient should receive
and also when there is interest in using a predictive model to discriminate subjects as likely
to have a certain characteristic from those who do not.
Missing values can severely affect the results if there is dependence between the outcome and
the missing data process, therefore dealing with missingness in the data becomes necessary.
Despite the important nature of the problem, a large number of researchers routinely employ
old standby techniques that have been criticized in the methodological literature. A simple and
common strategy is to ignore cases with missing values, which means reducing the size of the
original data set and can introduce substantial biases in the analysis and inference. Deletion
methods are among the worst methods available for practical applications [113] and this can
lead to severe bias if especially the missing data are not occurring in a purely random manner.
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Define the complete data set as Y = (yij), where yij denotes the j
th observation for individual
i = 1, 2, · · · , N and j = 1, 2, · · · , ni. Note that Y includes both observed and unobserved
values. Thus the data Y can be partitioned as Y = (Yobs, Ymis), where Yobs and Ymis denote
the observed and missing part of the complete dataset respectively. To the dataset Y we also




1 if yij is observed,
0 if yij is missing.
A common modeling approach for missing data is to assume the missing data mechanism is
characterised by the conditional distribution of I given Y , that is f(I|Y, φ), where φ denotes
missing data parameters. The joint probability distribution of the response variables and the
missing data indicator variables can be expressed as
f(Y,R|θ, ψ) = f(Y |θ)f(R|ψ, Y ), (4.1)
where f(Y |θ) and f(R|ψ, Y ) denote the marginal distribution of the response variable and
the conditional distribution of missing data, conditional on the response variable, respectively.
The probability model 4.1has two sets of parameters θ and ψ representing the parameters of
interest and the missing data parameters, respectively. In model (4.1), the correct inferences
on θ in general need to be conducted.
It is important to have a clear understanding of the so-called missing data mechanisms. Rubin
et al. [113, 115] introduced three missing data mechanisms. These mechanisms describe the
relationships between measured variables and the probability of missing data. While these
terms have a precise probabilistic and mathematical meaning, there are different reasons for
why the data were missed.
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4.1. Missing reasons
According to [115] there are three missingness mechanisms. In this section we give a conceptual
description of each mechanism and for more details on these mechanisms, we refer the readers
to (Allison [5], Enders [36], Little and Rubin [81], Rubin [113], Schafer and Graham [118]).
4.1.1 Missing completely at random (MCAR)
The first mechanism is called missing completely at random (MCAR) and it happens when
the probability of missing observations is unrelated to the value of that observation or to the
value of any other variable. That is f(I|(Yobs, Ymis), φ) = f(I|φ) for all Y and φ.
There are many and varied reasons for the data to be missed completely at random (MCAR).
It can happen, for example, as a result of equipment malfunction, inclement weather, illness
incapacitating subjects or testers; or incorrectly entered data. When we say data are missing
completely at random, we mean that the probability that an observation Xi being missing is
unrelated to the value of Xi or to the value of any other variables. Thus data on family income
would not be considered MCAR if people with low incomes were less likely to report their
family income than people with higher incomes. Similarly, for example, if in the USA Whites
were more likely to omit reporting income than African Americans, we again would not have
data that were MCAR because missingness would be correlated with the factor of ethnicity.
However if a participant’s data were missing because s/he was stopped for a traffic violation
and missed the data collection session, his/her data would presumably be missing completely
at random. This is supported by the fact that being stopped due to traffic violation can occur
to any participant regardless of the value his/her outcome.
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An interesting feature of data that are MCAR is that the analysis remains unbiased even if
complete cases only are used. We may lose power for our design, but the estimated parameters
are not biased by the absence of data. However the key concluding comment here is that
practically the MCAR assumption is hard to justify.
4.1.2 Missing at random (MAR)
The second mechanism of missing data is when data are missing at random (MAR). This
happens when the probability of a missing observation depends only on available information.
Thus the MAR mechanism can be expressed as: f(I|(Yobs, Ymis), φ) = f(I|Yobs, φ) for all
Ymis and φ. The MAR mechanism requires a less stringent assumption about the reason for
missing data. This terminology is often confusing because of the use of the word random. The
MAR mechanism is in fact is not random at all and it describes systematic missingness where
the propensity for missing data is related to other measured variables in the analysis model,
but not to the underlying values of the incomplete variables [113]. Sometimes we refer to
MAR as ignorable missingness. MCAR missingness also falls under the ignorable missingness.
Cases of missing not at random (MNAR), to be introduced next, could be labeled as cases of
nonignorable missingness.
4.1.3 Missing not at random (MNAR)
Data that are not MCAR or MAR are classified as Missing Not at Random (MNAR). As an
example if we are studying mental health and people who have been diagnosed as depressed
are less likely than others to report their mental status, the data is missing not at random.
Clearly the mean mental status score for the available data will not be an unbiased estimate
58
Chapter 4 – Missing data and imputation methods
of the mean that we would have obtained with complete data. The same thing happens when
people with low income are less likely to report their income on a data collection form. In
this case the probability that income is not reported depends on the unobserved income value
itself.
The data are classified as Missing Not at Random (MNAR) when the presence of miss-
ing data depends on variable values, which are themselves subject to missingness. That is
f(I|(Yobs, Ymis), φ) 6= f(I|Yobs, φ). To obtain an unbiased estimate of parameters we have to
model the missingness itself. In other words we need to formulate and estimate a model that
accounts for the missing data. That model could then be incorporated into a more complex
model for estimating missing values (see [35] for an example).
4.1.4 Ignorable and non-ignorable missingness
Difficulties appear when we have data that are MNAR. We say that the mechanism controlling
missing data is non-ignorable. That means we cannot sensibly solve a model unless we are
also able to write a model that controls missingness. Modeling the missingness is not an easy
task and most discussions, including this one, do not discuss the treatment of data whose
missingness is non-ignorable. On the other hand, if data are at most MAR, the mechanism
for missingness is ignorable. Thus we can proceed without worrying about the model for
missingness. The intention is to find better estimators of the parameters in our model, but we
do not have to write a model that incorporates missingness. In the next section we introduce
some strategies seeking an improvement in the estimation.
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4.2. Imputation strategies
There are several ways to deal with missing data. One of them is to discard subjects with
incomplete sequences and then analyse only the units with complete data [101]. Methods that
use this approach are called deletion methods. These methods do not replace or impute
missing values and do not make other adjustments to account for missing values.
The main advantages of deletion methods are their simplicity and that they can be applied
easily with much of the available statistical software. Some of the deletion methods are good,
but are applicable only under certain conditions [18]. Ideally for the analysis to be valid one
strong condition or assumption is that the data need to be missing completely at random.
These conditions do not generally hold, therefore McKnight et al. [94] proposed that deletion
methods be avoided whenever is possible. Furthermore Little and Rubin [81] do not recommend
any of the available deletion methods except if the amount of missing data is limited. The
simplest deletion approach is the complete case analysis or list-wise deletion analysis in which
the analysis uses only those subjects with completely recorded observations, that is complete
observations. Some of the advantages of complete case analysis are:
• It is simple, in the sense that the method can be quite effective and may be satisfactorily
used with small amounts of missing data. However, it is important to make sure that,
even in such a situation, the deleted cases are not unduly influential [118].
• It is easy to carry out. It is used by default routines in most statistical software packages,
but implementation details vary.
The primary disadvantages of this method - which clearly outweigh the advantages - are that:
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• It can produce inefficient estimates, in the sense of loss of statistical power specifically
when drawing inferences for sub-populations.
• When data are not MCAR, then the method can lead to seriously biased results. In
other words, this method is valid only when data are MCAR [80]. We remark that even
when MCAR holds, it can still be inefficient [118].
• If the units with missing values differ systematically from observed cases, this could bias
the complete-case analysis.
• If many variables are included in a model, there may be very few complete cases, so that
most of the data would be discarded for the sake of a simple analysis. Thus McKnight
et al. [94] state that one should give careful consideration before the use of this method
regardless of its ease of use.
• It is easy to imagine situations where complete case analysis can be very misleading.
Kenward et al. [74] and Wang-Clow et al. [149] presented examples where the complete
case has led to misleading results.
Next we discuss further deletion methods that can be considered as a replacement for listwise
deletion.
Pairwise deletion is a well-known deletion method. Under this approach each element of the
intercorrelation matrix is estimated using all available data. As an example if one participant
reports his/her income and life satisfaction index, but not his/her age, s/he is included in
the correlation of income and life satisfaction, but not in the correlations involving age. The
problem with this approach is that the parameters of the model will be based on different sets
of data, with different sample sizes and different standard errors.
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It is known that if there are only few missing observations, it does not affect the use pairwise
deletion. If there are many missing observations, this may lead to inappropriateness in the
analysis.
Another simple approach is available case analysis, where different aspects of a problem are
studied with different subsets of the data. For example, in the 2001 Social Indicators Survey
carried out in New York, USA, all 1501 respondents stated their education level, but 16%
refused to state their earnings. We could thus summarize the distribution of education levels
of New Yorkers using all the respondents and the distribution of earnings using the 84% of
respondents who answered that question. A major problem of this approach is that different
analyses will be based on different subsets of the data and thus will not necessarily be consistent
with each other. In addition, as with complete case analysis, if the nonrespondents differ
systematically from the respondents, this will bias the available case summaries.
We now turn to discuss methods that generate possible values for the missing data. These
alternative methods are called imputation methods, where one “fills-in” (imputes) the missing
data to obtain a full data set. Then the resultant data are analysed by standard statistical
methods without concern as if the new set represented the true and complete data set [80, 115].
This is the key idea behind commonly used procedures for imputation which include simple
and multiple imputation [80]. Multiple imputation fills in more than one value for each missing
item to allow for the appropriate evaluation of imputation uncertainty [80, 115]. In contrast
to multiple imputation, simple imputation techniques substitute one value for every missing
value in the data set [80, 81]. Simple imputation methods are valid under the ignorability
assumption [5, 115, 118]. Simple imputation methods that were used in the current research
are
• Mean imputation, where missing observations are replaced with the estimated mean of
62
Chapter 4 – Missing data and imputation methods
the data set;
• Hot Deck imputation, where the missing data can be replaced with the observed data
taken from matched data from the variables that contain non-missing values.
Simple imputation methods are general and flexible for handling missing data and can be
implemented quickly in several statistical software packages.
We now discuss in details some of the simple imputation methods that have been used in this
work.
4.2.1 Mean imputation
The single imputation method is a simple technique for handling missing data and consists of
replacing any missing observation with a plausible value. The most common single imputation
techniques are the overall mean imputation for continuous variables and the mode imputation
for categorical variables. The mean imputation can be used either by using a conditional mean
based on other variables in the data set or by using the unconditional mean of the variable
of interest. The mean and mode summary statistics are used because they seem to provide
reasonable point estimates. However it is important to mention some of the advantages and
disadvantages of the mean imputation method.
Advantages of mean imputation:
• This technique is easy to implement for any type of variable.
• Once missing values are imputed and incorporated into the data set, multiple users can
use the data with consistent results.
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• If knowledge regarding the mechanism producing missing values is available, imputed
values can often be improved to reflect this additional information.
Disadvantages of mean imputation:
• Rubin [115] showed that one imputed value cannot reflect sampling variability and
marginal distributions and associations are distorted as there is no residual variance
after the imputation.
• The tendency of this technique to reduce the overall variance and increase the significance
of individual covariates within a regression model leads to type II modelling errors. This
problem can be controlled only under the strong mostly unattainable MCAR assumption,
where the variance estimation is consistent with the true variance adjusted by a correction
factor [108].
• Imputed missing data do not represent additional uncertainty when the reason for non-
response is unknown.
• All observed values are considered as actual observations.
4.2.2 Hot deck imputation
The second simple imputation strategy we discuss is the nearest neighbor hot deck imputation
(also known as distance function matching). The term hot deck indicates that the information
of responding units (donors) come from the same dataset as the recipients. Following this
approach [7, 108] the missing values of one or more variables for the non-respondents are
replaced by values from observed closest similar donors in the sample. This is a donor method
64
Chapter 4 – Missing data and imputation methods
where the donor is selected by minimising a specified distance. This method involves defining
a suitable distance measure, where the distance is a function of the auxiliary variables.
There are several reasons for the popularity of the hot deck method among survey practitioners.
As with all imputation methods, the result is a rectangular data set that can be used by
secondary data analysts employing simple complete-data methods. It avoids the issue of cross-
user inconsistency that can occur when analysts use their own missing-data adjustments. The
hot deck method does not rely on model fitting for the variable to be imputed and thus is
potentially less sensitive to model miss specification error.
Advantages of hot deck imputation: [23]:
• Missing values are imputed with real observed values.
• Nearest neighbor is more efficient than other hot deck methods as it uses the information
of the auxiliary variables.
• It makes no distributional assumptions, in other words it is a distribution free method.
• We can use standard analysis for the imputed dataset.
Disadvantages of hot deck imputation:
• Requires some programming to be implemented
• Requires complete information on auxiliary variables
• Estimated values depend on the selected auxiliary variables.
• Most implementations don’t provide an uncertainty assessment.
The nearest neighbor hot deck imputation (NNI) method has some interesting features:
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• It is a hot deck method in the sense that non-respondents are substituted by a value of
the same variable from a respondent of the same pool; the imputed values are actually
occurring values, not constructed values, and they may not be perfect substitutes, but
are unlikely to be nonsensical values.
• It is more efficient than other hot deck methods in the sense that non-respondents are
imputed by deterministic values, given the y-respondents and x-values [108]. It is im-
portant to keep in mind that the hot deck method makes implicit assumptions through
the choice of the metric to match donors to recipients, and the variables included in this
metric, so it is far from assumption free.
• Only plausible values can be imputed, since values come from observed responses in the
donor pool.
• There may be a gain in efficiency relative to complete-case analysis, since information
about the incomplete cases is being retained.
• There is also a reduction in non-response bias, to the extent that there is an association
between the variables defining imputation classes and both the propensity to respond
and the variable to be imputed.
• It makes use of auxiliary information and does not use an explicit model and hence it
is expected to be more robust against model violations than methods based on explicit
models, such as ratio imputation and regression imputation.
• The NNI method provides an asymptotically valid distribution.
Let xi = (xi1, · · · , xiq) be the values for subject i of q covariates that are used to create
adjustment cells and let C(xi) denote the cell in the cross classification in which subject i falls.
66
Chapter 4 – Missing data and imputation methods
Then matching the recipients i to donors j in the same adjustment cell is the same as matching
based on the metric:
d(i, j) =

0 if i ∈ C(xi),
1 if j 6∈ C(xi).
The other measure of potential closeness of potential donors to recipients can be defined to
be the maximum deviation, d(i, j) = maxk |xik − xjk| where xk have been suitably scaled to
capture differences comparable (e.g. by using ranks and then standardizing). The Mahalanobis
distance [108],
d(i, j) = (xi − xj)T v̂ar(xi)−1(xi − xj),
where ̂var(xi) is an estimate of the covariance matrix of xi, or the predictive mean,
d(i, j) = (Ŷ (xi)− Ŷ (xj))2,
where Ŷ (xi) = x
T
i β̂ is the predicted value of Y for non-respondent i from the regression of Y
on x using only the respondents’ data. One way to define the donor set for non-respondent i
is as the set of respondents with (d(i, j) < δ), for a pre-specified maximum distance δ. If the
closest respondent to j is selected, the method is called nearest neighbor hot deck.
Nonetheless despite the availability of the single imputation techniques (e.g. mean and hot
deck), they are not at all recommended when the rate of missing values and number of param-
eters are large. A major shortcoming in using them is that single imputation does not account
for imputation error.
4.2.3 Multiple imputation
In multiple imputation (MI) each missing value is replaced with several imputed values that
reflect the uncertainty of the imputation model. Multiple imputation is a method to handle
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incomplete data in statistical inferences and was first proposed by [115]. Under MI, m ≥ 2
independent imputations are carried out for each missing value to create m complete data sets.
Next each complete imputed data set is analysed separately using an appropriate standard
analysis method and the results are finally combined to produce estimates and confidence
intervals for parameter values. Multiple imputation operates under the assumption that given
the variables used in the imputation procedure, the missing data are Missing At Random
(MAR), which means that the probability that a value is missing depends only on observed
values and not on unobserved values [118]. In other words, after controlling for all of the
available data (i.e., the variables included in the imputation model) any remaining missingness
is completely random [57]. MI procedures are very flexible and can be used in a broad range
of settings. Because MI involves creating multiple predictions for each missing value, the
analysis of multiple imputed data take into account the uncertainty in the imputations and
yield accurate standard errors. On a simple level, if there is not much information in the
observed data (used in the imputation model) regarding the missing values, the imputations
have high variability, leading to high standard errors in the analyses. In contrast, if the
observed data are highly predictive of the missing values the imputations will be more consistent
across imputations, resulting in smaller, but still accurate standard errors [58]. The method
of multiple imputation ensures high efficiency even for a small number of imputations. The
efficiency of this method is given by




where γ is the fraction of missing information due to non-response. For m imputations we have
m estimates θ̂i, i = 1, 2, · · · ,m each with an estimated sampling variance. Then the overall
MI estimator for the parameter of interest (which can be vector-valued) is simply given by
the average of the m estimators obtained from each of the m complete data sets and this is
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The standard error is obtained by taking into account of within imputation variance, as well as
between imputations variance. These two variances are then combined together and the square
root of the sum determines the standard error. Average sampling variance of m estimates result















The total imputation variance T of θ is then given by




Multiple imputation has a number of advantages over the other missing data imputation ap-
proaches. Multiple imputation involves filling in the missing values multiple times, creating
multiple complete datasets. Following [118], the missing values are imputed based on the
observed values for a given individual and the relations observed in the data for other partici-
pants, assuming the observed variables are included in the imputation model. The MI inference
assumes that the model used in analysing the multiple imputed data (the analysis model) is
the same as the model used to impute missing values in MI (the imputation model). However,
practically, the two models might not be the same [116]. The quality of the imputation model
will influence the quality of the analysis model results, so it is important to carefully consider
the design of the imputation model. Therefore, in order to obtain high quality imputations
for a particular variable, the imputation model should include variables that are potentially
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related to the imputed variable and variables that are potentially related to the missingness
of the imputed variable [116]. Van Buuren et al. [143] recommended including the following
covariates in the imputation model:
• Variables in the analysis model.
• Variables associated with missingness of the imputed variable.
• Variables correlated with the imputed variable.
However, one can include auxiliary variables which may or may not have missing values. Gen-
erally, including variables that do not have missing values is recommended in the imputation
model. For more details of the imputation model, the reader may consult [117, 118, 143].
Advantages of MI:
• It is applicable to any type of variables.
• It represents missing data uncertainty.
• It takes into account the variability given by the multiple imputed data set with appro-
priate statistical inference.
• It yields robust estimates.
• The use of standard analysis in each imputed data set.
Imputation methods keep the full sample size, which can be advantageous for bias and precision;
however, they can yield different kinds of bias. Whenever a single imputation strategy is used,
the standard errors of estimates tend to be too low. The intuition here is that we have
substantial uncertainty about the missing values, but by choosing a single imputation we
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in essence pretend that we know the true value with certainty. Although MI is intuitively
appealing, it still has some defects. Disadvantages of MI:
• Analysis of multiple data sets is time consuming and requires statistical expertise.
• MI can introduce bias over a complete case analysis if not carried out appropriately.
The MI is the most commonly used approach to deal with missing data. MI is generally pre-
ferred to Inverse-Probability Weighting (IPW) as it is more efficient. If the imputation model
is correctly specified, MI should work well. Furthermore, we were interested in comparing
between single and multiple imputation methods in order to estimate time-dependent AUC.
We are planning to use the IPW in the future work.
4.2.4 Multiple imputation via chained equations
Multiple Imputation via Chained Equations (MICE) is a particular multiple imputation tech-
nique [111, 144]. The name chained equations refers to the fact that the Gibbs sampler can
be easily implemented as a concatenation of univariate procedures to fill out the missing data.
Implementing MICE when data are not MAR could result in biased estimates. Many of the
initially developed multiple imputation procedures assumed a large joint model for all of the
variables, such as a joint normal distribution. In large datasets, with hundreds of variables
of different types, this is rarely appropriate. MICE is an alternative, flexible approach to
these joint models. In fact, MICE approaches have been used in datasets with thousands of
observations and hundreds of variables [65, 129]. In the MICE procedure, a series of regres-
sion models are run whereby each variable with missing data is modeled conditional upon the
other variables in the data. Thus MICE falls under the general class of models called the fully
conditional specification (FCS) of the joint distribution. This means that each variable can
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be modeled according to its distribution for example, binary variables modeled using logistic
regression and continuous variables modeled using linear regression. Let X1, X2, · · · , Xk be a
set of variables some or all having missing values, the MICE algorithm can be described as
follows:
• IfX1 has missing values, it will be regressed on other variables, the estimation is restricted
to individuals with observed X1. The missing values in X1 are then replaced by simulated
draws from the posterior predictive distribution of X1.
• The following variable with missing values is regressed on all other variables, thus the
estimation is restricted to individuals with observed values for that variable and uses the
imputed values of X1.
• This process is repeated for all other variables for c cycles, which is suggested to be more
than 10 for the convergence of the sampling distribution of imputed values. The entire
process is repeated independently m times.
The number of cycles to be performed can be specified by the researcher. At the end of these
cycles, the final imputations are retained, resulting in one imputed dataset. Generally, ten
cycles are performed [112]. The idea is that by the end of the cycles, the distribution of the
parameters governing the imputations (e.g., the coefficients in the regression models) should
have converged in the sense of becoming stable. This will, for example, avoid dependence on
the order in which the variables are imputed. In practice, researchers can check the convergence
by, for example, comparing the regression models at subsequent cycles, as discussed in [65].
Different MICE software packages vary somewhat in the exact implementation of this algorithm
but the general strategy is the same. To make the MICE approach more concrete, imagine
a simple example where we have three variables in our dataset: age, income, and gender,
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and all three have at least some missing values. The MAR assumption would imply that the
probability of a particular variable being missing depends only on the observed values and
that, for example, whether someone’s income is missing does not depend on their (unobserved)
income. In step 1 of the MICE process, each variable would first be imputed using, for example,
mean imputation, temporarily setting any missing value equal to the mean observed value for
that variable. Then in step 2 the imputed mean values of age would be set back to missing.
In step 3, a linear regression of age predicted by income and gender would be run assuming all
cases were observed [11]. In step 4, predictions of the missing age values would be obtained
from that regression equation and imputed. At this point, age does not have any missingness.
Steps 2 to 4 would then be repeated for the income variable. The originally missing values of
income would be set back to missing and a linear regression of income predicted by age and
gender would be run using all cases with income observed. Imputations (predictions) would be
obtained from that regression equation for the missing income values. Then steps 2 to 4 would
again be repeated for the variable gender. The originally missing values of gender would be
set back to missing and a logistic regression of gender on age and income would be run using
all cases with gender observed. Predictions from that logistic regression model would be used
to impute the missing gender values. This entire process of iterating through the 3 variables
would be repeated until convergence. The observed data and the final set of imputed values
would then constitute one complete data set. The process is repeated again to yield the second
complete data set and again until m complete data sets ready for analysis are created via this
simulation and estimation algorithm.
Advantages of MICE:
• It is considered a flexible approach because it gives flexibility to the researcher having a
multivariate structure on the data.
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• It can handle variables of different types.
• It can handle arbitrary missing-data patterns.
• It can accommodate certain important characteristics of the observational data.
Disadvantages of MICE:
• If the imputation model has too many variables it may lead to multicollinearity problems.
• It also requires comprehensive computational skills.
• Implementing MICE when data are not MAR could result in biased estimates.
Although facilitating computation is very important, such a viewpoint ignores the imputer’s
assessments and information inaccessible to the users [96]. In [96] it was mentioned that “This
view underlies the recent controversy over the validity of multiple-imputation inference when a
procedure for analyzing multiply imputed data sets cannot be derived from (is “uncongenial”
to) the model adopted for multiple imputation”. The uncongeniality arises when the analyst
and the imputer have access to different amounts and sources of information, and have different
assessments (e.g., explicit model, implicit judgement) about both responses and non-responses.
If the imputer’s assessment is far from reality, Rubin [115] stated “all methods for handling non-
response are in trouble”. Based on such assessment, all statistical inferences need underlying
key assumptions to hold at least approximately. If the imputer’s model is reasonably accurate,
the multiple imputation prevents the analyst from producing inferences with serious non-
response biases.
An issue of uncongeniality is that it reveals a unique feature of multiple imputation inferences
that has not been studied systematically and is therefore unfamiliar to some analysts [96]. For
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an analyst, conducting multiple imputation inferences remove two major burdens of analysing
incomplete data: the difficulty of modeling missing data mechanisms and the computational
complications of incomplete data analyses. It is therefore recommended that the imputation
model should be rich enough and include all the variables that are used in the analysis model
including auxiliary variables if any. This condition was met in the current research because
our imputation model used all the information that was used in the analysis model.
75
Chapter 5
Combining multiple biomarkers in
diagnostic testing for cross-sectional
data
5.1. Introduction
In medicine a biomarker is a characteristic that is objectively measured and evaluated as an
indicator of normal, pathogenic processes or a pharmacologic response to therapeutic inter-
vention [128]. More specifically, a biomarker indicates a change in expression or state of a
protein that correlates with the risk or progression of a disease, or with the susceptibility of
the disease to a given treatment. Biomarkers have gained immense scientific, clinical value
and interest in the practice of medicine. For example clinical signs, symptoms, laboratory
tests, gene expression technology and combinations of the afore-mentioned rely on the use of
biomarkers.
Complex organ functions or general characteristic changes in biological structures can also
serve as biomarkers. Although the term biomarker is relatively new, they have been used
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in pre-clinical research and clinical diagnosis for a considerable length of time. Biomarkers
measure the progress of disease and assist in the evaluation of the most effective therapeutic
regimes for the disease. In medicinal biology, they play major roles and help in early diagnosis,
disease prevention, drug target identification and evaluation as well as drug response. Before
diagnosis, markers may be used for screening and risk assessment. During diagnosis, markers
can determine the staging, grading, and selection of initial therapy. During treatment, they can
be used to monitor therapy, select additional therapy, or monitor recurrent diseases. An ideal
biomarker should be safe and easy to measure. If the biomarker is to be used as a diagnostic
test, it should be sensitive and specific and have a high predictive value. In other words, most
patients without the disease should have negative test results and vice-versa [72]. Biomarkers
may be used alone or in combination to allow classification of an individual to a unique group
with defined characteristics. Biomarkers are also used in fields like geology, astronomy and
chemistry.
A critical challenge in clinical research is the combination of multiple biomarkers into models
to improve disease or outcome predictive accuracy. In medical research data, scientists are
evaluating a number of biomarkers simultaneously, which introduces an added complexity to
the analysis. In addition to providing an improved understanding of factors associated with
infection and disease development, a combination of relevant markers is important to the
diagnosis and treatment of disease. In this chapter we are mainly interested in combining
multiple biomarkers since this combination may possess a better diagnostic accuracy than any
single test on its own. For example, a single biomarker may not give sufficient sensitivity and
specificity in the study of a population with ovarian cancer, however combinations of biomarkers
may do so. Combining biomarkers can be used to identify important disease features, diagnosis
and prognosis. Therefore it is of interest to develop methods that can achieve this goal.
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Correct diagnosis of disease is a real challenge and medical researchers invest considerable
time and effort to the enhancement of accurate disease diagnosis. In the field of genomics
or genetic analysis, genotyping methods are being advanced to enhance accurate detection of
disease presence or disease stage generally. The ROC is a commonly used statistical tool for
describing the discriminatory accuracy and performance of a diagnostic test. The prediction
error can be used for model comparisons and evaluation, but it is not a meaningful indicator
for disease discriminatory capacity and may not necessarily represent the targeted population.
Thus we proposed the use of the AUC estimator as an evaluation method.
Features selection methods must be taken into account to improve the inferior univariate
selection of features based on traditional inference tests. Although univariate models have
some appealing strengths and are comparatively easy to fit. However, correlation cannot
be modeled using univariate process thus multivariate models provide more comprehensive
analysis. It is well-known that evaluating the model on the same data that was used to build
it will cause an over-fitting problem, thus resampling methods should be used. There has
been much recent work on developing methods for combining multiple biomarkers. Su and Liu
[130] proposed linear combination of markers to maximise sensitivity over the entire specificity
range. They also provided a solution of the best linear combination of markers in the sense
that the AUC of this combination is maximised among all possible linear combinations. Pepe
and Thompson [103] proposed a distribution free rank based approach for optimising the AUC.
In [93] McIntosh and Pepe showed that the risk score defined as the probability of disease given
data on multiple markers is the optimal function that maximises the ROC curve at every point.
Etzioni et al. [43] proposed screening rules based on the consideration of logical combinations of
biomarker measurements. Yuan and Ghosh [153] proposed a novel model combining algorithms
for classifying biomarkers in studies.
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In this chapter, multivariate stepwise logistic regression is used to select the biomarkers. Then
the bootstrap leave one out cross-validation (LOOCV) technique is applied to evaluate the di-
agnostic performance of the combined markers using the ROC analysis. The process of variable
selection is applied to each training set. In a simulation study, we developed a statistical model
based on the multivariate normal distribution and used it to show that accounting for statisti-
cal correlation among the biomarkers is useful to help improving the predictive accuracy. The
method is applied to a real data set collected to study the occurrence of TB-IRIS in patients
from Cape Town, South Africa. The method is designed for the analysis of cross-sectional
data.
5.2. Variable selection
Feature selection, also known as variable selection is the technique of selecting a subset of rele-
vant features or variables for building models. Variable and feature selection have become the
focus of much research when tens or hundreds of thousands of variables are available. Feature
selection is the common first step when developing a class predictor based on microarray data
[122]. In fact it is reasonable to assume that only some subsets of many of measured biomark-
ers contribute useful information for distinguishing the phenotype classes. By removing most
redundant biomarkers or variables from the data, feature selection helps improve the perfor-
mance of models. However, prior to variable selection it is important to ensure that distorting
features such as identification of outliers are properly handled. This may include exclusion of
outliers and transformation of variables appropriately. The objective of variable selection is to
avoid over-fitting, improve model performance and provide faster and more effective predictors.
Faraway [46] states that among several plausible explanations for a phenomenon, the simplest
and smallest that fits the data is best. It is well known that unnecessary predictors will add
noise to the estimation of other quantities that are of interest and degrees of freedom will be
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unnecessarily wasted. Moreover, collinearity is caused by having too many variables trying to
achieve the same goal. Finally, if the model is correctly identified, we can save time and cost
by not measuring and including redundant predictors.
One approach to feature selection is to select variables based on their statistical significance in
univariate tests of differences between the classes. For this purpose the t-test or Wilcoxon rank-
sum test can be used to assess univariate statistical significance [122]. Then those variables
considered statistically significant are to be identified for inclusion in the multivariate model.
The most commonly used methods for variables selection are backward elimination, forward
selection, and stepwise selection. We briefly summarize these methods.
5.2.1 Backward elimination
Backward elimination is the simplest of all variable selection procedures and can be easily
implemented without special software. Backward elimination begins with a full model consist-
ing of all candidate predictor variables. Variables are sequentially eliminated from the model
until a predefined stopping rule is satisfied. The variable whose elimination would result in
the smallest decrease in a summary measure is eliminated. A common stopping rule is to stop
when all variables that remain in the model are significant at a pre-specified significance level.
Below are the steps for backward variable selection:
1. Start with all the predictors in the model.
2. Remove the predictor with highest p-value greater than the pre-specified one.
3. Refit the model and return to step 2.
4. Stop when all p-values for the remaining predictors are less than the pre-specified level
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such as α = 0.05.
Backward elimination does not perform well in the presence of multicollinearity and it cannot
be used if there are more variables than observations, p > n. Additionally it may be compu-
tationally expensive if there are many variables. A classical alternative is forward selection.
5.2.2 Forward selection
Forward selection reverses the backward selection and begins with an empty or null model.
Variables are added sequentially to the model until a pre-specified stopping rule is satisfied. At
a given step in the selection process, the variable whose addition would result in the greatest
increase in the summary measure is added to the model. A typical stopping rule is that
if any added variable would not be significant at a pre-specified significance level, then no
further variables are added to the model. Below are the key steps under the forward selection
procedure.
1. Start with no variables in the model.
2. For all predictors not in the model, check their p-value if they are added to the model
and choose the one with lowest p-value less than a pre-specified threshold value such as
0.05.
3. Continue until no new predictors can be added.
5.2.3 Stepwise regression
Stepwise regression is a standard procedure for variable selection, which is based on the proce-
dure of sequentially introducing the predictors into the model one at a time. Stepwise selection
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is a combination of backward elimination and forward selection. At each step of the variable
selection process, after a variable has been added to the model, variables are allowed to be
eliminated from the model. For instance, if the significance of a given predictor is above a
specified threshold, it is eliminated from the model. The iterative process is ended when a pre-
specified stopping rule is satisfied. In other words, this addresses the situation where variables
are added or removed early in the process and we want to change our mind about them later.
At each stage a variable may be added or removed and there are several variations on exactly
how this is done. It is important to realize that a stepwise approach is not guaranteed to lead
to the best possible model. But it almost always leads to a good model.
Various model selection methods such as Akaike Information Criterion (AIC) and Bayesian
Information Criterion (BIC) are available and commonly used criteria. The AIC is a measure
of the goodness of fit of an estimated statistical model. The AIC is a method of assessing
the trade-off between the complexity of an estimated model against how well the model fits
the data. The preferred model is the one with the lowest AIC value. The AIC and BIC are
respectively given by
AIC = −2 logL+ 2p
while
BIC = −2 logL+ p log n,
where L is the likelihood of the data given the model parameters, p is the number of model
parameters and n is the number of observations. Note that BIC penalizes larger models more
heavily and so will tend to prefer smaller models in comparison to AIC. Both AIC and BIC
can be used as selection criteria for all models both nested and non-nested, although for nested
models the likelihood ratio test is preferred.
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5.3. Resampling methods in the context of combining multiple biomarkers and
estimation of the AUC
Diagnostic tests are important components in modern medical practice. Recall that the ROC
curve is a graphical tool for evaluating the discriminatory accuracy of diagnostic tests and the
AUC is the most popular summary index of discriminatory accuracy. When we have several
biomarkers with varying information about a condition or disease, it might be beneficial to
combine them in order to obtain better diagnostic accuracy with a goal of maximising the
AUC over all possible combinations (Fang et al. [44]).
As pointed out in Fang et al. [44], the procedure of combining multiple test results has been
well studied. For example, Su and Liu [130] discussed the optimal linear combination under
the multiple-normal assumption; Pepe and Thompson [103], Pepe, Cai, and Longton [106];
and Ma and Huang [84] discussed this procedure under the generalised linear model (GLM)
assumption or formulation. Copas and Corbett [25] addressed the over-fitting problem (arguing
that using the same data both to fit the prognostic score and to calculate its ROC tends to
give an over optimistic estimate of the performance of the score) when combining tests through
a logistic regression model. In this thesis we use the logistic regression model, which is often
used to find a linear combination of covariates that best discriminates between two populations.
The purpose of this section is to briefly discuss the resampling methods with application to
estimating the AUC in the context of variable selection.
In recent years many emerging statistical analytical tools, such as resampling methods have
been gaining attention among psychological and educational researchers. However, many re-
searchers tend to embrace traditional statistical methods rather than experimenting with these
new techniques, even though the data structure does not meet certain parametric assumptions.
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Resampling techniques are rapidly entering mainstream data analysis; some statisticians be-
lieve that resampling procedures will soon overtake common traditional non-parametric pro-
cedures and may displace most parametric procedures as well.
Resampling procedures are statistical inference methods based on generating repeated samples
drawn from the original sample. Compared to standard methods of statistical inference, these
modern methods often are simpler and more accurate, require fewer assumptions. Resampling
provides clear advantages when assumptions of traditional parametric tests are not met, as
with small samples from non-normal distributions. Additionally, resampling can address ques-
tions that cannot be answered with traditional parametric or non-parametric methods, such as
comparisons of means, medians or ratios. Thus, resampling also has the advantage of concep-
tual simplicity. Classical parametric tests compare observed statistics to theoretical sampling
distributions. Resampling is a revolutionary methodology because it departs from theoretical
distributions. Rather, the inference is based upon repeated sampling within the same sample.
Indeed, the resampling method is tied to the Monte Carlo simulation, in which researchers
“make up” data and draw conclusions based on many possible scenarios [83]. Monte Carlo
simulations are widely used by statisticians to study the actions of different statistical proce-
dures. In resampling one could explore all possible combinations, but such a strategy can be
too time-consuming and computing-intensive.
5.3.1 Over-fitting
In statistics, over-fitting occurs when a statistical model describes random error or noise instead
of the underlying systematic relationship. An over-fitting problem can also be defined as fitting
a statistical model with too many degrees of freedom in the modeling process. Thus over-
fitting leads to users being too optimistic about the performance of the model. Over-fitting
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unrealistically leads to a complex model making the training data set too noisy and too small,
in addition it gives a very rich hypothesis space. The possibility of over-fitting exists because
the criterion in the training data model may not be the same as the criterion used to judge the
efficacy of a model. In particular, a model is typically trained by maximising its performance
on some set of training data. However, its efficacy is determined not by its performance on
the training data but by its ability to perform well on unseen data. It may occur that a model
begins to memorize training data rather than learning to generalise to new data. In other
words, validating a model using the same data used to develop it is no evidence of prediction
accuracy for the data.
One very common way of selecting variables for a regression model is to start with a series
of univariate models to study the relation between each variable and the response. Then one
selects only those variables significant for entry into the subsequent multivariate regression
analysis. However the process still leads to degrees of freedom being spent against the sample
and leading to increased risk of over-fitting. Using univariate prescreening also creates other
problems in the context of multivariable modeling. Variables in isolation may behave quite
differently with respect to the response variable than when they are considered simultaneously
with one or more other variables. The relation between a variable and an outcome may not
appear to be important at all in the univariate case, but may become quite important after
adjustment for other covariables and vice-versa.
In order to avoid over-fitting, it is necessary to use additional techniques such as cross-validation
and bootstrapping. The basis model validation techniques is either to explicitly penalize overly
complex models, or to test the model’s ability to generalise by evaluating its performance on
a set of data not used for training, which is assumed to approximate the typical unseen data
that a model will encounter.
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Bootstrap validation of models also has been shown to be superior to older techniques of model
validation, such as splitting the data set into training and validating data sets. Enhancements
to models - such as shrinkage techniques - allow us to understand the extent of over-optimism
and generate an estimate of how well the model might fit in a new sample. In the following
we discuss some of the above mentioned resampling techniques.
5.3.2 Cross-validation
Cross-validation is useful in dealing with the problem of over-fitting. Validation techniques are
motivated by fundamental problems such as model selection and performance estimation. As
we mentioned before, over-fitting is one aspect of the larger issue of what statisticians refer
to as shrinkage. Cross-validation techniques are one way to address this over-fitting bias and
it is a model evaluation method that is better than simply looking at the residuals. Residual
evaluation does not indicate how well a model can make new predictions on cases it has not
already handled. Cross-validation techniques tend to focus on not using the entire data set
when building a model but rather on subdividing the data into training and validation or
testing subsets. Some cases are removed before the data is modelled; these removed cases
are often called the testing set. Once the model has been built using the cases - often called
the training set - the cases which were removed - the testing set - can be used to test the
performance of the model on the “unseen” data.
Recall that the prediction error (PE) is a quantity that measures how well the model predicts
the response value of a future observation. It is often used for model selection since it is
sensible to choose a model that has the lowest prediction error among a set of candidates
[39]. In regression models it is referred to as the expected squared difference between a future
response and its prediction from the model that is PE = E(y − ŷ)2.
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Cross-validation is mainly used in settings where the goal is prediction and one wants to
estimate how accurately a predictive model will perform in practice. It is a strong standard
tool for estimating prediction error and it is a specialized resampling procedure that is designed
specifically for application in model validation problems. It can be used to estimate the error
of a given model as a basis for model selection by choosing one of several models that has the
smallest estimated prediction error. Cross-validation is important especially in cases where
further samples are costly or impossible to collect.
Cross-validation is only valid if the test set is not used in any way in the development of
the model. Using the complete set of samples to select markers violates this assumption and
invalidates cross-validation. With proper cross-validation, the model must be developed from
scratch for each leave-k-out training set. This means that feature selection must be repeated
for each leave-k-out training set. The objective of variable selection is to avoid over-fitting,
improve model performance and provide faster and more effective predictors.
As we have indicated earlier; if many diagnostic tests are available and some of them are
redundant, then we want to seek an optimal subset of diagnostic tests where the combined
test has the largest AUC. Note here the term test has same meaning as a biomarker. Thus
for each subset of diagnostic tests we calculate the cross-validation estimation of the AUC
and then we choose the subset of diagnostic tests, which give the largest - or maximises - the
cross-validated AUC as the best one. We remark that including the redundant diagnostic tests
in the combination will decrease the AUC. This gives rise to the variable selection problem
[39].
Cross-validation is accomplished by implementing the following steps.
• Leaving out a portion of the sample.
87
Chapter 5 – Combining multiple biomarkers in diagnostic testing for
cross-sectional data
• Building the prediction rule on the remaining sample (training set).
• Predicting the class labels of the left out (test set) sample.
There are many types of cross-validation. We will discuss some of them below.
5.3.3 K−fold cross-validation
K−fold cross-validation can be summarized in the following steps:
• Split the full dataset into K randomly equal sized subsets. Keep one of them for testing
the model and use the other K − 1 parts as training data.
• Fit the model to the K− 1 parts included and calculate the prediction error of the fitted
model when predicting the k-th part of the data left out.
• repeat the above step for all k = 1, 2, · · · ,K data subsets and average the K results from
the K-fold prediction.
The advantage of this method is that all observations are used for both training and testing
and each observation is used for testing exactly once and used for training K − 1 times. Note
that the variance of the resulting estimate is reduced as K is increased. On the other hand
the training algorithm has to be rerun from scratch K times.
The simplest case of K−fold cross-validation is when K = 2 (2−fold cross-validation). For
each fold, we randomly assign data points to two sets, so that both sets are equal size. We
then train on the first set and test on the second set, followed by training on the second set and
testing on the first set. This has the advantage that each data point is used for both training
and validation on each fold.
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5.3.4 Leave one out cross-validation (LOOCV)
This is same as the K-fold cross-validation with K being equal to the number of observations
in the original sample. We use a single observation from the original sample as the validation
data, and the remaining observations as the training data. This is repeated such that each
observation in the sample is used once as the validation data. Leave one out cross-validation
is a common choice for small sample sizes. It is accomplished through the following steps:
• The full dataset is divided into training and test (validation) sets. The test set contains
a single observation.
• The prediction rule is built from scratch using the training set.
• The rule is applied to the observation in the test set for class prediction.
• The process is repeated until each observation has appeared once in the test set.
Cross-validation is a method for estimating the error rate given test data not used in the
training stage. Regardless of what value you set for K-fold cross-validation, using a K of 10-20
gives better results than using a smaller number, but each number could result in a slightly
different error estimate.
5.3.5 Bootstrap method
In 1979 Efron [37] introduced the bootstrap as a general method for estimating the sampling
distribution of a statistic based on the observed data.
Bootstrapping can be used to estimate measures of accuracy to statistical estimates. Bootstrap
estimation of the true error rate [122] is an alternative to cross-validation. Bootstrapping is
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accomplished by selecting with replacement n observations from among the original set of n
observations (unlike in the cross-validation). With bootstrapping the original sample could be
duplicated as many times as computing resources allow. Also every resample has the same
number of observations as the original sample. Thus the bootstrap method has the advantage
of modeling the impact of the actual sample size. It should be noted that a predictive model is
developed from scratch; this includes the variable selection step with each bootstrap replicate.
The model is then used to predict the class for each observation not in the bootstrap sample.
Each prediction is recorded as correct or incorrect. This process is repeated for many bootstrap
samples and the average number of misclassifications per prediction is used as an estimate of
the misclassification rate [122]).
To understand bootstrap, suppose it were possible to draw repeated samples of the same size
from the population of interest, a large number of times. Then it is possible to get a fairly
good idea about the sampling distribution of a particular statistic from its estimated values
arising from these repeated samples. The purpose of a sample study is to gather information
cheaply in a timely fashion. The idea behind bootstrap is to resample with replacement from
the sample data at hand and create a large number of bootstrap samples. The sample summary
is then computed on each of the bootstrap samples.
The bootstrap method has been shown to be successful in many situations, therefore being
accepted as an alternative to the asymptotic methods. In fact, it is better than some other
asymptotic methods, such as the traditional normal approximation.
In this method estimates θ∗b , b = 1, 2, · · · , B of the parameter of interest θ are calculated from
B pseudo samples. Then an estimate of the bootstrap variance of the parameter of interest is
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It has been suggested that the number of replicate samples needs to be large. Efron[39] stated
that a large B would be 200 replicates and generally variance decreases as the number of
replicate samples increases. For this reason we use 1000 bootstrap replicates in both simulation
studies and application to real dataset.
5.3.6 Bootstrap standard errors and confidence intervals
Let F̂ be the empirical distribution. A bootstrap sample is defined to a random sample of size
n drawn from F̂ , say x∗ = (x∗1, · · · , x∗n). The bootstrap data points (x∗1, · · · , x∗n) are a random
sample of size n drawn with replacement from the population of n objects (x1, · · · , xn). Thus
some members of original data may not appear in the bootstrap sample and others may appear
more than one times. A bootstrap replicate estimate θ̂∗ is given by:
θ̂∗ = s(x∗),
where s(x∗) is the estimating function S(.) applied to x∗ as was applied to x. The bootstrap
estimates of standard error seF̂ (θ̂
∗) is the standard error of θ̂ for data sets of size n randomly
sampled from F̂ . Below is the algorithm for estimating the standard error of θ̂ = s(x) from
the observed data x.
• Select B independent bootstrap samples x∗1, · · · , x∗B each consisting of n data values
drawn with replacement from x. The number of bootstrap replicates B will ordinarily
be in range 25− 200.
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• Evaluate the bootstrap replication estimate corresponding to each bootstrap sample,
θ̂∗(b) = s(X∗b), b = 1, 2, · · · , B.


















Confidence intervals for a given population parameter θ are sample based whose range [θ1, θ2]
given out for the unknown number θ . The range possesses the property that θ would lie
within its bounds with a high (specified) probability. The latter is referred to as confidence
level. Of course this probability is with respect to all possible samples, each sample giving rise
to a confidence interval which thus depends on the chance mechanism involved in drawing the
samples. The two mostly used confidence coefficients are 95% and 99%. We limit ourselves
to the level 95% for our work here. Traditional confidence intervals rely on the knowledge of
sampling distribution of θ̂, exact or asymptotic as n→∞.
There are two rules for the number of replicates:
• Even a small number of bootstrap replicates, for example B = 25, is usually informative
and B = 50 is often enough to give a good estimate of seF (θ̂).
• Very seldom are more than B = 200 replications needed for estimating a standard error,
Much bigger values of B are required for bootstrap confidence intervals.
Standard errors are often used to assign approximate confidence intervals to a parameter θ of
interest. Given an estimate of θ̂ and estimated standard error ŝe the usual 95% confidence
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interval for θ is
θ̂ ± 1.96ŝe.
The number 1.96 comes from standard normal table.
5.3.7 Bootstrap cross-validation
The method is proposed by Fu et al. [51] to handle small sample problems. The procedure
generates B bootstrap samples of size n from the observed sample and then calculates a leave-
one-out cross-validation estimate on each bootstrap sample. Averaging the B cross-validation
estimates gives the bootstrap cross-validation estimate for the prediction error. The authors
of [51] did not carefully address the issue of feature selection when the method is applied
to high dimensional gene expression data. The bootstrap cross-validation method tends to
underestimate the true prediction error.
5.3.8 Leave-one-out bootstrap
The leave-one-out bootstrap procedure [39] generates a total of B bootstrap samples of size n.
Each observation is predicted repeatedly using the bootstrap samples in which the particular
observation does not appear. In this way, the method avoids testing a prediction model on
the observations used for constructing the model. The leave-one-out bootstrap is basically a
smoothed version of the leave-one-out cross-validation. The leave-one-out bootstrap estimate
has much smaller variability than the leave-one-out cross-validation estimate. A bootstrap
sample of size n contains roughly 0.632n distinct observations from the original sample. It is
often inadequate to represent the distribution of the original data when the sample size n is
small. Hence the leave-one-out bootstrap estimate tends to overestimate the true prediction
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error.
For estimation of bootstrap leave one out cross-validated AUC, we drew a bootstrap sample and
performed AUC cross-validation on the bootstrap sample. We used 1000 bootstrap replicates
and obtained 1000 AUC estimates, and then we calculated the mean for these 1000 AUCs in
order to obtain a single AUC.
Bootstrapping was used to get the variance estimates for the cross-validated AUC as the
bootstrap estimates have smaller variances, especially for small sample sizes.
In our case we used leave-one-out cross-validation (LOOCV) as it is nearly unbiased, easy to
implement and to understand. In the LOOCV function, we split the full dataset into training
and a test, which contains a single observation. The training set consists of the other remaining
observations. For the training set, we used logistic regression to build our predictive models
together with stepwise variable selection method based on AIC criteria. This gives prediction
values between 0 and 1. The process is repeated until all the possible sets are selected. Finally
the tested observations are then pooled together to estimate the AUC. Formally, the AUC is








where H is the Heaviside step function defined by
H(x) =

1 if x ≥ 0.5,
0 if x < 0.5,
C{i} and C{j} denote classifiers trained without the i
th and jth respectively and X+ ⊂ X and
X− ⊂ X denote the positive and negative samples in the training set X respectively.
94
Chapter 5 – Combining multiple biomarkers in diagnostic testing for
cross-sectional data
5.3.9 Algorithm to obtain the AUC through cross-validation
The following is a leave one out cross-validation algorithm.
• The full dataset is divided into training and test (validation) sets. The test set contains
a single observation.
• For the training set, feature selection is performed from scratch to build a predictive
model.
• Predicting the part of the data left out.
• This gives a value in (0,1) for each subjects.
• The process is repeated until all the possible sets are selected.
• These values can be used to estimate the AUC.
5.3.10 Algorithm to estimate the variance of AUC through bootstrapping
The Bootstrap is used to obtain variance estimates of the cross-validated AUC. The following
is the procedure to do this.
• Draw a bootstrap sample, stratifying by disease status.
• Perform cross-validation as described in previous algorithm on the bootstrap sample.
• Estimate the SE of the cross-validated AUC based on the bootstrap replicates.
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5.4. Logistic regression
Logistic regression is part of a broader family of generalised linear models (GLMs), where the
conditional distribution of the response falls in the Bernoulli or Binomial distribution, and
the parameters are set by the linear predictor. Ordinary least-squares regression is the case
where response is Gaussian, with the mean equal to the linear predictor, and constant variance.
Logistic regression is the case where the response is binomial, in R, any standard GLM can be
fit using the (base) glm function. The major wrinkle is that, of course, one needs to specify the
family of probability distributions to use, by the family option “binomial” defaults to logistic
regression.
Logistic regression is commonly used when the outcome or response is the presence or absence
of a condition, often a disease. In these cases, the explanatory variable is often a test or pro-
cedure used to detect this condition. Logistic regression allows us to convert these agreement
proportions into probabilities of having the disease. In addition, these probabilities can be
converted into sensitivity and specificity which can be used to determine the accuracy of a
procedure or test in successfully predicting the absence or presence of a condition. The most
common regression model used to model binary outcomes such as disease outcomes is the
logistic regression model given by
log
P (Y )





where Yi, i = 1, 2, · · · , p are the p disease markers of interest measured from each subject or
case and Y = (Y1, · · · , Yp)
′
, βi, i = 1, 2, · · · , p is the regression coefficient for Yi, and β0 is the
intercept, the value of the log odds when Yi = 0 for all i i.e. the null model with no additional
information on the odds of the outcome. The model falls under a broader class of models
called generalized linear models [92]. We can compute the probability P from the regression
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equation also. So, if we know the regression equation, we could, theoretically, calculate the
expected probability that D = 1 for a given value of the vector Y = (Y1, Y2, · · · , Yp)
′
. Logistic
regression is one of the most commonly used tools for applied statistics.
Advantages of logistic regression:
• The technique is traditional and easy to understand and implement. It is very useful
for understanding the influence of several independent variables on a single dichotomous
outcome variable.
• The quantity log p/(1− p) plays an important role in the analysis of contingency tables
(the log odds). Classification is a bit like having a contingency table with two columns
(classes) and infinitely many rows (values of y).
• It is closely related to the exponential family which arises in many contexts in statistical
theory, thus there are lots of problems which can be turned into logistic regression.
• It often works surprisingly well as a classifier.
• The dependent and independent variables do not have to be normally distributed.
• It does not assume a linear relationship between the dependent and independent vari-
ables.
• It may handle nonlinear effects.
• There is no homogeneity of variance assumption.
• Normally distributed error terms are not assumed.
Disadvantages of logistic regression:
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• Logistic regression cannot predict continuous outcomes.
• Logistic regression requires that each data point be independent of all other data points.
When using the logistic distribution, we need to make an algebraic conversion to arrive at our
usual linear regression equation. The goal of logistic regression is a bit different, because we are
predicting the likelihood that Y is equal to 1 rather than 0 given certain values of Y . That is,
if Y and D have a positive linear relationship, the probability that a person will have a score of
D = 1 will increase as values of Y increase. So we are concerned about predicting probabilities
rather than the scores of dependent variable. As mentioned before logistic regression predicts
probabilities and since the modeling is based on a given distributional assumption, the Bernoulli
model, we can fit or estimate the model using a likelihood approach. Since the probabilities of





P (Y )D(1− P (Y ))1−D.

















log(1− P (Y )) +
n∑
i=1




− log(1 + exp(β0 + Y β)) +
n∑
i=1
D(β0 + Y β).
Iterative methods such the Newton-Raphson, Iterated (Re-)Weighted Least squares and the
Fisher scoring can easily be used to estimate the parameters of the model including their
asymptotic variances.
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5.5. Linear discriminant analysis
Discriminant analysis is a statistical technique that allows one to understand the differences
between two or more groups with respect to several variables simultaneously. In other words,
the aim of discriminant analysis is to classify an observation, or several observations, into these
known groups. In general, discriminant analysis is concerned with the development of a rule
for allocating objects into one of some distinct groups. Then the constructed classification rule
will be used to determine a group membership for some future objects.
In different papers (see for example [42, 103, 130]), linear combinations of markers that max-
imise the area under the receiver operating characteristic curve have been proposed. However,
none of them can be applied in all possible scenarios.
We used the normal linear discriminant approach LDA to estimate the true value of the AUC.
As it has been mentioned before the simulated outcomes yD and yD are distributed as a
multivariate normal with means µD and µD for the diseased and non-diseased populations
respectively and corresponding variance-covariance matrices given by ΣD and ΣD. With the










where Φ denotes the standard normal cumulative distribution function [103].
5.6. Algorithm
In this section we supply an algorithm for the computations of the AUC.
• The first step is to evaluate the diagnostic performance of biomarkers: We estimate the
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diagnostic accuracy of each biomarker by computing and plotting the ROC curve and
estimating its area under the ROC curve using roc and auc functions in pROC package in
R software. The area under an ROC curve captures the overall diagnostic accuracy of the
test. In our proposed algorithm, a non-parametric estimate of the area using trapezoidal
rule is used in this step for the classical ROC curve (binary response). AUC with high
values indicate diagnostically informative biomarkers and low values suggesting a low
discriminatory performance of the biomarkers. We also obtained the confidence interval
for each biomarker AUC using bootstrapping. However, since the diagnostic performance
of one biomarker may be correlated with that of others the single biomarker may not
give a good AUC and thus the biomarker combination method was used. This leads to
step two below.
• The second step is undertaken to optimise the set of biomarkers with high and indepen-
dent diagnostic information content in a multivariate setting. There are critical issues
that need to be considered in this step: choosing an appropriate statistical method for
multivariate analysis, choosing the number of diagnostically informative biomarkers to
be entered into the multivariate model and using an appropriate method to optimise the
number of finally selected biomarkers. As the outcome variable is by definition dichoto-
mous, the likely choices can be methods like logistic regression or probit regression. In
our algorithm we use logistic regression (implemented using the glm function in stats
R package) for binary response outcomes and linear discriminant function model which
is an extension of the linear regression model and can also be used in place of logistic
regression. Therefore the linear discriminant score is used. Stepwise regression using
backward elimination procedure based on stepAIC function within the MASS package
was used.
• Before applying the algorithm to derive a discriminatory rule and in order to avoid the
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over-fitting problem associated with model selection, we split each original dataset into
a training set and a validation set. This split is done as many times as the number
of individuals, because we use leave one out cross-validation (LOOCV) as described
in Subsection 5.3.9. We also report bootstrapping LOOCV estimator of AUC and its
variance as in Subsection 5.3.10. We wrote our own code in R for estimating the bootstrap
LOOCV AUC and its variance. Feature Selection was done from scratch for each training
set.
5.7. Simulation studies
In this section we are mainly concerned with examining the performances of different methods,
with particular interest to cross-validation and bootstrap cross-validation, as methods for the
estimation of the AUC and its variance. Our simulation is based on different assumptions of
biomarkers correlations in order to understand the effect of different correlations on the AUC
estimation.
We simulate datasets under the following group settings: Assume that there are K diagnostic
tests (corresponding to K biomarkers) Y1, Y2, · · · , YK . In our case, we let K = 5, that is five
biomarkers Y1, Y2, Y3, Y4 and Y5. Let the mean vector of the K biomarkers in diseased and
non-diseased be denoted by µDk and µ
D
k respectively.
With the above settings, the biomarker outcomes yDik and y
D
jk for diseased and non-diseased
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where the notation and assumptions in our case are
• n (resp. m) is the number of individuals from diseased (resp. non-diseased) population
and i (resp. j) is the index for the set {1, 2, · · · , n} (resp. {1, 2, · · · ,m}),
• k is the index for a biomarker,
• aDi (resp. aDj ) is the subject specific random effect which is assumed to follow the normal
distribution that is aDi ∼ N(0, 0.5) (resp. aDj ∼ N(0, 0.5)) and
• εDik (resp. εDjk) is the random error effect also assumed to follow the normal distribution
εDik ∼ N(0, 0.25) (resp. εDjk ∼ N(0, 0.25)).
We use small variances (0.25 and 0.5) in simulation since low variance means that, in general,
samples will be close to the mean and hence to each other.
The outcome vectors yD and yD are respectively generated from three multivariate normal
distributions with means given by µDk = (0.5, 0.25, 0, 0, 0) and µ
D
k = (0, 0, 0, 0, 0) for three
group settings defined by three different variance-covariance matrices. The three variance-
covariance matrices are as follow:
• For the first setting (Model 1) we assume independence between all the biomarkers and
consequently we will have variances in the main diagonal and zeros elsewhere.
• For the second setting (Model 2) we add dependence for the biomarkers Y1 and Y2.
• For the third setting (Model 3) we assume the same dependence across all the biomarkers.
The resulting covariance structure is the exchangeable or compound symmetry.
Biomarkers from simulated datasets were used to evaluate whether a combination of these
102
Chapter 5 – Combining multiple biomarkers in diagnostic testing for
cross-sectional data
biomarkers can accurately discriminate between two groups of diseased and non-diseased indi-
viduals after applying logistic regression to predict the disease outcome for different biomarker
combinations and applying re-sampling methods. Stepwise regression is a standard procedure
for variable selection, which is based on the procedure of sequentially introducing the predictors
into the model one at a time. Stepwise selection is a variation of forward selection. At each
step of the variable selection process, after a variable has been added to the model, variables
are allowed to be eliminated from the model. In the simulations and application we applied
stepwise variable selection using the AIC criterion to select the biomarkers implemented using
the stepAIC function from MASS R package.
An original R program was written to carry out this process for the simulated data. We
calculated the AUC (from the auc function available in pROC package) after combining the
biomarkers using bootstrap Cross-Validation which we denote by AUCbcv. Computing cover-
age probability is complex in this setting, therefore we evaluated the performance of the fixed
predictor model on a large simulated dataset of sample sizes set at 10 000.
Table 5.1 shows a summary of different types of quantities which were estimated from the
analysis. These include first: The true AUC based on LDA (AUCTLD), the mean of Cross-
Validated AUCs (AUCcv) across 1000 simulations, the mean of Bootstrap Cross-Validated
AUCs (AUCbcv) across 1000 simulations, in columns 1, 2 and 3 respectively.
Columns 4, 5 and 6 include respectively the confidence interval (CI) of Cross-Validated AUC
(AUCcv) across 1000 simulations, the confidence interval for AUCcv based on standard errors
obtained from the Hanley and McNiel [61] method, the confidence interval of AUCbcv based
on asymptotic normality using bootstrap standard errors.
Proportion of times lower confidence limits of AUCcv and AUCbcv excludes 0.5, are listed
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in columns 7 and 8 respectively. In columns 9 and 10 we show respectively the coverage
probabilities of AUCcv and AUCbcv that include the true AUC (TAUC).
Columns 11, 12, 13 and 14 display respectively the empirical standard errors for AUCbcv
(SEb.e), bootstrap standard errors (SEb), the empirical standard errors for AUCcv (SEe.cv)
and the standard errors for AUCcv (SEcv) using the Hanley and McNeil Equation [61].
Finally the last three quantities reported are the prediction errors (PE), true prediction errors
(TPE) and the true AUC (TAUC) obtained from a large dataset.
With a total sample size N = 200, bootstrap replicates B = 1000 and number of simulations
nsim = 1000, we used the proposed three variance-covariance matrices specified under Models
1, 2 and 3 respectively in Table 5.1 together with the mean vectors of diseased and non-diseased
µD and µD to perform our simulation. In the simulations 1000 AUC values were estimated.
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Table 5.1 (continued)
SEe.b SEb SEe.cv SEcv PE TPE TAUC
Model 1: (the no 0.039 0.0525 0.0515 0.0387 0.389 0.384 0.662
correlation case)
Model 2: (with





between all 0.033 0.0434 0.048 0.036 0.342 0.339 0.722
the biomarkers)
From Table 5.1, we can see that:
• For Model 1, the AUCTLD equals to 0.6772 while the TAUC equals to 0.662 which means
that using a large dataset gives AUC values (TAUC) nearly close to true AUC from LDA
(AUCTLD). The values of AUCcv and AUCbcv are very close to each other and they are
nearly unbiased as their values are very close to the true AUC values.
Based on CIs for both AUCcv and AUCbcv we deduce that the two methods yield a
significant discriminatory probability (the CI’s do not include 0.5). We also investigated
the the level of discrimination of the two methods by looking at how often the lower
limits exclude an AUC = 0.5. The proportion of times lower limits of CIs for AUCcv
and AUCbcv exclude 0.5 are 0.903 and 0.875 respectively. Clearly, both methods (cross-
validation and bootstrap cross-validation) perform well given only 9.7% and 12.5% of the
times do the lower limits respectively include the threshold of 0.5.
The coverage probabilities (proportion of times the CI’s include the true AUC values)
for AUCcv and AUCbcv, shows that 875 out of 1000 CI’s of AUCcv include the true
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AUC values, while 963 out of 1000 CI’s of AUCbcv include the true AUC values. This
indicates that the bootstrap cross-validated AUC estimation method performs better
than just cross-validated AUC estimation. We also found that the bootstrap method
produces larger variances therefore yielding larger standard errors while using the Hanley
and McNeil method gives smaller standard errors. Finally, both PE and TPE values are
similar to each other.
• For Model 2, the AUCTLD equals to 0.6628 while the TAUC equals to 0.649. The AUCcv
and AUCbcv equal to 0.639 and 0.655 respectively. This result indicates that values of
AUCcv and AUCbcv based on a model with some correlation are close to each other and
nearly unbiased since their values are close to the true AUC values.
Based on CIs for both AUCcv and AUCbcv we deduce that the two values of AUCcv and
AUCbcv are statistically significant because they both exclude 0.5 the value under H0.
However the AUC values tend to be lower here than in Model 1. The results from Model
2 also show that the bootstrapping is better than just cross-validation for estimating the
coverage probability and it gives AUC values close to true AUC.
• From Model 3 CIs for both AUCcv and AUCbcv we deduce that the two values of AUCcv
and AUCbcv are statistically significant (the CI’s do not include 0.5).
The proportion of times lower limits of CIs for both AUCcv and AUCbcv that exclude
0.5 are 0.982 and 1 respectively. The coverage probabilities of CI’s (include true AUC
values) for both AUCcv and AUCbcv are 0.896 and 0.960 respectively, indicating that the
bootstrap affords confidence intervals that most of them include the true AUC.
From the above results we can see that LOOCV is nearly unbiased as a method of estimating
the AUC for the three models. It appears that the bootstrap cross-validated AUC values are
larger than the cross-validated AUC values. Most of the bootstrap cross-validated confidence
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intervals contained the true values of AUC. We conclude by remarking that using Model 3
(with correlation) is preferable since it yielded the highest AUC values and smallest variance
compared to other two models. Furthermore the bootstrap method gives larger variances
compared to empirical variances.
5.8. Application to TB-IRIS
The dataset that is used was collected in a study to investigate the occurrence of tuberculosis
immune reconstitution inflammatory syndrome (TB-IRIS). According to a recent paper by
Marais et al., [90], paradoxical TB-IRIS occurs in 8 − 43% of HIV-infected patients receiving
TB treatment after starting antiretroviral therapy (ART) in South Africa. It was reported
that TB-IRIS results from rapid restoration of Mycobacterium tuberculosis (M. tuberculosis)-
specific immune responses. A prospective observational study targeting adults (≥ 18 years)
ART-naive HIV-infected patients presenting with meningitis was carried out at GF Jooste
Hospital, a public sector referral hospital in Cape Town. The hospital serves a low-income,
high-density population in which the TB notification rate exceeds 1.5% per year with 70% of TB
cases co-infected with HIV. This study was carried from March 2009 through October 2010. For
more details about these biomarkers, we refer the reader to [9, 27, 82, 88, 107, 142, 148]. There
are not many published studies describing tuberculous meningitis TBM-IRIS. The authors
of [90] investigated clinical and laboratory findings in ART-naive HIV-infected patients who
presented with TBM. They based their study on serial cerebrospinal fluid (CSF) samples in
patients who did and did not develop TBM-IRIS.
Five biomarkers, namely Interleukin 6 (il6), interleukin 10 (il10), interleukin 12p40 (il12p40),
interferon gamma (infg), and tumor necrosis factor alpha (tnfa) were selected as candidate
markers of TBM-IRIS. These biomarkers were measured in CSF at the time of TBM diagnosis.
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The authors of [90] suggested an analysis model for evaluating the multivariate biomarkers
model. They selected significant biomarkers using Wilcoxon rank sum tests for a logistic re-
gression model and the final model was found by dropping the non-significant biomarkers. The
authors of [90] used bootstrap cross-validation method to build the model and the permuta-
tion test to provide a cross-validated estimate of the AUC and confidence intervals. In this
manuscript we used bootstrapped cross-validation to estimate AUCs and CIs and in addition
to that we did not pre-specify the biomarkers but allowed the most informative biomarkers
come out of the model.
First we considered AUC estimation individually for each biomarker in order to evaluate the
performance of each biomarker in distinguishing between IRIS and Non-IRIS groups. However
our main purpose was to calculate the AUC after combining biomarkers using resampling
methods. Baseline levels of five biomarkers were used to evaluate whether a combination of
these biomarkers could accurately discriminate between IRIS and non-IRIS patients. This was
accomplished by applying AUC analysis and resampling.
Graph 5.1 plots the estimated disease risk versus the risk distribution. Risk estimates are based
on a generalised linear binary model for disease risk as a function of the specified marker.
Table 5.2 contains the AUC values for each of the above biomarkers, their 95% confidence
intervals (CI) and standard errors SE. The CI and SE were estimated using the bootstrap
method with 1000 replicates.
As already stated a larger AUC value would suggest that the marker or test is more accurate
in distinguishing between IRIS and non-IRIS subjects and it is expected that the higher the
AUC, the less variability there would be (for example from Table 5.2 the biomarker with the
highest AUC value has the smallest SE). As can be seen in Table 5.2, the results show that
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Figure 5.1: Predictiveness curves for TB-IRIS biomarklers
Table 5.2: AUC values for TB-IRIS biomarkers
Biomarkers AUC value CI SE
il12p40 0.67 (0.48, 0.84) 0.09
tnfa 0.87 (0.74, 0.96) 0.06
infg 0.77 (0.58, 0.94) 0.09
il10 0.66 (0.45, 0.84) 0.1
il6 0.86 (0.74, 0.96) 0.06
fitting a logistic regressions for each biomarker, the smallest AUC values were for il12p40 and
il10 equal to 0.67 and 0.66 respectively and the CIs both include 0.5. The bootstrap technique
provided 95% confidence interval of (0.48, 0.84) and (0.45, 0.84) respectively and their respective
standard errors equal to 0.09 and 0.1. Based on the null hypothesis of H0 : AUC = 0.5 and
from the confidence intervals for the il12p40 and il10, we conclude that il12p40 and il10 AUCs
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are not statistically significant and therefore the two markers individually do not have a high
discriminatory ability between the two groups of IRIS and non-IRIS patients. In addition
their variances which are larger compared to other biomarkers is an indication of less precise
tests. The CI for infg indicates that the AUC for this biomarker is statistically significant;
the estimated AUC value suggests that this biomarker does have a fairly good ability to
discriminate between two groups of IRIS and non-IRIS.
From Table 5.2 we conclude that the two biomarkers tnfa and il6 have the best ability to dis-
tinguish between the two groups of IRIS and non-IRIS patients compared to other biomarkers
as they have the highest statistically significant AUCs values and less variable estimates.
Similar to simulation studies, we calculated the AUC from combination of the five biomarkers
using bootstrap cross-validation with repeated variable selection in each training set. We
also calculated the variance for bootstrap cross-validated AUC the same way we did for the
simulated data.
An R program similar to the one used in simulation studies, was written in order to apply the
bootstrap cross-validation technique of AUC and variance estimation to the IRIS data. In our
case we used 1000 bootstrap replicates.
Table 5.3 shows the results obtained from the application of the bootstrap cross-validation tech-
nique from the model that combines the biomarkers. The AUCbcv is estimated as 0.956 with
Table 5.3: Bootstrap cross-validation of AUC for composite marker from TB-IRIS
AUCbcv SEb CI
0.956 0.036 (0.8153, 0.9907)
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the corresponding bootstrap cross-validated standard error of 0.036. The confidence interval
was found to be (0.8153, 0.9907), which does not contain 0.5 and thus the estimated AUCbcv
is statistically significant. The values of AUCbcv, SEb and CI suggests that the combination
of biomarkers yields a high AUC value and small variability. This shows that the combina-
tion of biomarkers may have a high ability to distinguish between diseased and non-diseases
samples. Applying the cross-validation method (without bootstrapping), we found that the
cross-validated AUC (AUCcv) is given by 0.967, which is larger than the AUC from bootstrap
AUCbcv, although the difference is small. We also estimated the PE from cross-validation ap-
plied to the logistic regression as PE = 0.059, indicating that the model performance is good.
It is clear that the AUC obtained by combining multiple biomarkers using both cross-validation
and bootstrap cross-validation methods have high distinguishing accuracy between IRIS and
non-IRIS subjects compared to AUC based on involving single biomarker in the model.
Figure 5.2 contains the ROC curves, AUCs and CIs for two of the biomarkers, namely tnfa
with a high significant AUC of 0.87 (95%CI : 0.74, 0.96) and il10 with a low non-significant
AUC of 0.66 (95%CI : 0.45, 0.84).
Figure 5.3 shows empirical and smoothed ROC curves for tnfa. It also shows the AUC value
corresponding to the best threshold.
We conclude this section by remarking that resampling methods (e.g., cross-validation and
bootstrap) in terms of variable selection for the purpose of estimating the AUC for a model
that combine biomarkers for both simulated and real datasets (TB-IRIS) gives deep insight in
understanding the disease and provide a more accurate diagnosis of the disease.
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Figure 5.2: ROC curves for tnfa and il10
5.8.1 Conclusion
In this chapter, we used stepwise logistic regression combined with LOOCV bootstrapping in
the estimation of the AUC. The AUC which is the area under the ROC is a popular summary
index to evaluate the discriminatory accuracy of a diagnostic method. It can also be used to
assess the ability of a prognostic factor to correctly distinguish patients who have an event
such as a disease from those who do not. In the application to TB-IRIS data, for example, our
estimated AUC value using the composite marker was 0.96. This means that the combination
of biomarkers has high ability to predict TB-IRIS.
We studied the proposed methodology by simulating three correlation scenarios (no correlation,
two biomarkers with some correlation, same correlation between all pairs of biomarkers or the
exchangeable correlation structure).
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Figure 5.3: ROC curve for tnfa
We found that Model 3 gives higher AUC values compared to the other models. This shows
that accounting for correlation between biomarkers gives a better predictive model than a
model that ignores it. We also deduced that LOOCV gives nearly unbiased AUC estimates
and using bootstrap LOOCV estimator gives high coverage probability. We note that the
bootstrap method gives larger variances compared to empirical variances, and its coverage
probability is at or above the nominal level. In addition AUC estimates based on bootstrap
cross-validation are larger than those based on cross-validation alone. An interesting point
noted is that our proposed method gives similar AUC estimates to those using either large
independent dataset or LDA.
An application to IRIS dataset reveals that the bootstrap LOOCV for combining TB-IRIS
biomarkers gave higher AUC value than using a single biomarker in the model. Both cross-
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validation and bootstrap cross-validation yield AUC estimations closely to each other.
We would like to mention that in [90], the authors produced a cross-validated AUC of 0.91
which is less than our estimated cross-validated AUC (with or without bootstrapping of 0.956
and 0.967 respectively). In our opinion this is because in this earlier analysis the biomarkers
were pre-specified. This agrees to what we mentioned before that variable selection should be
done in each training set.
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6.1. Introduction
Current available methods in analysing ROC curves are limited to complete data sets and
classical ROC analysis. However in the development of prognostic models the presence of
missing data is a frequently encountered problem and cannot be overlooked. Using the complete
case analysis to deal with missing values will reduce the sample size for analysis considerably if
the missing rate is high. This might distort the results by introducing bias into the estimation
of model parameters and the prediction accuracy in a predictive model. Thus it is necessary
to consider some of the methods for handling missing data in order to mitigate this problem in
diagnostic testing. It is also important to make robust assumptions regarding the missing data
mechanism. In this work, we use three imputation techniques namely, mean, nearest neighbor
hot-deck and multiple imputation (discussed in Chapter 4) to impute variables containing
missing values.
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The classic ROC curve deals with dichotomous diagnostic outcomes (presence or absence of
disease) but in the real world we often deal with time-dependent disease outcomes and thus
ROC curves that vary as a function of time become necessary [66].
The aim of this chapter is to improve the discriminating accuracy and performance of a di-
agnostic test, and compare imputation methods when estimating the time dependent AUC in
the presence of missing values. That is to discriminate between subjects who may have an
event of interest and those who may not. In addition it is appealing to use resampling meth-
ods to adjust for over-fitting associated with model selection that have been applied to choose
important biomarkers or covariates. We applied different imputation methods when handling
missing values and evaluated different resampling methods to estimate the time dependent
area under ROC curves. Such an approach can be summed up as imputation before AUC
estimation.
In this chapter, the biomarkers are combined using the Cox and logistic regression models
in order to come up with a predictor index. We then predicted the status of cases in the
validation set and then used the predicted values to calculate the time dependent AUC at time
t. Bootstrap cross-validated time dependent AUC values were computed using the nearest
neighbor estimation to measure the predictive accuracy [3, 66]. The bootstrapping technique
was used to obtain the variances of the estimators of interest. The estimation methods were
evaluated using simulations and illustrated using data on primary biliary cirrhosis PBC.
6.2. Missing data and imputation methods
Recall from Chapter 4 that missing data are quite common in biomedical research studies.
Some methodologists have described missing data as one of the most important statistical
and design problems in research. The problem of missing data is of a greater concern when
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decisions are to be made about the appropriateness of the care a patient should receive and
also when we are interested in discriminating subjects as likely to have a certain characteristic
from those who do not.
Recall that Rubin [113, 115] came up with three missing data mechanisms (discussed in Sec-
tion 4.1). These mechanisms describe the relationships between measured variables and the
probability of missing data. While these terms have a precise probabilistic and mathematical
meaning, they essentially have different explanations for why the data were missed.
In this chapter we consider the three imputation methods (mean, nearest neighbor hot-deck
and multiple imputation) discussed in Section 4.2.
6.3. Methods for estimation of AUC(t)
Let Y be a continuous biological biomarker whose values are an indicator of disease. Suppose
if Y > c for some cut off c it implies an individual is diseased and disease free otherwise. With
survival data we take the time to the event into account since the accuracy may be higher when
the markers are measured closer to the onset of disease. ROC curves that vary as a function of
time may be more appropriate to derive the corresponding time dependent ROC curves [67].
Definitions of time dependent ROC curves rely on first defining time dependent sensitivity
(TPR(c, t) ) and specificity (1 − FPR(c, t)). Then using simple plots of TPR(c, t) versus
FPR(c, t) to get the ROC curve at a specific time point, t. The sensitivity and specificity are
considered as time dependent functions and are given by Equations (3.1) and (3.2).







As mentioned before in Section 3.1 and according to Heagerty and Zheng terminology [67],
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there are two ways of defining cases; cases are said to be incident if Ti = t and cumulative if
Ti ≤ t is used instead. On the other hand, controls are said to be static if Ti > t∗, where t∗ is
a fixed point in time and controls are said to be dynamic if Ti > t.
In this chapter we are interested in distinguishing between people who may experience the
event of interest (which in our case is death) before a given time and those who may still
be event free after that time. Thus we use the theory introduced by Heagerty [66], where
they proposed summarizing the discrimination potential of a marker Y measured at baseline
(t = 0), by calculating cumulative/dynamic ROC(t) curves. They proposed an estimator that
can accommodate censored survival data, which is based on a nearest neighbor estimator for
the bivariate distribution function of (Y, T ), where T represents survival time. This estima-
tor guarantees monotonicity and moreover the censoring process is allowed to depend on the
diagnostic biomarker. Using these definitions (cumulative/dynamic), they defined the corre-
sponding ROC curve for any time t, ROC(t) by using an estimator of the bivariate distribution
function F (c, t) = P (Y ≤ c, T ≤ t), or equivalently S(c, t) = P (Y > c, T > t), provided by
Akritas [3]. This estimator is based on the representation S(c, t) =
∫∞
c S(t|Y = s)dFY (s),
where FY (s) is the distribution function for Y.
We used the Heagerty et al. [66] approach which is briefly presented below. The authors
proposed summarizing the discrimination potential of a marker Y , measured at baseline (t = 0),
by calculating ROC curves for cumulative disease incidence by time t, denoted as ROC(t).
A typical complexity with survival data is that observations may be censored. Two ROC
curve estimators that can accommodate censored data were proposed by Heagerty et al. [66].
A simple estimator is based on using the Kaplan-Meier estimator for each possible subset
{i : Yi > c}. However, this estimator does not guarantee the necessary condition that
sensitivity and specificity are monotone in Y. Another problem with KM-based ROC estimator
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is that the conditional Kaplan-Meier estimator ŜKM (t|Y > c) assumes that the censoring does
not depend on Y . This assumption may be violated as the intensity of follow-up efforts are
influenced by the base line diagnostic marker measurements. An alternative estimator is based
on a nearest neighbor estimator for the bivariate distribution function of (Y, T ), where T
represents survival time. This estimator guarantees monotonicity in addition to the fact that
it allows censoring to depend on Y .
The authors considered sensitivity and specificity as time-dependent functions defined as:
sensitivity(c, t) = P (Y > c|D(t) = 1)
specificity(c, t) = P (Y ≤ c|D(t) = 0)
In the first method Heagerty et al. [66] used the Bayes Theorem to rewrite the sensitivity and
the specificity as
P (Y > c|D(t) = 1) = 1− S(t|Y > c)P (Y > c)
1− S(t)
,
P (Y ≤ c|D(t) = 0) = S(t|Y ≤ c)P (Y ≤ c)
S(t)
,
where S(t) is the survival function S(t) = P (T > t) and S(t|Y > c) is the conditional survival
function for the subset defined by Y > c. Define τn, to be the unique values of Xi, for observed







j 1(Xj = s)∆i∑
j 1(Xj ≥ s)
]
.
The KM estimator uses all of the information in the data, including censored observations, to
estimate the survival function. When obtaining the KM estimator, censoring is assumed to
occur after an event therefore censored observation at or after an event time will be included
in the risk set at that time.
A simple estimator for sensitivity and specificity at time t is then given by combining the KM
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estimator and the empirical distribution function of the marker covariate, Y, as
P̂KM (Y > c|D(t) = 1) =
{1− ŜKM (t|Y > c)}{1− F̂Y (c)}
{1− ŜKM (t)}
,
P̂KM (Y ≤ c|D(t) = 0) =
ŜKM (t|Y ≤ c)F̂Y (c)
ŜKM (t)
,
where F̂Y (c) =
∑
1(Yi ≤ c)/n. One problem with this simple estimator is that it does not guar-
antee that sensitivity (or specificity) is monotone. By definition, we require P (Y > c|D(T ) =
1) > P (Y > c
′ |D(t) = 0) for c′ > c. A valid ROC solution can be provided by using an
estimator of the bivariate distribution function, F (c, t) = P (Y ≤ c, T ≤ t), or equivalently
S(c, t) = P (Y > c, T > t), provided by Akritas [3]. This estimator is based on the represen-
tation S(c, t) =
∫∞
c S(t|Y = s)dFY (s) , where FY (s) is the distribution function for Y . As






Ŝλn(t|Y = Yi)I(Yi > c),
where Ŝλn(t|Y = Yi) is a suitable estimator of the conditional survival function characterised
by a parameter λn.
Define the weighted Kaplan-Meier estimator as:





jKλn(Yj , Yi)I(Zj = s)δj∑
jKλn(Yj , Yi)I(Zj ≥ s)
,
where Kλn(Yj , Yi) is a kernel function that depends on a smoothing parameter λn. Akritas [3]
shows that the nearest neighbor estimator (NNE) is a semiparametric efficient estimator.
The resulting estimates of sensitivity and specificity mentioned by Heagerty et. al. [66] are
given by:
P̂λn(Y > c|D(t) = 1) =
[(1− F̂Y (c))− Ŝλn(c, t)]
1− Ŝλn(t)
,
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where Ŝλn(t) = Ŝλn(−∞, t).
The proposed estimators of Heagerty et al. [66] yield time-dependent ROC curve methods
that provide a natural way for handling censored survival data, and involve no parametric
assumptions. Heagerty et al. assume the measurement time for the prognostic marker, Y, is
fixed at baseline and as a result the ROC curve is only a function of the disease ascertainment
time t. When a marker is measured repeatedly over time, a method that also incorporates the
time at which the measurement was obtained allows for an updating of the medical decision at
the current follow-up time. Heagerty et al. estimators assume that the data are derived from
a cohort study where sampling does not depend on the disease outcome D(t).
6.4. Models for predictive scores
Since we have several prognostic variables, there is need to use multivariate approaches. In
this work we used two statistical models to estimate predictor scores, then use these scores to
estimate the AUC(t). First, logistic regression (discussed in Section 5.4) was used to build the
model when the outcome or response is defined as the presence or absence of a condition or
disease.
Logistic regression cannot deal with censored observations and does not take account of time.
Thus an alternative method is to use survival analysis models in the presence of censoring.
One very popular model for survival data is the Cox proportional hazards model (CPH), which
was proposed by Cox [6, 137]
The Cox model [6] is based on a modeling approach to the analysis of survival data. It is a
statistical technique for exploring the relationship between the survival of a patient and several
explanatory variables. The Cox model provides an estimate of the treatment effect on survival
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after adjustment for other explanatory variables. In addition, it allows us to estimate the
hazard or risk of death for an individual, given their prognostic variables. In a clinical trial
the Cox model is used to analyse the survival of patients. The model can also be used if it
is known that there are other variables besides treatment that influence patient survival and
these variables cannot be easily controlled in a clinical trial. Using this model may improve
the estimate of treatment effect by narrowing the confidence interval. The regression method
introduced by Cox is used to investigate the effect of several variables on the hazard function.
It is also known as proportional hazards regression analysis. Briefly, the procedure models or
regresses the hazard of an event on the explanatory variables. Thus final model from a Cox
regression analysis will yield an equation for the hazard as a function of several explanatory
variables.
The Cox proportional hazards model describes survival data with covariates in terms of a
hazard function of the form:
h(t|X) = h0(t) exp(β′X),
where β is an unknown vector of parameters, h0(t) is the baseline hazard and X is a vector of








where R(ti) is the risk set at event time ti and f different failure times t1 < t2 < · · · < tf with
exactly one failure at each time. The estimate of the survival function for an individual with
covariates X may be obtained via:
S(t) = [S0(t)]
exp(β′X).
Note in the above equation S0(t) is known as the baseline survival when X = 0. The Cox
regression analysis yields an equation for the hazard as a function of several explanatory
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variables. A coefficient for a single covariate give the log-hazard for that variable given all
other variables included in the model. A positive regression coefficient for an explanatory
variable means that the hazard is higher, and thus the prognosis is worse. Conversely, a
negative regression coefficient implies a better prognosis for patients with higher values of that
variable. This model is a semi-parametric model because it makes no assumptions about the
form of h0(t) the non-parametric part of the model, but assumes a parametric form for the
effect of the predictors on the hazard. Corresponding to h0(t) is S0(t) - also known as the
baseline survival - which also remains unspecified. The beauty of this model, as observed by
Cox, is that if one is to use such a model, and one is interested in the effects of the covariates
on survival, then one does not need to explicitly specify the form of h0(t). A standard Cox
regression model can be used to derive a composite marker effect as a weighted combination
of biomarkers and clinical variables, in which the weights are determined by the estimated
regression coefficients. Recall that a Cox regression model is specified via the hazard function,
which is defined as the instantaneous rate at which failures occur for individuals that are
surviving at time t, therefore it is formally defined as
h(t) = lim
4t→0
P [t ≤ T < t+4t]
4t
.
The Cox regression model employs a log function to relate the hazard function to a linear
combination of biomarkers and clinical variables:







where βi are regression parameters that correspond to biomarkers Xi and γi are regression
parameters that correspond to clinical variables Zi. Since h(t) is a product of h0(t) and a term
that is a function of the biomarkers and clinical variables this leads to a proportional hazards
model if both the biomarkers and the clinical variables are baseline variables and are constant
over time. Censoring can be accommodated in likelihood-based estimation of the regression
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parameters, but censoring must be assumed to be independent of survival, i.e. non-informative
censoring. The estimated regression coefficients can then be used to derive a composite marker








To quantify the predictive accuracy of the composite marker, M can be used as the input to
a time-dependent ROC analysis. Note that M(t) is time dependent because now cases are
defined according to a time to event outcome.
It is not desirable to use the same data to both develop and evaluate the models, thus cross-
validation and bootstrapping were used to estimate the time dependent AUC denoted by
AUC(t) in the context of variable selection. Using the same data both to fit the score and to
calculate its ROC at a specific time leads to what is known as over-fitting and this problem
tends to give an over optimistic estimate of the performance of the score [25]. We remark that
variable selection should be done from scratch using a number of training sets not the complete
data.
Leave-one-out cross-validation (LOOCV) was used together with multivariate Cox and logistic
regression models to fit the prediction model. Bootstrapping was used to get the bootstrap
cross-validated AUC(t) and its variance estimate. In this case we used 200 bootstrap replicates
in both simulation studies and application to real data set.
For each of the training sets, both the logistic regression and CPH models were used to build
the predictive model and for each variable selection was applied from scratch for each training
set. We then predicted the part of the data left out. These procedures are repeated until every
observation appears once in a validation set. Finally the predicted values were used to estimate
the time dependent AUC. Bootstrapping was applied to estimate AUC(t) as well as its vari-
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ances and therefore standard errors for confidence interval estimation. We were interested in
comparing the two models in three aspects namely, obtaining the predictive scores, evaluation
of two resampling methods in terms of variable selection as methods to estimate AUC(t) and
finally performance models (when comparing between imputation methods discussed earlier)
for handling missing values.
6.5. Algorithm
The following is an algorithm to estimate the AUC.
• Considering the missing value problem. Most of the current research ignores this problem
yet it is very important to deal with missing values. In our algorithm we consider single
and multiple imputation methods as described in Chapter 4. For mean imputation we
used mean function from “ForImp” package in R software. The function “impute.NNHD”
in HotDeck Imputation was used to apply nearest neighbor hot deck imputation and
MICE for multiple imputation via chained equations. We evaluate and compare these
methods in order to estimate time dependent AUC.
• The second step needs to be undertaken to optimise the set of biomarkers with high and
independent diagnostic information content in a multivariate setting. In our algorithm
we use logistic regression using glm function in stats package and Cox model using coxph
in survival package.
• Before applying the algorithm to derive a discriminatory rule and in order to avoid
an over-fitting problem associated with model selection, we split each original dataset
into a training set (to build the model) and a validation set (to test whether the score
discriminates between the same diagnostic classes in an independent group of subjects).
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This split was done as many as the number of individuals, as we use LOOCV. We also
reported bootstrap LOOCV estimator of the AUC(t) and its variance. The diagnostic
performance of the discriminant score was assessed by estimating sensitivity, specificity
and diagnostic accuracy by plotting the ROC curves at our interested time. As stated
earlier, variable or feature selection should be done from scratch for every training set.
• For the prediction score from the logistic regression or Cox model, a non-parametric esti-
mator proposed by Heagerty [66] for time dependent AUC was used. The survivalROC.C
function in R was used with nearest neighbor estimation of time dependent AUC.
6.6. Simulation studies
In order to evaluate the performance of the suggested resampling methods and different im-
putation techniques for computing time dependent AUCs, we conducted simulation studies as
follows. For each of N = 50 subjects we simulated a survival time including five biomarkers
with a possibility of missing values. The survival time T was generated from the exponential
distribution. The censoring indicator was generated using the binomial distribution with 40%
censoring rate.
Missing values on the biomarkers were generated using missing rates of 10% and 20% under
MCAR and MAR assumptions. As a summary our simulated data sets contain the survival
times, the censoring indicator and five biomarkers with missing values. Then we imputed these
missing values using the mean, nearest neighbor hot-deck (NNE HD) and multiple imputation
methods.
Biomarkers from the simulated data set were used to evaluate whether a model output based
on a combination of these biomarkers can accurately discriminate between individuals who are
127
Chapter 6 – Predictive accuracy of multiple time dependent biomarkers with
missing values in diagnostic testing
likely to experience the event before a given time (120 days) from those who may not after
that time. This was accomplished by applying time dependent AUC analysis and resampling
methods for imputed data sets.
Our analysis of simulated data was based on estimation of the following quantities: Cross-
validated time dependent AUC denoted by AUCtC , bootstrap time dependent AUC denoted
by AUCtB, bootstrap standard error denoted by SEB, confidence interval using bootstrapping
denoted by CIB. We summarize these results in Table 6.1 below.
From Table 6.1, under MCAR assumption and when the missing rate is 10% using Cox model
and mean imputation, the estimated value of AUCB(t) is equal to 0.724 and according to its
confidence interval (0.571, 0.877), this diagnostic test is statistically significant (CI excludes
0.5). Thus it has the ability to distinguish between patients who are likely to die during the
first four months and those who are likely to survive beyond that time. The estimated value of
AUCcv(t) is equal to 0.687. Using the NNE HD imputation, the estimated value of AUCbcv(t)
is equal to 0.743 and according to its confidence interval (0.613, 0.902, ) this diagnostic test
is statistically significant. The standard error based on bootstrapping equals to 0.081. With
the MI, the estimated value of AUCbcv(t) equals to 0.746 and associated standard error equals
to 0.083. The confidence interval (0.583, 0.909) shows that the diagnostic test is statistically
significant and could predict the survival at 120 days.
Under MCAR assumption and when the missing rate is 10% using logistic regression and
mean imputation, the estimated value of AUCbcv(t) is equal to 0.638. According to its CI
(0.434, 0.842), the combinations of biomarkers are not statistically significant (CI includes 0.5)
and do not have any ability to discriminate between subjects who may die during 120 days and
those who may not. The estimated value of SEB is equal to 0.104. With the same settings
but using NNE HD and MI we obtained the same conclusion.
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Table 6.1: Mean of the time dependent AUC at 120 days obtained from 250 simulated samples
under MCAR and MAR for each combination of censoring rate, predictive model and impu-
tation method. B = 1000 bootstrap replications are performed for computing the AUCcv,
AUCbcv, SE and CIs for the AUCs
Mechanism of Missing rate Models Imputation AUCbcv(t) SEB CIbcv AUCcv(t)
missingness methods
Mean 0.724 0.078 (0.57112, 0.87688) 0.687
Cox HD 0.743 0.081 (0.6134, 0.90176) 0.711
10% MI 0.746 0.083 (0.58332, 0.90868) 0.706
Mean 0.638 0.104 (0.43416, 0.84184) 0.592
Logistic HD 0.659 0.106 (0.45124, 0.86676) 0.62
MCAR MI 0.635 0.109 (0.42136, 0.84864) 0.59
Mean 0.732 0.078 (0.65712, 0.88488) 0.693
Cox HD 0.784 0.074 (0.63896, 0.92904) 0.757
20% MI 0.770 0.072 (0.62888, 0.91112) 0.736
Mean 0.641 0.104 (0.43716, 0.84484) 0.598
Logistic HD 0.734 0.086 (0.56544, 0.90256) 0.698
MI 0.630 0.084 (0.46536, 0.79464) 0.661
Mean 0.709 0.074 (0.56396, 0.85404) 0.673
Cox HD 0.714 0.073 (0.571, 0.85708) 0.707
10% MI 0.704 0.078 (0.55112, 0.85688) 0.682
Mean 0.605 0.109 (0.39136, 0.81864) 0.542
Logistic NNE HD 0.68 0.104 (0.47616, 0.88384) 0.602
MAR MI 0.614 0.107 (0.40428, 0.82372) 0.608
Mean 0.746 0.069 (0.61076, 0.88124) 0.738
Cox NNE HD 0.813 0.078 (0.66012, 0.96588) 0.802
20% MI 0.800 0.069 (0.66476, 0.93524) 0.800
Mean 0.674 0.096 (0.48584, 0.86216) 0.644
Logistic NNE HD 0.751 0.086 (0.58244, 0.91956) 0.726
MI 0.719 0.1 (0.523, 0.915) 0.686
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Under MCAR assumption for 20% missing rate, the estimated values of AUCbcv(t) using the
Cox model with the three imputation methods suggested that the combined markers have the
discrimination ability.
Under MCAR assumption for 20% missing rate, the estimated values of AUCbcv(t) using
the logistic model with mean and multiple imputation methods suggested that the combined
markers do not have the ability to discriminate between patients who will die during the first
four months and those who may be alive after that time. However with NNE HD imputation
the confidence interval (0.565, 0.903) excludes 0.5.
In all the above cases bootstrap cross-validation seems to perform better than just cross-
validation. The NNE HD performed better in most cases when compared to other imputation
methods in that there are slightly higher AUC(t) estimations. All imputations methods per-
form equally well if the missing mechanism is MCAR. It is the difference that the Cox model
for time dependent AUC is clearly better than the logistic regression as the predictive model.
For the MAR mechanism when the missing rate is either 10% or 20%, using Cox model the
estimated values of AUCbcv(t) from the three imputation methods are similar (NNE HD ob-
tained slightly higher AUC(t) estimations) and statistically significant. These results suggest
that the combination of biomarkers have the ability for discrimination in 120 days.
Under MAR assumption and when the missing rate is 10% using logistic regression with the
mean imputation, NNE HD imputation and MI, the estimated values of AUCbcv(t) equal
to 0.605 ,0.68 and 0.614 respectively. The combinations of biomarkers are not statistically
significant and do not have any ability to discriminate between subjects who may die during
120 days and those who may not.
Under MAR assumption and when the missing rate is 20% using logistic regression and mean
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imputation, the estimated value of AUCbcv(t) equals to 0.674 with SEB = 0.096. We found
that the combinations of biomarkers are not statistically significant.
When the missing rate is 20%, it could be seen that with all imputation techniques- and for
MAR- the resulting AUCbcv(t) values are better than those when the mechanism is MCAR.
This indicates that for higher missing rates- and specially if MAR was the case- then applying
imputation methods will be necessary and may help improve the results.
The true simulated AUC(t) is 0.742 which is clearly close to the values estimated under the
Cox model than those estimated under the logistic regression model. This emphasizes the
point that the Cox model is best suited to handle the estimation of time dependent AUCs
than the logistic regression.
From Table 6.1 we found that nearest neighborhood hot deck reveals higher AUCbcv(t) and
AUCcv(t) estimates. However the difference between AUC estimates obtained using the three
imputation methods were not statistically significant. The Cox regression as a predictive model
is better than the logistic regression. Its AUC values are higher than those from the logistic
model. This tells us that the appropriate model for the data should be the first step in the
process. Since in this work the data set is time to event, it is obvious that Cox regression
model performs better as it gives AUC(t) estimations similar to the true AUC. Bootstrapping
performed better than cross-validation, however the differences in values of AUCs are small.
6.7. Application to primary biliary cirrhosis (PBC)
This data is from the Mayo Clinical trial in primary biliary cirrhosis (PBC) of the liver con-
ducted between 1974 and 1984. A total of 424 PBC patients, referred to Mayo Clinic during
a ten-year interval, met eligibility criteria for the randomized placebo controlled trial of the
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drug D-penicillamine. The first 312 cases in the data set participated in the randomized trial
while the other 112 cases did not. Here we consider the first 312 cases.
In Table 6.2 we show the missingness rate for the covariates that have missing values:
Table 6.2: Missing rate in PBC dataset
Covariate chol copper trig platelet
Missings rate 28 (9%) 2 (1%) 30 (10 %) 4 (1 %)
We used the PBC data set to develop the clinical prediction model. In our analysis we compare
between model scores using the time dependent ROC analysis. Table 6.3 contains results for
two models- namely that based on list wise deletion (Model 1) and the multiple imputation
model (Model 2). We fitted the multivariate Cox model as the predictive model under both
missing data handling method and this table gives the significant variables from each model,
which are strong indicators of mortality. The number of observations is 276 after list wise
deletion, meaning 36 patients were not used in analysis. From the table we can see that there
is a covariate that appears under Model 1 and does not appears in the Model 2 results and
vice-versa. This indicates that the method used to deal with missing data may affect the final
predictive model even if not in a big way.
We considered time dependent AUC estimation distinguishing between people who may die
and those who may not.
A larger AUC(t) value would suggest that the model score is more accurate in its discriminatory
capacity. Based on Cox regression results for each model in Table 6.3, the estimated AUC(t)
value for Model 1 is equals to 0.90 and the estimated AUC(t) value for Model 2 is equals
to 0.92. These results suggest that both predictive models have high ability to distinguish
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Table 6.3: Cox regression estimates for PBC dataset
Covariate Estimate SE Z-statistic p-values CI
age 0.00007173 0.0000309 2.322 0.0203 * (1.00, 1.0001)
edema 0.9248 0.3782 2.445 0.0145 * (1.2014, 5.2915)
Model 1 log(bili) 0.7221 0.1618 4.463 8.1e-06 *** (1.4993, 2.8272)
albumin -0.678 0.3049 -2.223 0.0262 * (0.2792, 0.9228)
stage 0.3867 0.1757 2.201 0.0277 * (1.0432, 2.0772)
age 0.00007493 0.00002833 2.645 0.00818 ** (1.00, 1.0001)
edema 0.8375 0.3283 2.551 0.01074 * (1.2142, 4.3969)
Model 2 log(bili) 0.7342 0.1504 4.883 1.04e-06 *** (1.5519, 2.7980)
albumin -0.7039 0.2802 -2.512 0.01199 * (0.2857, 0.8566)
log(protime) 2.798 1.191 2.349 0.01882 * (1.5898, 169.5695)
where in Table 6.3, “*” means that the p-value is less than 0.05, the “**” means that the
p-value is less than 0.01 and the “***” means that the p-value is less than 0.001.
between patients who are likely to die from those who are not. However the imputation model
(Model 2) is better than the model that ignores missing values (however the difference is very
small).
We also obtained time dependent AUCs when we used the Cox and logistic regression models.
Figure 6.1 contains time dependent ROC curves for the two models at the first year. It is clear
that the two ROC curves are very close to each other at 365 days. We expect the Cox model
to perform better, thus we investigate the performance of the two models over long period.
Figure 6.2 explains the performance of the two models and their AUC values from minimum
time until ten years.
In the first 1000 days the two models are quite similar which is supported by Figure 6.2.
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However after over time, the Cox regression model seems to perform better and thus the score
obtained has higher ability for discrimination purpose.
Figure 6.1: ROC curves for Cox model and logistic regression for t = 365 days using PBC
dataset
In survival data, the accuracy may be higher when the markers are measured closer to the
onset of disease. In Figure 6.3 we plotted three ROC(t) curves at different times to investigate
the performance of the model and its ability to discriminate with time.
Figure 6.3 shows that predictive accuracy decreases with increasing time since baseline. It is
clear that the best ROC(t) is when time is 180 days. However the area under the ROC(t)
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Figure 6.2: AUC estimates up to 10 years for PBC dataset
Figure 6.3: ROC curves at different times using the Cox regression model for PBC dataset
curves become smaller when it goes to 1000 days and thereafter. This indicates that the closer
the biomarkers are measured to the event time the better is the AUC(t) and thus there is a
better discrimination ability.
Table 6.4 shows the results for AUC(t) values based on resampling methods and when variable
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selection were used to evaluate whether the obtained scores could accurately discriminate
between people who are likely to die before the first year and those who may still be alive
after that time. In this table we list the values of AUCB(t), SEB, CIB and AUCC(t). These
estimates were based on the Cox and logistic regression models under three imputation methods
for missing values.
Table 6.4: The AUCcv and AUCbcv estimations using mean imputation, nearest neighbor
imputation and multiple imputation
Models statistic Mean imputation Hot deck imputation Multiple imputation
AUCB(t) 0.932 0.0.930 0.931
SEB 0.034 0.034 0.035
Cox CIB (0.865, 0.999) (0.863, 0.997) (0.862, 1)
AUCC(t) 0.932 0.925 0.924
AUCB(t) 0.0.921 0.922 0.922
SEB 0.032 0.030 0.0.030
Logistic CIB (0.858, 0.984) (0.863, 0.981) (0.863, 0.982)
AUCC(t) 0.932 0.0.932 0.932
The following is an explanation for the results in Table 6.4.
• Using the Cox model to build the predictive model for the predicted scores, we found
the following:
– With the mean imputation method, the estimated AUCB(t) is equal to 0.932 and
estimated SEB equal to 0.034. The 95% bootstrap CI is (0.865, 0.999) which means
that this score is statistically significant and has a high ability to discriminate at
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365 days.
– With the NNE HD method the values of AUCB(t), their CIBs, suggest that this
predicted score is statistically significant. It is also appears that the obtained value
of AUCC(t) is also high and very close to AUCB(t).
– With multiple imputation method, the estimated AUCB(t) equals to 0.931 and
according to SEB and CIB the score has high ability to discrimination at the first
year. The obtained value of AUCC(t) is a bit smaller than AUCB(t), however the
difference is very small.
• Using the logistic regression model to build the predictive model for predicted scores, we
have the following:
– With the mean imputation method, the estimated bootstrap AUC AUCB(t) and
its corresponding CI confirm that this score is statistically significant which shows
it has a high ability to discriminate between subjects who are likely to die before
120 days and those who are likely to survive beyond that time.
– With the NNE-HD and MI methods the estimated values are almost identical and
very close to the estimate obtained by using the mean imputation as well. These
results suggest that the score is statistically significant.
From all the above findings, we conclude that both resampling methods perform well and
similarly. Bootstrapping seems to perform better but the difference is small. Estimates
from all the imputation techniques are very similar to each other in both estimated
AUC(t)s from resampling methods. According to the null hypotheses
H0 : AUCA = AUCB, H0 : AUCA = AUCC or H0 : AUCB = AUCC ,
where A, B and C are three different imputation strategies, the obtained statistics suggest
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that there is no evidence to reject H0 and thus it will not make difference to which
imputation method we use in order to estimate the AUC(t).
Parameter estimates for some covariates (with missing values) obtained from multiple imputa-
tion with m = 5 are given in Table 6.5. In this table, W, B and T stand for: within, between
and total imputation variances respectively.
Table 6.5: Pooled estimates from MI for some variables in PBC dataset
Covariate Est W B T
Copper 97.66 23.63 0.32 24.01
Platelet 261.98 29.20 0.57 29.88
Cholesterol 367.08 174.75 10.58 187.44
triglycerides 124.91 13.46 0.44 13.99
6.8. Conclusion
The time dependent area under receiver operating characteristic is an important summary
index of discriminatory accuracy in modern clinical medicine. In this chapter we evaluated
some of the imputation techniques and resampling methods for the purpose of estimating time
dependent AUCs in the presence of missing data.
According to our simulation studies, we deduced that LOOCV gives good estimates of the AUC,
however bootstrapping LOOCV seems to perform even better. An interesting observation is
that the three imputation methods gave rise to similar discrimination accuracy where the
AUC(t) estimates obtained by the nearest neighborhood hot deck method were slightly higher.
However we recommend the use of multiple imputation method as it represents missing data
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uncertainty and takes into account the variability given by the multiple imputed data set with
appropriate statistical inference. The Cox model performed better than the logistic regression
and specifically at 120 days most results suggest using the logistic regression as the combination
method did not have ability to discriminate at that time.
An application to the PBC data set reveals that both cross-validation and bootstrap cross-
validation yield AUC(t) estimations are close to each other. Cox regression outperforms the
logistic regression for large period estimation time.
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7.1. Introduction
Early diagnosis of disease has the potential to reduce morbidity and mortality. Biomarkers
may be useful for detecting disease at early stages before it becomes clinically apparent. Our
interest is to evaluate the predictive and discriminatory capacity for the diagnostic index.
Meningitis causes significant mortality and morbidity in HIV infected persons [16, 56, 71, 89,
131]. Tuberculous meningitis (TBM) accounts for a substantial proportion of deaths, particu-
larly in high tuberculosis (TB) prevalence areas [71]. However, few studies have investigated
the predictors of mortality in patients with HIV associated TBM.
Missing data is a common problem in many fields especially in medical clinic research. It is
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very important to consider missing values in order to reduce the bias associated with parameter
estimates. We applied nearest neighbor hot-deck imputation (discussed in Subsection 4.2.2) to
consider missing values associated with TBM/HIV data set. This method is suitable for any
kind of variable because it does not require strong distributional assumptions and standard
statistical methods could easily be applied to the imputed data.
When we have many variables and the interest is to estimate the diagnostic test accuracy, we
have to select the best variables in order to have better predictive accuracy. Moreover resam-
pling methods are recommended to adjust for over-fitting associated with variable selection.
To estimate the AUC(t), we used the proposed method by Heagerty [66] to calculate ROC
curves for cumulative disease or death incidence by time t, which we denote as ROC(t)C/D.
See Section 3.1 for more details.
A retrospective study of Tuberculous Meningitis in a high HIV prevalence settings at GF
Jooste Hospital in Cape Town is used to describe the application of cross-validation, 632 and
632+ bootstrapping to estimate AUC(t). We also described the presentation and outcome of
patients with TBM. The nearest neighbor hot-deck technique was used to impute the missing
values in the variables used to construct the TBM-IRIS scores. These scores were then used
to estimate the AUC(t) with respect to discriminate between TBM-IRIS patients who may die
before six months and those who may survive after that time.
Penalized regression models provide a statistically appealing method to build prediction mod-
els, where the aim is to simultaneously select features and to fit the model [45, 121]. Since
the introduction of the LASSO for linear regression models (Tibshirani [138]), the method-
ology has been extended to generalized linear regression models and time-to-event endpoints
among others. In addition to the well-known L1-norm (LASSO) and L2-norm (ridge) penalty
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functions, various other penalties have been proposed in recent years to select features and/or
estimate their effects. In particular, we will use the L1-norm and L2-norm.
We used two methods to estimate the cross-validated, 632 and 632+ AUC(t). These are the
proposed method of using ridge-Cox regression and least absolute selection and shrinkage oper-
ator (LASSO)-Cox regression [50]. Ridge-Cox regression and LASSO-Cox regression methods
were evaluated through simulation studies. The AUC(t) was used to compare resampling meth-
ods with respect to predictive power. Estimation of the variances of the estimated AUC values
are very necessary when the interest is to evaluate the performance of combined biomarkers
or predictor index. Thus we considered and evaluated (through simulation studies) two level
bootstrapping to estimate standard errors and then confidence intervals.
7.2. Penalized Cox methods
The Ordinary Least Squares (OLS) estimates are obtained by minimising the residual squared
error [138], which is the difference between the observed and estimated function value. There
are some problems with estimates obtained by OLS, the first is the difficult interpretation. In
addition to that OLS estimates demonstrate large variances despite having low bias.
There are two solutions to improving OLS estimation [138], namely subset selection and ridge
regression. Subset selection has interpretable models but can be extremely variable because it
is a discrete process and regressors are either retained or dropped from the model. A small
change in data can result in different models being selected and this can reduce its prediction
accuracy. Ridge regression has been proposed as an alternative, it is a continuous process that
shrinks coefficients and hence is more stable. However it does not set any coefficients to zero
and hence does not give an easily interpretable model [138].
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7.2.1 LASSO-Cox regression
Tibshirani [138] proposed the least absolute selection and shrinkage operator (LASSO) for
variable selection and shrinkage. The proposal by Tibshirani is based on minimising the log
partial likelihood subject to the sum of the absolute values of the parameters being bounded
by a constant. This technique shrinks coefficients and reduces some to zero.
As we mentioned in Section 6.4, β could be estimated through maximisation of the partial
likelihood. Denote the partial log-likelihood of β as `(β) which is given by: `(β) = logL(β).
Then there are two definitions for LASSO [138] to estimate β, these definitions are:
• β̂ = argmax`(β), subject to
∑
‖ βj ‖≤ s, where s > 0 is user specified parameter and
‖ . ‖ is L1 norm,
• β̂ = argmax`(β)− λ ‖ β ‖1,
where β is the vector of regression coefficients and λ is the tuning parameter for L1. LASSO
is attractive as a regularisation method because it simultaneously performs variable selection
and shrinkage. It shrinks all regression coefficients towards zero and automatically sets many
of them exactly to zero. Variable selection is desirable in order to obtain an interpretable
prediction rule, and shrinkage is desirable to prevent over-fitting.
Geoman [53] proposed a method that presents a novel full gradient algorithm for maximising
the LASSO-penalized likelihood. It follows the gradient of the likelihood from a given starting
value of β. Their method uses the full gradient at each step, furthermore the algorithm can
automatically switch to a Newton Raphson algorithm when it gets close to the optimum [53].
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Let β = (β1, · · · , βP )T , the target function is defined as:
`pen(β) = `(β)− λΣPi=1|βi|. (7.1)
This function includes two terms, the first term is the log likelihood function and the second
one is penalty p(β) = −λΣPi=1|βi|. Geoman [53] mentioned two important points: Firstly the
penalized likelihood function is the sum of two concave functions and it is itself a concave
function. However this is not generally strictly concave. Secondly, the penalized likelihood
function is not differentiable everywhere due to the lack of differentiability of the penalty
function.
The gradient ascent algorithm is very simple to understand, but it requires a large number
of steps to converge. Geoman [53] proposed the option of switching to the Newton Raphson
algorithm to avoid too many steps. For more details about this two algorithms we refer the
reader to [53].
It is possible to define a directional derivative




[`pen(β + tv)− `pen(β)], (7.2)
for every point β in every direction v ∈ R. The gradient can then be defined for every β as the
scaled direction of steepest ascent. Let vopt be the direction that maximises `
′
pen(β, v) among
all v with ‖ v ‖= 1 then the gradient can be defined as `′pen(β, vopt)− vopt if `′pen(β, vopt) ≥ 0
and 0 otherwise, where 0 is a p-vector of zeros. We can define the directional second derivative
as:




[`′pen(β + tv, v)− `′pen(β, v)]. (7.3)
For the penalized log likelihood the directional second derivative is given for every β and v by:
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In practice it is hardly ever necessary to calculate the full Hessian matrix of `(β) to calculate
the directional second derivative, as the direction v of interest, which is the direction of the
gradient, will typically have many zeros. Furthermore, in the Cox proportional hazards model,





where X is an n × p design matrix and W an n × n weights matrix. This structure of the
Hessian matrix allows the algorithm to avoid construction of the full p × p Hessian. The
gradient ascent algorithm uses a series of Taylor approximations. At each step it approximates
the penalty locally from β in the direction of the gradient by a directional second order Taylor
approximation, given by:




This approximation is meaningful only within a single sub domain of gradient continuity, for











1 if x > 0,
0 if x = 0,
−1 if x < 0.





provided topt < tedge, otherwise it is at tedge. The algorithm proceeds in every next step
with a new directional Taylor approximation from the optimum found in the previous one.
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Convergence occurs when g(β) = 0. If there is not a unique optimum, the algorithm will
converge to a point in the optimal area.
• Start with some β0.
• For steps i = 0, 1, · · · of the algorithm, iterate the following
βi+1 = βi + min(topt, tedge)g(β
i).
Let β̃ = (βJ1, · · · , βJm)T and let g̃(β) = (gJ1(β), · · · , gJm(β))T be the gradient in the con-




, k, l = 1, · · ·m. (7.9)
A step of the Newton Raphson algorithm in the current subdomain would propose:
β̃i+1 = β̃i − [H̃(βi)]−1g̃(βi).
Then the Newton Raphson algorithm is implemented as follows:
• Start with some β0.




i) if topt ≥ tedge,








We also proposed the use of ridge-Cox regression model in order to estimate the AUC using
632+ and compare it to LASSO to estimate the 632+ AUC as proposed by [50]. Ridge
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regression scales all the coefficients towards 0, but sets none to exactly zero. Ridge regression
better handles correlated predictors and achieves a stable fit even in the presence of strongly
correlated predictors, shrinking each coefficient based on the variation of the corresponding
variable. If two predictors are very correlated, ridge regression will tend to give them equal
weight. Starting from the Cox model, the estimated coefficients can be constrained to satisfy
the condition β′β < C for some choice of C. This is known as ridge penalty which is only
applied to linear and generalised linear models. To control the estimates, a penalty term











The penalized likelihood is maximised by taking the scores and using the Newton Raphson
method. At the end of the procedure, the Breslow estimator can be used to obtain an estimate
for the baseline hazard [139]. The authors of [145] suggested the use of the full likelihood to fit
the same model. The authors of [151] used an iterative weighted least squares procedure based
on the result that the partial likelihood is equivalent to the likelihood function of independently
sampled poisson random variables. The same procedure is used in [139] for fitting the LASSO
method.
7.3. Resampling methods
In this section we discuss the use of cross-validation and different bootstrap methods for esti-
mating AUC(t). Also the proposed method for variance estimation is described.
The bootstrap family was introduced by Efron and is fully described in Efron and Tibshirani
[138]. Efron [38] introduced the bootstrap, double bootstrap and the 632 estimator (all vari-
ations on the bootstrap) and compared them to the leave-one-out estimate using a variety of
147
Chapter 7 – Use of resampling methods to predict the outcome of tuberculous
meningitis in high HIV prevalence patients in South Africa
small sample simulations with Gaussian features.
7.3.1 632 bootstrap
The 632+ bootstrap was proposed by Efron and Tibshirani [138] in order to reduce the upward
bias of the leave-one-out bootstrap estimator. A bootstrap 632 estimator has been shown to
be superior to leave-one-out estimator in a variety of situations with small training sample
sizes [138].
Bootstrap cross-validated FN and FP fractions are obtained by:





FNF b(c, t), (7.11)





FPF b(c, t). (7.12)
The corresponding ROC curve is FPFBCV (c, t), 1− FNFBCV (c, t), c ∈ R and AUCBCV (c, t)
is the corresponding bootstrap cross-validation estimation of the AUC at time t. For a large
sample size (n > 40), the probability that the individual appears in the training set is approx-
imately equal to 1 − (1 − 1/n)n ≈ 0.632. The proportion of 0.368 is composed of completely
independent data from the replicated data included in the training set, which causes an un-
derestimation of the prognostic capacity. Efron [38] proposed the 632 estimator to correct
this underestimation:
FNF 632(c, t) = 0.368FNF (c, t) + 0.632FNFBCV (c, t), (7.13)
FPF 632(c, t) = 0.368FPF (c, t) + 0.632FPFBCV (c, t), (7.14)
where FNF (c, t) and FPF (c, t) are the apparent rates, calculated using the B training sets.
More precisely, the apparent FNF and FPF can be calculated using only the data included in
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the bootstrap sample





FNF b(c, t), (7.15)





FPF b(c, t). (7.16)
The 632 ROC curve is FPF 632(c, t), 1− FNF 632(c, t), c ∈ R and AUC632(c, t) is the corre-
sponding 632 estimation of the AUC at time t.
7.3.2 632+ bootstrap
The 632 rates may be associated with over estimations if the apparent estimations are very
small when over-fitting data. Efron and Tibshirani [38, 138] improved the correction with
the 632+ estimator [50]. The no-information rates associated with FNF and FPF may be
estimated using all the data and considering the independence between Y and T : γN (c, t) =
1− γP (c, t) = F̂ (c).
These no-information probabilities are used to define the over-fitting rates:
rN (c) =
FNFBCV (c, t)− FNF (c, t)
γN (c, t)− FNF (c, t)
, (7.17)
rP (c) =
FPFBCV (c, t)− FPF (c, t)
γP (c, t)− FPF (c, t)
. (7.18)
The authors of [50] assigned these rates to 0 for negative values and to 1 for values higher than
1. The 632+ estimations of the false negative and positive rates are thus defined by:
FNF 632+(c, t) = [1− ϕ(γN (c, t))]FNF (c, t) + ϕ(γN (c, t)))FNFBCV (c, t), (7.19)
FPF 632+(c, t) = [1− ϕ(γP (c, t))]FPF (c, t) + ϕ(γP (c, t)))FPFBCV (c, t), (7.20)
where ϕ(f) = 0.6321−0.368f .
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The corresponding 632+ ROC curve is FPF 632+(c, t), 1− FNF 632+(c, t), c ∈ R andAUC632+(c, t)
is the corresponding 632+ estimation of the AUC at time t [50].
7.3.3 Estimation of standard errors
Estimation of the time dependent AUC together with its standard error are very important to
help in computing the confidence intervals. We can then use this to decide if the diagnostic
index has ability to discriminate between two populations or not. We applied the two-level
bootstrapping, where we performed B bootstrap samples from which B AUC(t)′s are computed
by any of the re-sampling methods discussed in Subsections 7.3.1 and 7.3.2. Then confidence
interval will be the 2.5th and the 97.5th percentiles of the B AUC(t) estimates at time t.
In this way we can clearly declare whether the associated predictor index has the ability to
distinguish or not. In this method, estimates θ∗b , b = 1, 2, · · · , B of the parameter of interest
θ are calculated from B pseudo samples. Then an estimate of the bootstrap variance of the


















. Note that in the two-level
bootstrapping approach the θ̂b
∗
is estimated from another bootstrap sample as in previous
function. We wrote a specific R program for this function.
7.4. Algorithm
The following is an algorithm to estimate the AUC(t) using different methods of imputation,
variable selection and resampling.
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• Step 1: Considering missing values. In the algorithm we use nearest neighbor hot deck
imputation method.
• Step 2: Evaluation of diagnostic performance of biomarkers by estimating the AUC. The
AUC captures the overall diagnostic accuracy of the combined biomarker test.
• Step 3: This important step needs to be undertaken to optimise the set of biomarkers with
high and independent diagnostic information content in a multivariate setting. There are
a number of critical issues to consider in this step: These are choosing an appropriate
statistical method for multivariate analysis, choosing the number of diagnostically infor-
mative biomarkers to be entered into the multivariate model and using an appropriate
method to optimise the number of finally selected biomarkers. The Cox proportional
hazards model was used for the regression of hazard of experiencing an event of interest
according to quantitative factors. LASSO penalty was used as it is very reliable; it is a
variable selection method and results in considerably better prediction performance. We
also suggested the ridge-Cox regression model to estimate the AUC(t) as a comparative
competing model to LASSO-Cox penalty.
• Before applying the algorithm to derive a discriminatory rule and in order to avoid the
over-fitting problem associated with model selection, we split each original data set into
a training set and a validation set. This split was done using ordinary bootstrap, 632 and
632+ estimators of time dependent AUC and their variances as we mentioned before. We
used “boot.ROCt” function in “ROC632” package for estimating AUC(t) using various
resampling methods. Bootstrap and cross-validated AUC(t) estimates were estimated
using our own updated R code.
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7.5. Simulation studies
Simulation studies represent an important statistical tool to investigate the performance, prop-
erties and adequacy of statistical models, test statistics and estimation techniques considering
pre-specified conditions. In this work we apply the proposed two level bootstrapping method
with respect to estimating the AUC variance. In addition we also used simulation studies to
compare between different resampling methods to estimate AUC(t).
We simulate datasets under the following group settings: Assume that there are K diagnostic
tests (corresponding to K features) Y1, Y2, · · · , YK . In our case, we let K = 5, that is five
features Y1, Y2, Y3, Y4 and Y5. Denote the mean vector of the K features by µk.
With the above settings, the features outcomes yik is given by
yik = µk + ai + εik,
where the notation and assumptions in our case are
• n (resp. m) is the number of individuals and i is the index for the set {1, 2, · · · , n},
• k is the index for a feature,
• ai is the subject specific random effect which is assumed to follow the normal distribution
that is aDi ∼ N(0, 0.5) and
• εik is the random error effect also assumed to follow the normal distribution εik ∼
N(0, 0.25).
The outcome vector y are respectively generated using three model assumptions from the
normal distribution with mean given by µk = (1, 0.5, 0.25, 0, 0) for three different covariance
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structures given by:
• For the first setting (Model 1) we assume independence among the five biomarkers or
features.
• For the second setting (Model 2) we assume the same dependence across all the features.
The resulting covariance structure is the exchangeable or compound symmetry.
• For the third setting (Model 3) we remove dependence for the first three features.
We simulated data sets with sample size N = 50 and bootstrap replicates B = 200 for both
levels of bootstrapping. The time to event was simulated from the exponential distribution
and the censoring time was generated independently such that we fix the censoring rates to
30%.
Table 7.1 shows a summary of different types of quantities which were estimated from the
analysis. These include the AUC and it standard deviation based on different methods using
apparent, bootstrap cross-validation, 632 bootstrap and 632+ bootstrap, which is given in col-
umn 3. Column 4 includes standard error for AUC using our proposed two level bootstrapping.
Columns 5 and 6 include the lower and upper confidence limits of the AUC based on bootstrap
standard errors. Proportion of times lower confidence limits of AUC excludes 0.5, are listed
in column 7 for different estimation methods within a given model assumption. Finally, the
coverage probabilities that the CIs for different resampling methods include the true AUC are
listed in column 8.
From Table 7.1 we can see that:
For Model 1, the apparent AUC equals to 0.848 while the bootstrap cross-validated one equals
0.858. The values of 632 and 632+ AUC are almost the same. All estimated AUC’s are very
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Table 7.1: Mean of the time dependent AUC at 6 months obtained from 250 simulated samples
for each scenario B =200, bootstrap replications are performed for computing the apparent,
BCV, 632, 632+ and 2-level bootstrap standard error(SE) for the AUCs
Model Estimation method AUC(STD) SE Lower limit Upper limit Proportion of lower Coverage
limit excludes 0.5 probabilities
Apparent 0.848(0.0661) 0.053 0.744 0.952 0.985
Model1 BCV 0.858(0.044) 0.037 0.785 0.931 0.985 0.854
632 0.855(0.047) 0.036 0.784 0.926 0.995 0.968
632+ 0.855(0.047) 0.0.04 0.777 0.933 0.991 0.911
Apparent 0.812(0.064) 0.064 0.687 0.937 0.975
Model2 BCV 0.823(0.057) 0.055 0.714 0.930 0.985 0.950
632 0.819(0.055) 0.054 0.712 0.924 0.997 0.995
632+ 0.821(0.057) 0.0.056 0.731 0.931 0.995 0.955
Apparent 0.809(0.056) 0.064 0.684 0.934 0.980
Model3 BCV 0.82(0.055) 0.054 0.714 0.926 0.985 0.950
632 0.816(0.050) 0.055 0.708 0.924 0.995 0.990
632+ 0.818(0.055) 0.0.054 0.712 0.924 0.975 0.935
close to each other. Based on the CI’s, which do not include 0.5, for all AUCs from resampling
methods, we deduce that the combined biomarker yields a significant discriminatory ability.
In all scenarios, the BCV, the 632 and the 632+ estimates were similar to the true apparent
estimations. This conclusion can be made regardless of the simulation models.
In addition to comparing AUC values from different resampling methods, it is more important
to evaluate the performance of the score index or diagnostic tests in each resampling method.
Thus we obtained variances and confidence intervals for AUC estimations. We also investigated
the level of discrimination of the two level bootstrapping methods by firstly looking at how
often the lower limits exclude an AUC = 0.5. Secondly, we looked at how often the CIs for AUC
estimators (using resampling methods) include the true AUC. For example, the proportion of
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times lower limits of CI’s for 632 AUC that exclude 0.5 is 0.995 under Model 1. The coverage
probabilities (under Model 1) for AUC using 632 show that 242 out of 250 CI’s include the
true AUC values, while 228 out of 250 CI’s, using 632+, include the true AUC values. The
coverage probabilities for 632 estimator were 0.968, 0.995 and 0.990 for Model 1, Model 2 and
Model 3 respectively. This indicates that the two level bootstrap methods with 632 estimators
perform better compared to BCV and 632+ estimators. Two level bootstrap methods for all
scenarios perform very well in terms of proportion and coverage probabilities. However this
solution is time consuming and we need to investigate it with more simulations.
From Table 7.1, BCV, 632 and 632+ yielded significant diagnostic AUC results. We also found
that there is no statistical difference for resampling methods and true value which indicates
these estimators are nearly unbiased. Moreover we obtained the two level estimations of AUCs
with the same conclusion. We conclude by remarking that using Model 2 (with correlation)
is preferable since it yielded the highest coverage probabilities and proportion of times lower
limits of CI’s for AUC that exclude 0.5.
We are also interested in comparing the use of LASSO estimation of AUC [50] and our proposed
method of using ridge-Cox regression to estimate the AUC. We simulated data sets with sample
size N=50 and bootstrap replicates B = 200. Censoring rates were fixed to 10% and 30%. We
distinguished the following two scenarios:
First, among five biomarkers three are associated with the time to event, β = (log(1.2),− log(1.2),
0, log(2), 0). Indeed, there is no over-fitting because only five biomarkers are analysed by using
at least 50 individuals.
The second scenario involves 100 biomarkers, no biomarker is associated with the time to
event, β = (0, 0, · · · , 0). It is clear that this case leads to severe over-fitting as the number
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of biomarkers is larger than the number of individuals and there is no association between
biomarkers and time to event.
Table 7.2: Mean of the time dependent AUC at 6 months obtained from 250 simulated samples
for each combination of over-fitting level, censoring rate and penalized model, B =200 bootstrap
replications are performed for computing the apparent, BCV, 632 and 632+ estimations
Missing rate Model Method Apparent BCV 632 632+
model 1 (5 variable) LASSO 0.808 0.815 0.813 0.813
10% Ridge 0.809 0.825 0.819 0.821
100 variables (over-fitting) LASSO 0.829 0.834 0.832 0.832
Ridge 0.839 0.843 0.842 0.844
model 2 (5 variable) LASSO 0.833 0.832 0.832 0.831
30% Ridge 0.846 0.853 0.850 0.852
100 variables (over-fitting) LASSO 0.834 0.827 0.829 0.828
Ridge 0.844 0.848 0.847 0.848
From Table 7.2 and - when the censoring rate is 10%, - LASSO-Cox regression and ridge-Cox
regression obtained very closed AUC(t) values using the two scenarios. When the censoring
rate is 30%, it is clear that our proposed estimator using ridge-Cox regression model from the
first scenario resulted in a slightly higher estimation of AUC(t). As for the LASSO method,
the 632+ estimator was 0.831, whereas for ridge-Cox it was 0.852. Both methods performed
very well as their estimators of AUC using 632+ are very close to each other. The ridge-
Cox regression model and LASSO-Cox regression model revealed similar AUC results under
the second scenario. As for LASSO-Cox method the 632+ estimator was 0.828 whereas for
ridge-Cox regression it was 0.848. Thus using ridge-Cox to estimate 632+ bootstrap AUC(t)
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resulted in a slightly higher estimations than the LASSO-Cox method.
In the first scenario (no over-fitting) with 10% censoring rate, both ridge-Cox and LASSO-Cox
regressions obtained similar AUC(t) estimates. However the 632 estimator appeared to give
AUCs more close to the true AUC (apparent). The same conclusion can be made with 30%
censoring rate.
7.6. Application of tuberculous meningitis (TBM) in high HIV prevalence
This section is an application to TBM/HIV data set. The first subsection describes tubercu-
lous meningitis HIV data. The next subsection contains the statistical analysis, results and
discussion.
7.6.1 The TBM/HIV description
Mycobacterium tuberculosis is a common, devastating cause of meningitis in HIV-infected
persons. Meningitis causes significant mortality and morbidity in HIV infected persons. Tu-
berculous meningitis (TBM) accounts for a substantial proportion of cases, particularly in high
tuberculosis (TB) prevalence areas. Due to international rollout programs, access to antiretro-
viral therapy (ART) is increasing globally. Starting ART during TB treatment is associated
with reduced mortality in TB/HIV co-infected patients [1, 28]. However, few studies have
reported the influence of ART on the outcome of patients with HIV-associated TBM [26, 140].
The data of the study was collected at GF Jooste Hospital in Cape Town, South Africa. This
hospital serves a high density low income community. It is a 200-bed public sector referral
hospital that serves adult patients from a community of approximately 1.3 million people.
This predominantly low income, high density population is at the epicenter of the TB/HIV
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pandemic. In some parts of the referral area the reported TB case notification rate exceeds 1500
cases per 100 000 people per year and the HIV seroprevalence at antenatal clinics reaches 30%
[89]. All patients accessing public sector care facilities with suspected meningitis are referred
to GF Jooste Hospital for investigations, including a lumbar puncture (LP). Adult patients
(18+ years) who had a LP performed over a six-month period (1 March 200931 August 2009)
were identified from laboratory logs and included in the study. Definite, probable and possible
TBM were diagnosed according to published case definitions [140].
7.6.2 Statistical analysis, results and discussion
The demographic, clinical and investigative findings for patients with definite, probable and
possible TBM are detailed in Table 7.3. The majority of TBM cases (68%) presented with
advanced TBM disease (Stage 2 or 3). The percentage of patients who were receiving TB
treatment at the time of presentation was 23% (26/115). Median age for definite probable
and possible patients were 35, 36 and 38 respectively. The percentage of females who were
diagnosed as definite was of 47%. The percentage of patients who were HIV positive - of which
41% of them were definite TBM - was 88% (106/120). For HIV status a typical cerebrospinal
fluid (CSF) findings in patients with definite TBM (n = 47) included, a polymorphonuclear
cell predominance (median = 6.50, SE = 9.43 and CI = (12.26, 50.26)), a glucose level with
median 1.59 mmol/L.
The percentage of patients with probable TBM who received corticosteroids was 70%, which
is similar to that of the definite TBM group. The percentage of overall inpatient mortality
amongst patients who were hospitalized (for four days after LP) was 38% (45 out of 120
patients). The percentage of patients (discharged from hospital) who were HIV-infected and
not on ART at time of presentation was 57% (31 out of 54 patients). For those patients who
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Table 7.3: The demographic, clinical and investigative findings for patients with definite,
probable and possible TBM
Definite TBM (n = 47) Probable TBM (n = 35) Possible TBM (n = 38)
Age median SE (CI) 35.00 1.54 (32.98, 39.19) 36.00 2.4 (34.35,44.11) 38.00 1.65 (33.73,40.43)
Female, n/N (%) 22/47 (47) 16/35 (46) 22/38 (58)
HIV status, n/N (%)
Infected 43/47 (91) 27/35 (77) 36/38 (95)
Uninfected 2/47 (4) 5/35 (14) 1/38 (3)
Unknown 2/47 (4) 3/35 (9) 1/38 (3)
CD4+ median SE (CI) 63 10.22 (57.19,98.94) 103.00 21.49 (79.33,168.26) 109 17.12 (91.83,161.43)
On ART , n/N (%) 2 9/41 (22) 6/27 (22) 5/35 (14)
Previous TB, n/N (%) 15/43 (35) 7/34 (21) 12/38 (32)
On TB treatment, n/N (%) 9/43 (21) 8/34 (24) 9/38 (24)
BMRC TBM Disease Grade
Stage1 10/42 (24) 7/34 (21) 16/38 (42)
Stage2 9/42 (69) 23/34 (68) 20/38 (53)
Stage3 3/42 (7) 4/34 (12) 2/38 (5)
Hemoglobin median SE (CI) 10.45 0.36 (10.09, 11.53) 12.0 0.38 (11.13,12.68) 10.000 10 .39 (9.14,10.72)
Wcc 6.00 0.63 (6.04,8.57) 5.60 1.00 (4.95,8.98) 7.65 0.68 (6.77, 9.53)
Sodium (CI) 126.0 0.79 (124.51,127.71) 129.0 1.00 (127.46,131.54) 130.0 1.05 (128.79,133.05)
Protein (CI) 2.60 2.4 (2.50,12.16) 2.41 2.59 (2.3, 12.82) 1.21 0.15 ( 1.19, 1.81)
Glucose (CI) 1.59 .14 ( 1.36, 1.92) 1.87 .20 (1.6, 2.39) 2.66 .17 (2.41,3.09)
Lymphocytes (CI) 77.0 26.39 (93.02, 199.33) 58.50 27.69 (61.78,174.45) 12.00 21.56 (.85, 88.47)
Polymorphonuclear (CI) 6.50 9.43 (12.26, 50.26) 0.0 9.83 (4.5 ,44.50) 0.000 2.86 (.34, 11.95)
initiated ART during the six months of TB treatment at six month follow-up, the percentage
of TBM patients who had died was 48% while 10% were lost to the follow-up process.
Table 7.4 describes the management and outcome in patients with TBM.
Table 7.5 shows factors analysed for association with inpatient mortality for all patients (n=
120) in univariate and multivariate analysis. A higher BMRC TBM disease stage (2 or 3 versus
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Table 7.4: Management and outcome in patients with TBM
Outcome
History of previous TB No 81/115 (70%) yes 34
TB treatment On treatment at time of presentation yes 26/115 (23%) No 89
Corticosteroids started yes 64/113 (57%) No 48
on ART No 81/100(81%) yes 19
ART started 6 months after starting TB treatment Yes 31/54(57%) No 89
Inpatient mortality yes 45/120 (38%) No 75
1) remained predictive of mortality in multivariate analysis.
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Table 7.6 shows factors analysed for association with inpatient mortality for HIV-infected
patients (n= 106) only. In a univariate analysis, CD4 count (p-value=0.0296) and a higher
BMRC TBM disease stage (p-value=0.00952) remained predictive of mortality same as was
with a multivariate analysis.
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Table 7.7 shows factors analysed for association with mortality for all patients (n= 120) in
univariate and multivariate analysis. A higher BMRC TBM disease stage (2 or 3 versus
1) (p-value=0.0417) and protein (p-value=0.00585) remained predictive of mortality in the
multivariate analysis.
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Table 7.8 shows factors analysed for association with mortality for HIV-infected patients (n=
106) only and similar results to Table 7.7 were obtained - in which a higher BMRC TBM
disease stage and protein remained predictive of mortality.
Analysis of factors associated with six-month mortality is reported only for HIV-infected hos-
pital survivors for whom the outcome was known at the six-months follow-up. Patients on
ART at presentation, or having started ART during TB treatment, were negatively associated
with six-month mortality.
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Figure 7.1 is a Cox proportional hazard model showing survival curves of TBM/HIV patients
On/Not ART and it is clear that the survival curves for patients on ART is higher than the
curve for patients did not take or start ART, suggesting that the survival experience is possibly
slightly better for patients on ART.
Figure 7.1: Survival curves for patients on ART and non ART for TBM/HIV dataset
Figure 7.2 is a Cox proportional hazard model showing survival curves of TBM stage for
patients (stage 1, stage 2 and stage 3). As expected the resulting survival curves for stage 1
is higher than the curves for stage 2 and stage 3, suggesting that the survival experience is
better for patients with stage 1.
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Figure 7.2: Survival curves for TBM stages for TBM/HIV dataset
Figure 7.3 is Cox proportional hazard model survival curves of TBM diagnosis as definite,
probable and possible TBM. The survival curve for possible diagnosed subjects is lower than
the curves for definite and probable patients, suggesting that the survival experience is worse
for possible TBM patients.
From figure 7.4 we can see that the survival curve for negative HIV status is higher than the
curve for positive HIV status, confirming that the survival experience for negative HIV status
is better for positive status.
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Figure 7.3: Survival curves for TBM diagnosis for TBM/HIV dataset
We are interested in investigating which variables are important and should be used to obtain
better AUC. We used time dependent AUC estimation with penalized LASSO-Cox regression
for variable selection. The use of the penalty LASSO-Cox regression model appears to be
the best approach as it balances between prediction and interpretation [50]. We used the
cross-validation, 632 and 632+ estimations of the ROC(t) and, the missing data were imputed
according to the nearest neighbor hot deck strategy (see Subsection 4.2.2).
In addition to comparing AUC values from different resampling methods, it is more important
to evaluate the performance of score index or diagnostic tests in each resampling method. Thus
we obtained variances and confidence intervals for AUC estimations. From Table 7.9, CV, 632
and 632+ estimators obtained significant diagnostic test - which means that the index scores
have an ability to discriminate between the TBM/HIV subjects who are likely to die before
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Figure 7.4: Survival curves for HIV status for TBM/HIV dataset
the first 6 months and those who may still alive beyond that time.
In Table 7.9, all the estimation methods yielded similar AUC values. The smallest among
them is that estimated using the BCV method and the 632+, with respective values 0.846 and
0.849. The highest value was from the apparent method followed by the 632. The standard
error was the smallest under the 632 resampling method. The BCV and apparent method
yielded similar SEs and it was highest under the 632+ method.
We estimated the 632+ AUC(t) as 0.85 for a prognosis up to 6 months. Thus a patient who
will die before 6 months has a 85% chance of having a score higher than a patient who will
be alive at this time. The AUC estimates from all methods are high which confirms the
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Table 7.9: AUC values from different resampling methods for composite biomarker from
TBM/HIV dataset
Methods AUC SE Lower-limit Upper-limit
apparent 0.858 0.076 0.709 0.998
BCV 0.846 0.075 0.774 0.993
632 0.850 0.069 0.715 0.985
632+ 0.849 0.087 0.678 0.997
discriminatory capacity between patients who will die before six months and those who are
alive after that time according to confidence intervals. The resulting p-values were strongly
statistically significant and suggested that they all agree that the prognostic score has a high
discriminatory capacity.
We propose the use of Ridge-Cox regression model to estimate the AUC as a competing method
to LASSO-Cox regression. Both the LASSO (L1) and Ridge (L2) penalized estimation meth-
ods shrink the estimates of the regression coefficients towards zero relative to the maximum
likelihood estimates [138]. The purpose of this shrinkage is to prevent over-fitting that arise
from either collinearity of the covariates or high-dimensionality. Although both methods are
shrinkage based methods, the effects of L1 and L2 penalization are quite different in practice.
Applying an L2 penalty tends to result in all small but non-zero regression coefficients, whereas
applying an L1 penalty tends to result in many regression coefficients shrunk exactly to zero
and a few other regression coefficients with comparatively little shrinkage.
The results are presented in Table 7.10, the AUCs obtained from LASSO using the 632+
estimator were 0.658 and 0.630 in 9 months and the first year respectively. The area decreased
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Figure 7.5: Observed values of multivariate signature for TBM/HIV dataset
Table 7.10: AUC estimations using LASSO and ridge methods for TBM/HIV dataset in dif-
ferent time points
method time BCV 632 632+
LASSO 270 days 0.653 0.661 0.658
365 days 0.610 0.637 0.630
Ridge 270 days 0.744 0.777 0.769
365 days 0.735 0.772 0.760
with prognostic time, illustrating that long-term failures are often more difficult to predict.
This illustrates the utility of this signature to predict mortality over different times; however
it explains that these signatures alone are not sufficient for medical decision making.
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From Table 7.10, it is clear that our proposed estimator using ridge-Cox regression model
resulted in higher AUC estimates. As for LASSO-Cox method the 632+ estimators in the
first year was 0.630 whereas for ridge-Cox regression it was 0.774, means that the ridge-Cox
regression appeared to be overoptimistic. From Figure 7.6, the over-fitting was high with
an apparent AUC around 0.86 (using the ridge-Cox regression). In contrast, the prognostic
capacity appeared to be underestimated when using the BCV estimator. The 632+ estimations
were less optimistic than the 632 estimations.
Figure 7.6: AUC according to the prognostic times and the different estimators using the
ridge-Cox model regression for TBM/HIV dataset
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7.7. Conclusion
In this chapter we used the LASSO method variable selection method in order to estimate
AUC(t). The LASSO uses a penalty like ridge regression, except the penalty is the L1 norm of
the coefficient vector, which causes the estimates of some coefficients to be exactly zero. This
is in contrast to ridge regression which never sets coefficients to zero. The fact that the LASSO
sets coefficients to zero can be a big advantage for the sake of interpretation - unlike ridge which
tend to give higher values of AUC(t) but is difficult in terms of interpretation. It is mentioned
in [50] that the use of the penalized LASSO-Cox regression appears to be the best approach
as it balances between prediction and interpretation. However our proposed method of using
ridge-Cox regression models appeared to perform similarly to LASSO-Cox regression in terms
of AUC(t) estimations. Our simulations showed that two level bootstrap methods performed
better with the 632 estimator in terms of confidence intervals. The application on TBM/HIV
data showed that CD4 and TBM could significantly predict mortality. More specifically CD4
counts could strongly distinguish between patients who may die before six months and those
who may survive thereafter.
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Chapter 8
The role of ambiguous nucleotides as
biomarkers of recent HIV infection
in rural KwaZulu-Natal, South Africa
8.1. Introduction
HIV infection is a global health problem as thousands of people are newly infected every year,
therefore HIV infection has become one of the most common health problems in the world.
However, it is a challenge to determine the difference between a recent infection and a chronic
infection. It is well known that using ART for the management of HIV infected patients has
been associated with reduction in morbidity and mortality. Estimation of the HIV incidence
in populations is important for developing specific prevention strategies. HIV incidence is
classically estimated by prospective cohort studies which are expensive and time consuming.
In recent years, several methods based on viral sequences have been developed to identify re-
cent HIV infection. Importantly, Kouyos et al. [76] showed that the proportion of ambiguous
nucleotides is correlated with the time elapsed between HIV infection and sampling for geno-
typing. In a study in Switzerland, the ambiguous nucleotide method performed well using a
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threshold of 0.5% as the cut off giving a high sensitivity of 86.8%, a reasonably high specificity
of 70% and a high negative predictive value of 98.7%. However, it has yet to be determined
if this method of measuring ambiguous nucleotides within a patient between sampling times
could be used to determine recent infections in South Africa.
The aim of this chapter is to evaluate the use of the proportion of ambiguous base cells in
HIV population sequences as a biomarker for use in an HIV incidence assay. To achieve this,
we used samples from ART-naive study patients from a South African HIV Study. We are
interested in distinguishing HIV recent infection (≤ 36 months) from long-term HIV infection
(> 36 months) using genetic data from a high risk HIV region in the province of KwaZulu-Natal
in South Africa.
We analysed the proportion of ambiguous nucleotides as biomarkers to distinguish between HIV
status. Samples from treatment naive participants from three rounds of an annual population
based HIV surveillance programme in rural KwaZulu-Natal were genotyped for drug resistance.
The sample types included capillary blood microtubes in 2010 and dried blood spots (DBS)
in 2011 and 2012. Using the genetic data available, the proportion of ambiguous nucleotides
was calculated. The receiver operator characteristic analysis (ROC) was used to evaluate the
diagnostic performance of ambiguities and determine the best cut-off values to identify recent
infection. The chi-squared test was used to test for difference in the proportion of participants
with ambiguities between recent and chronic infected patients.
In this chapter, we discuss some methods for evaluation the ambiguities as a biomarker in
Section 8.2. Results and interpretation of results are described in Section 8.3.
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8.2. Methods
8.2.1 Data description
The study [85, 86] used samples collected from a population-based HIV surveillance conducted
in 2011 and 2012 in KwaZulu-Natal, South Africa. The Africa Centre for Health and Population
Studies (Africa Centre) has conducted a longitudinal, population-based HIV surveillance pro-
gramme in the rural district of uMkhanyakude in northern KwaZulu-Natal since 2003. Adult
(15-49 years) HIV prevalence in 2011 was 29% [154] and crude HIV incidence was 2.63 per 100
person years. There has been rapid expansion of ART coverage in the area since 2004 with
an estimated 37% of all HIV-infected adults on ART in July 2011 [136]. HIV treatment and
care is delivered through a decentralized primary health care programme in accordance with
the national Department of Health guidelines. HIV-1 viral load tests were done on all dried
blood spot (DBS) samples that tested positive for HIV-1 during the 2011 and 2012 surveillance
rounds. Only samples from treatment naive participants with viral loads greater than 10,000
RNA copies/ml were genotyped. For participants with more than one sample during the study
period, only the earliest sample was used for analysis because the DBS genotyping protocol
has low amplification rates at viral loads < 10, 000 RNA copies/ml. The HIV-1 RNA was
extracted using an automated platform the NucliSense EasyMag - BioMerieux with an elution
volume of 50ml for the viral load determination. The same RNA extract was used for HIV-
1 drug resistance genotyping within six hours of extraction. Previously published sequences
from 2010 were also used in this analysis. The previously described SATuRN/Life Technologies
genotyping system was used for the genotyping [85, 86]. Briefly, the extracted RNA was re-
verse transcribed using the Superscript III first strand synthesis kit (Life Technologies, Foster
City, CA) followed by nested PCR using Platinum Taq polymerase (Life Technologies, Foster
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City, CA). Successful PCR amplification was assessed using 1% agarose gel (Bioline, Taunton,
Massachusetts) electrophoresis run at a 100V and 400mA for 40 minutes. The PCR products
were cleaned up using the PureLink QUICK PCR Purification Kit (Life Technologies, Foster
City, CA) and sequenced using the Big Dye Terminator kit ver3.1 (Life Technologies, Foster,
City) and a set of four bidirectional primers. Capillary sequencing electrophoresis was done on
3130Xl Genetic Analyser (Life Technologies, Foster, CA). The sequences covering all the 99
protease codons and the first 300 reverse transcriptase codons were assembled using Geneious
Pro genetic analyser [34]. The quality of the sequences was assessed using the HIV-1 Quality
Analysis Tool [4] and the Calibrated Population Resistance (CPR) tool [54]. HIV-1 subtyping
was performed using the REGA HIV-1 Subtyping Tool ver 3.0 [102]. Phylogenetics was used
to rule out contamination among the samples.
The following table shows the encoding for the four bases (A, C, T, G) and for ambiguous
positions in the DNA sequence.
A adenosine C cytidine G guanine
T thymidine N A/G/C/T (any) U uridine
K G/T (keto) S G/C (strong) Y T/C (pyrimidine)
M A/C (amino) W A/T (weak) R G/A (purine)
B G/T/C D G/A/T H A/C/T
V G/C/A
With the above, every patient has a sequence of nucleotides, which is either A, C, T or G and
ambiguities, which is either W, S, M, K, R, Y, B, D, H, V or N. Thus there was a need to
count all the (A,C,T,G) sequences in the DNA sequences and the ambiguities. We compiled a
special program in JAVA for this purpose.
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The estimated date of infection was calculated as the midpoint between the last negative test
date and the first positive test date. The duration of infection (months) was determined by
calculating the time between the estimated date of infection and sample date. Participants
with a duration of infection up to 36 months were classified as recent infections and non-recent
otherwise.
8.2.2 Statistical methods
Our main goal is to evaluate the usefulness of the proportion sequences of ambiguities as a
biomarker to predict recent infected patients. For this purpose the generalised linear model
(GLM) function in the R software with infection status, recent versus chronic as the outcome
and ambiguities as an independent variable was used. Both crude and adjusted analyses,
using sex, age, viral load and resistance status were included as covariates, first in a univariate
analysis and then a full multivariate analysis.
The relationship between the proportion of ambiguities (the dependent variable) and the du-
ration of infection was investigated using GLM. We performed a bootstrap analysis with 1,000
replicates to obtain 95% confidence intervals in order to assess the ability to accurately dis-
criminate between the recently and chronically infected patients. The proportions of samples
with any ambiguity were compared in terms of recent and chronically infected patients, using
the Chi-squared test for trend, to see if there was any trend. The trend analysis was confirmed
using logistic regression. The model was fitted using the generalised linear model function us-
ing ambiguity status, having any ambiguity (W, S, M, K, R, Y, B, D, H, V, N) versus having
no ambiguity as the outcome and infection status as the independent variable.
The level of statistical significance was set at 0.05. We sought to identify a cutoff in the pro-
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portion of ambiguous sites to classify a patient’s infection status into recent (infected for ≤ 3
year) or chronic (infected for > 3 year). Optimal cut-off values of the proportion of ambigu-
ous sites were established to distinguish recent from long-term infections. The classification
performance of two categorizations of the proportion of ambiguous sites was evaluated with
receiver operating characteristic (ROC) analyses. Sensitivity, specificity, positive predictive
value (PPV) and AUC were calculated for ambiguities.
8.3. Results and discussion
Table 8.1 summarizes the HIV-1 variables in recent and chronic patients. The median was used
to explain continuous variables, and the fractions were used to explain categorical variables.
The median for age was 24 and 31 in recent and chronic patients respectively.
Most participants were females comprising of 80.6% of the sample. The proportion of females
in long-term infected patients is 84% while the male proportion was only 16%. We also found
that 5% of patients are drug resistant and 34% of all patients have at least one ambiguity. The
proportion of recently infected patients having ambiguities was 28% whereas 63% of chronically
infected patients did not have any ambiguity. We also obtained proportions of recently versus
chronically infected at different times as in Table 8.1. In this table, logvl is the log of viral
load, res is resistance and amb is ambiguity.
Univariate and multivariate analyses were performed to identify significant differences between
recently infected patients and longtime infected patients. The results of these analyses are
shown in Table 8.2.
In univariate analysis the proportion of ambiguities appeared to be significant (p-value = 0.03)
in addition to age and gender. However in multivariate analysis the proportion of ambiguities
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Table 8.1: Summary of the HIV-1 variables in recent and chronic patients
Variables Recent N = 179 Chronic N = 372
Age Min - Max (Median) 16 - 77 (24) 16 - 87 (31)
Gender Male 46/179 26% 61/372 16%
Female 133/179 74% 311/372 84%
Logvl (Median) 5.058 4.991
resistance res 10/179 6% 19/372 5%
non-res 169/179 94% 353/372 95%
ambiguities amb 50/179 28% 139/372 37%
non-amb 129/179 72% 233/372 63%
2010 44/179 25% 23/372 6%
Sampling frame 2011 92/179 51% 252/372 68%
2012 43/179 24% 97/372 26%
was not significant whereas age and gender remained significant.
We calculated the area under the curves for various variables, and the results are shown in
Table 8.3. Standard error and confidence intervals were also calculated using the bootstrap
method.
The p-value obtained from linear regression between the proportion of ambiguous and the
duration time of infection was 0.107. The proportions of samples with any ambiguity were
compared for recent and chronic HIV infected subjects, using the Chi-squared test for trend, to
see if there was any trend in ambiguities. The median value of ambiguous nucleotides fractions
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Table 8.2: Univariate and multivariate analysis for genetic HIV data
Models Variables Estimations SE Z-value P-value
ambiguities 0.431 0.198 2.18 0.0295 *
age 0.063 0.010 6.197 5.76e-10 ***
Univariate analysis sex -0.567 0.221 -2.566 0.0103 *
logvl -0.172 0.161 -1.069 0.285
resistance -0.0947 0.4017 -0.236 0.814
ambiguities 0.2801 0.235 1.192 0.233
age 0.070 0.012 5.844 5.09e-09 ***
Multivariate analysis sex -0.799 0.257 -3.105 0.0019 **
logvl -0.113 0.174 -0.650 0.516
resistance -0.321 0.428 -0.750 0.454
Table 8.3: AUC estimations for some variable in HIV genetic data
Variables AUC SE CI
sex 0.547 0.019 0.510 - 0.585
resistance 0.502 0.011 0.483 - 0.522
ambiguities 0.547 0.021 0.506 - 0.587
age 0.709 0.023 0.662 - 0.755
logvl 0.527 0.041 0.447 - 0.604
for recent and long-term infections were 27.9% and 37.4%, respectively. The trend analysis
was confirmed using logistic regression and the p-value for trend test is 0.029. We found that
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the fraction of ambiguous nucleotides varied between recent and long-term infections, with
the fraction increasing with long-term infections. Then we attempted to find the optimal cut-
off value of the fraction of ambiguous nucleotides to determine the difference between recent
infections and long-term infections. The optimal cut-off value for determination of early HIV-1
infection was 0.5. That is, if the fraction of ambiguous sites from a sequence was not larger
than 0.5, then the sequence was from a recently-infected patient, otherwise the sequence was
from a long-term infected patient. The sensitivity and specificity were 0.374 and 0.721. The
area under the ROC curve (AUC) was 0.547 (95% CI, 0.508− 0.590, p-value = 0.015).
Figure 8.1 is the AUC for the proportion of ambiguities and its confidence interval. The optimal
cut-off is included with its specificity and sensitivity.
Figure 8.1: Ambiguous AUC estimation using optimal cut-off from HIV genetic dataset
Figure 8.2 explains the proportion of ambiguities for individuals which is spread from 0 to
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2.0%.
Figure 8.2: Proportion of ambiguities for individuals from HIV genetic dataset
We also calculated the AUC for combination of the ambiguities and other predictors (e.g. sex
and age) which is equal to 0.719. This indicates that the combination did not give improvement
compared to age alone. In conclusion, the proportion of ambiguous nucleotides may not be a
useful marker to distinguish recent from long-term HIV-1 infections. This new genotypic tool
cannot be used alone and must be interpreted with clinical and serological data. This method
has not performed well in the South African population.
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Chapter 9
Conclusion and future work
Diagnostic tests are important components in modern medical practice. In clinical medicine,
correct diagnosis of disease is of great interest and hence researchers invest considerable time
in developing methods to enhance accurate disease diagnosis. The receiver operating charac-
teristic (ROC) is a commonly used statistical tool for describing the discriminatory accuracy
and performance of a diagnostic test. The area under receiver operating characteristic (AUC)
is a popular summary index of discriminatory accuracy. The first part of this work discussed
the terminology of the receiver operating characteristic curve in classic and time dependent
scenarios. We also introduced missing data and some of the imputation strategies, then we
evaluated many strategies in order to predict disease outcome using simulation studies and
applications to interesting real data sets.
In literature many standard approaches for cross-validation suffer from extensive bias or vari-
ance when the AUC is used as performance measure. In Chapter 5 we recommend the use of
bootstrapping LOOCV for performance estimation, as it avoids many of these problems. The
bootstrapping LOOCV estimator is firstly easy to understand and the interpretation of the
resulting AUC is straightforward and secondly, LOOCV obtained nearly unbiased estimates.
Our proposed methods also involves the variable selection in each bootstrap iteration. It is
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possible that the LDA would give higher AUC estimates (the differences were small), but
logistic regression would presumably be more robust if LDAs distributional assumptions are
violated. The LDA estimator is only valid with a normal distribution data set - although in
practice, the two approaches do usually give similar results.
In addition the LDA estimator is only valid with normal distribution. We demonstrated in
Chapter 5 that the bootstrap LOOCV estimator of ROC using stepwise logistic regression
is useful to estimate the predictive accuracy of prognostic signature. The simulation reveals
that the bootstrap cross-validation method is unbiased and outperforms the cross-validation
method. We also applied the proposed method to predict TB-IRIS in TB patients, which
constitutes an example of an application in medical decision making.
Further extensions of this work will include combining markers measured over time using time
to event outcomes including longitudinal data measurements with censored observations to
add new insight into the problem. It was noted that more simulation studies are required
to investigate other models based on the use of 632 and 632+ resampling methods in order
to further understand and improve the methods. Model choice based on predictive criteria
methods, which can be viewed as minimizing posterior predictive loss [78, 98] may add some
improvements.
In Chapter 6, three imputation methods revealed similar results in the estimation of the time
dependent AUCbcv(t). The difference between AUC estimates obtained using these three im-
putation methods were not statistically significant. This conclusion can also be made with
application to PBC data (Section 6.7). Practically the MCAR assumption is hard to justify
thus we recommend the use of multiple imputation method. We recall that the multiple impu-
tation is based on MAR assumption and allows for the appropriate evaluation of imputation
uncertainty. Cox model revealed AUC(t) estimations similar the true AUC(t) value, where
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logistic regression tends to underestimate the AUC(t).
The introduction of a longitudinal component to the analysis added complexities but will
be a good extension to the current approach. Considering other types of variable selection
methods (for example LASSO) will improve the estimations. In this current work we noted
that LOOCV can be time consuming, thus other types of cross-validation combined with
advanced bootstrapping methods such as 632+ may better improve the results.
In Chapter 7, a retrospective study of Tuberculous Meningitis in a high HIV prevalence setting
at GF Jooste Hospital in Cape Town is used to describe the application of cross-validation,
632 and 632+ bootstrapping. These methods were used together with a penalized Cox model
using LASSO variable selection algorithm to estimate the TBM-IRIS scores. We also proposed
two level bootstrapping techniques to estimate variances; the proposed method was evaluated
through simulation studies. Our simulation results show that the two level bootstrapping
method could easily estimate the variances. This method performed better with the 632
estimator compared to BCV and 632+ estimators in terms of coverage probabilities and the
proportion of times that the lower limit of confident intervals exclude 0.5, for various scenarios.
However this method is time consuming. Our proposed method of using ridge-Cox regression to
estimate AUC(t) obtained similar results to LASSO method, however more simulation studies
are required in order to do an appropriate investigation. The ridge-Cox regression model
with application to TBM/HIV appeared to be overoptimistic in terms of AUC estimations.
Exploring other survival models and alternative AUC estimation approaches will be good
extensions to current work. The application show that the CD4 counts could strongly predict
the TBM-IRIS patients and could distinguish between the patients who will die before 180
days and those who may survive after that time.
In Chapter 8 the suggested methods that could be applied to the problem of distinguishing
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between recent and non-recent HIV infections. We evaluated the use of genotypic tool to
distinguish HIV-1 recent infection from long-term HIV-1 infection in South Africa. We analysed
the proportion of ambiguous nucleotides as a biomarker to distinguish between HIV-1 status.
The aim of the chapter was to test the hypothesis that the method could be used to discriminate
between recent and non-recent infections for HIV. Our findings show that the proportion of
ambiguous nucleotides may not be a useful marker to distinguish recent from long-term HIV-1
infections. This new genotypic tool cannot be used alone and must be interpreted with clinical
and serological data. This method has not performed well in the South African population.
Considering the limitation in our study, more investigations are needed to confirm our findings.
In conclusion, we agree that evaluation of multiple biomarkers adds more complexity to the
analysis. In addition to providing an improved understanding of factors associated with infec-
tion and disease development, combinations of relevant markers is important to diagnose and
treat disease. In disease screening, the combination of multiple biomarkers often substantially
improves the diagnostic accuracy over a single marker. This is particularly true for longi-
tudinal biomarkers and may improve the diagnosis. We discussed many strategies to select
and combine biomarkers in order to address the diagnosis problem. However evaluating these
strategies in longitudinal biomarkers will be an interesting extension.
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[123] H. Skalská and V. Freylich, Web-Bootstrap estimate of area under ROC curve, Austrian
Journal of Statistics, 35(2-3) (2006), 325 - 330.
[124] I. Sohn and C. Sung, Predictive modeling using a somatic mutational profile in ovarian
high grade serous carcinoma, PLoS ONE 8(1) (2013), 540 - 589.
[125] H. H. Song, Analysis of correlated ROC areas in diagnostic testing, Biometrics, 53(1)
(1997), 370 - 382.
[126] K. A. Spackman, Signal detection theory: Valuable tools for evaluating inductive learning,
In: Proc. Sixth Internat. Workshop on Machine Learning. Morgan Kaufman, San Mateo,
CA, 1989, 160 - 163.
[127] S. A. Spector, Mother-to-infant transmission of HIV-1: the placenta fights back, J Clin
Invest. 107(3) (2001), 267 - 269.
203
BIBLIOGRAPHY BIBLIOGRAPHY
[128] K. Strimbu and M.D. Jorge A. Tavel, What are Biomarkers?, HIV AIDS, 5(6) (2010),
463 - 466.
[129] E. A. Stuart, M. Azur, C. E. Frangakis and P. J. Leaf, Practical imputation with large
datasets: A case study of the children’s mental health initiative, American Journal of
Epidemiology, 169(9) (2009), 1133 - 1139.
[130] J. Q. Su and J. S. Liu, Linear combination of multiple diagnostic markers, Journal of
the American Statistical Association, 88(424) (1993), 1350 - 1355.
[131] K. Subsai, S. Kanoksri, C. Siwaporn and L. Helen, Neurological complications in AIDS
patients: the 1-year retrospective study in Chiang Mai University, Thailand, Eur J Neurol,
11(11) (2004), 755 - 759.
[132] J. A. Swet and R. M. Pickett, Evaluation of Diagnostic Systems: Methods from Signal
Detection Theory, Academic Press, New York, 1982.
[133] J. A. Swet, Indices of discrimination or diagnostic accuracy: Their ROCs and implied
models, Pyschological Bulletin, 99(1) (1986), 100 - 117.
[134] J. A. Swet, Measuring the accuracy of diagnostic systems, Science, 240(4857) (1988),
1285 - 1293.
[135] J. A. Swet, R. M. Dawes and J. Monahan, Better decisions through science, Scientific
American, 283(4) (2000), 82 - 87.
[136] F. Tanser, T. Barnighausen, E. Grapsa, J. Zaidi and M. L. Newell, High coverage of ART
associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa,
Science, 339(6122) (2013), 966 - 971.
[137] T. Therneau and P. Grambsch, Modeling Survival Data: Extending the Cox Model,
Springer-Verlag, New York, 2000.
204
BIBLIOGRAPHY BIBLIOGRAPHY
[138] R. Tibishirani, Regression shrinkage and selection via the LASSO, Journal of the Royal
Statistical Society. Series B (Methodological), 58(1) (1996), 267 - 288.
[139] R. Tibshirani, The LASSO method for variable selection in the Cox model, Statistics in
Medicine, 16(4) (1997), 385 - 395.
[140] M. E. Torok, T. T. Chau, P. P. Mai, N. D. Phong, N. T. Dung and et al., Clinical and
microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults,
PLoS One, 3 (2008), e1772, DOI: 10.1371/journal.pone.0001772.
[141] A. N. Tosteson and C. B. Begg A general regression methodology for ROC curve estima-
tion, Medical Decision Making, 8(3) (1988), 204 - 215.
[142] F. F. Tuon, G. C. Mulatti, W. P. Pinto, de Siqueira Franca FO and R. C. Gryschek,
Immune reconstitution inflammatory syndrome associated with disseminated mycobacterial
infection in patients with AIDS, AIDS Patient Care STDS, 21(8) (2007), 527 - 532.
[143] S. van Buuren, H. C. Boshuizen and D. L. Knook, Multiple imputation of missing blood
pressure covariates in survival analysis, Statistics in Medicine, 18(6) (1999), 681 - 694.
[144] S. van Buuren, Multiple imputation of discrete and continuous data by fully conditional
specification, Statistical Methods in Medical Research, 16(3) (2007), 219 - 242.
[145] H. C. van Houwelingen , T. Bruinsma , A. A. Hart, L. J. van’tVeer, L. F. Wessels, Cross-
validated Cox regression on microarray gene expression data, Statistics in Medicine, 25(18)
(2006), 3201 - 3216.
[146] E. S. Venkatraman and C. B. Begg, A distribution free procedure for comparing receiver




[147] E. S. Venkatraman, A permutation test to compare receiver operating characteristic
curves, Biometrics, 56(4) (2000), 1134 - 1138.
[148] J. E. Vidal, S. Cimerman, R. Schiavon Nogueira and et al., Paradoxical reaction during
treatment of tuberculous brain abscess in a patient with AIDS, Rev. Inst. Med. Trop. Sao.
Paulo., 45(3) (2003), 177 - 178.
[149] F. Wang-Clow, M. Lange, N. M. Laird and J. H. Ware, A simulation study of estimators
for rates of change in longitudinal studies with attrition, Statistics in Medicine, 14(3)
(1995), 283 - 297.
[150] S. Wieand, M. H. Gail, B. R. James and K. L. James, A family of nonparametric statistics
for comparing diagnostic markers with paired or unpaired data, Biometrika, 76(3) (1989),
585 - 592.
[151] X. Xue, M. Kim and R. Shore, Cox regression analysis in presence of collinearity: an
application to assessment of health risks associated with occupational radiation exposure
Lifetime Data Analysis, 13(3) (2007), 333 - 350.
[152] W. Yu and T. Park, Two simple algorithms on linear combination of multiple biomark-
ers to maximize partial area under the ROC curve, Computational Statistics and Data
Analysis, 88(1) (2015), 15 - 27.
[153] Z. Yuan and D. Ghosh, Combining multiple biomarker models in logistic regression,
Biometrics 64(2) (2008) 431 - 439.
[154] J. Zaidi, E. Grapsa, F. Tanser, M. L. Newell and T. Barnighausen, Dramatic increase




[155] L. Zhang, Y. D. Zhao and J. D. Tubbs, Inference for semiparametric AUC regression
models with discrete covariates, Journal of Data Science, 9 (2011), 625 - 637.
[156] X. H. Zhou, N. A. Obuchowski and D. K. McClish, Statistical Methods in Diagnostic
Medicine, Wiley, New York, 2002.
[157] K. H. Zou, Receiver operating characteristic (ROC) literature research, Harvard 2002.
207
